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Department of Health, Boston Street One Building, Boston Street, Bellville. 
Determination of the genetically-significant dose from diagnostic radiology 
for the South African population, 1990-1991. 
February 1995 
The International Commission on Radiological Protection (ICRP) determines the policy 
regarding radiation safety internationally. To the ICRP, hereditary changes as a result of 
either high or low doses, are of a major concern. The SA Forum for Radiation Protection 
recommended that a research project to determine the genetically-significant dose (GSD) for 
the South African population should be done as such a project has never been undertaken to 
date. This term was at first defined by UNSCEAR in 1958. The National Radiological 
Protection Board derived a formula from this definition as shown in the NRPB Report, 
NRPB-R106 {1980). This formula was implemented in the project. It combines the 
frequency of radiological examinations obtained during the country-wide survey and 
estimates of gonadal doses for different examination types, together with population and 
child expectancy data . 
New procedures, techniques and data processing that were relevant to this project had to be 
developed because the available information and conditions are unique to South Africa. The 
task was set to find a model in order to draw the best representative sample of the population 
and it was determined in a unique way, namely the so-called Dollar Unit Sampling method. 
A sample of 27 institutions out of a possible 292 (9%) was drawn in comparison, e.g., with 
the 8% of France and 8% in Great Britain. It was necessary to rely mainly on the calculation 
of gonad doses due to a shortage of manpower, contrary to other countries that were able to 
physically measure doses. Information obtained in the survey was used in this regard. The 
"RADCOMP Entrance Skin Exposure Software Program " of Nuclear Associates was used 
to produce parametric Free Air Exposure tables based on doses from Table B.3, NCRP 
Report No. 102. After the skin entrance doses were calculated, it was possible to calculate 
the gonad doses. A computer program was obtained from the Food and Drug Administration 
in the USA for this purpose. Data analysis was performed by means of the software package 
Microsoft Excel version 4.0. 
The above-mentioned formula was used in order to obtain the final results. The GSD for the 
total SA-population was calculated as 94.6 µGy. The breakdown of the GSD for the various 
South African race groups was Asian - 229.0 µGy, Black - 66.5 µGy, Coloured - 112.2 µGy 
and White - 463.4 µGy. 
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Medical irradiation is the largest man-made contributor to the radiation dose received by 
mankind and diagnostic radiology is the most important component of medical irradiation. 
The radiation exposure of the world population has recently been reviewed by the United 
Nations Scientific Committee on the effects of Atomic Radiation (UNSCEAR). According 
to Gonzalez (1993), UNSCEAR revealed in its 1993 report to the UN General Assembly· 
that the collective exposure committed to the world population by a 50-year period of 
operation for continuing practices or by single events ( e.g. nuclear weapon testing) from 
1945 to 1992 (as a percentage) were as follows: 76.58% from natural sources; 10.68% 
from medical diagnostic exposure; 8.83% from radiotherapy; 3.53% from atmospheric 
nuclear weapons tests; 0.24% from nuclear power; 0.07% from severe accidents and 
0.07% from occupational exposures (Gonzalez, 1993). The collective exposure due to 
medical diagnostic examinations could be further subdivided. It was found in the UK 
(Hughes, Shaw and O'Riordan, 1989) that 93% was due to diagnostic X-rays, 6% to nuclear 
medicine and 1% to dental X-rays. 
In South Africa reliable as well as representative information was expected to be obtained in 
a nation-wide survey regarding the determination of the genetically-significant dose (GSD). 
All diagnostic X-ray equipment in the country had already been inspected on various 
occasions since 1973 and recommendations had been made according to international 
standards regarding the safety of X-ray units as well as the relevant technique factors and 
quality assurance procedures. 
The benefits of such a study in the South African context would include: 
(i) A comparison of the contribution of various examinations to the GSD with those of 
other countries (the technique factors required to calculate the GSD, i.e., kV, mA, etc., 
can be compared too). 
(ii) A determination by means of follow-up studies whether the above-mentioned 
contributions are increasing or decreasing ( as well as a change in technique factors). 
(iii) The identification of examinations where special hereditary ( as well as somatic ) 
health risks exist. 
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At the time that the survey was done for this project, 54 per cent of the population lived 
within South Africa's four provinces (Cape Province, Natal, Orange Free State and 
Transvaal) and the remainder in the black ethnic states or Bantu Homelands. Six of these 
states (Gazankulu, KaNgwane, KwaNdebele, KwaZulu, Lebowa and Qwa-Qwa) were 
designated self-governing and the other four (Bophuthatswana, Ciskei, Transkei and Venda) 
were independent. Data from the independent or so-called TBVC States (6.6 million 
people) was excluded from any data referring to the Republic of South Africa and was 
therefore not included in this project (Chief Directorate: Planning Support, 1992). 
Under the old Population Registration Act, the population was classified under four ethnic 
groups, namely Asians, Blacks, Coloureds and Whites. Approximately 75% of the 
population was Black, 13% White, 9% Coloured and 3% Asian (Chief Directorate: 
Planning Support, 1992). The population groupings can be defined as follows: 
(a) Asians - mainly of Indian descent. 
(b) Blacks - descendants of African peoples who migrated in a southerly direction from 
Central Africa. They comprise ten different ethnic groupings: Xhosa, Zulu, Swazi, 
South Ndabele, North Ndabele, N01thern Sotho, Southern Sotho, Tswana, Venda and 
Shangaan. 
( c) Coloureds - people of mixed parentage. Mainly descendants of the indigenous 
Khoikhoi people, the Malay slaves (introduced to the Cape by the Dutch East India 
Company) and the White settlers. 
( d) Whites - descendants of the European settlers, mainly Dutch, British, German, French, 
Portuguese, Greek, Italian and Jewish. 
Under the previous government South Africa was therefore in the unique position that 
information was available to calculate the GSD for four different race groups. 
The possible adverse genetic effects of exposure of the human population to low doses of 
ionising radiation regarding the population of the future, are discussed in Chapter 2. This 
might occur if deleterious mutations ( change in the structure of DNA) to the gametes were 
caused by the radiation exposure of people and was put in the gene pool, i.e. transmitted to 
the descendants. 
This study is primarily concerned with doses to the reproductive cells due to medical X-ray 
examinations. These doses will make no contribution to genetic effects in subsequent 
generations when received after completion of a person's reproductive cycle. The 
"genetically-significant dose" (GSD) is therefore obtained by multiplying the estimated 
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doses of the individuals with a weighting factor, namely the child expectancy of the patient. 
Doses thus obtained for different countries vary by a factor of almost ten. The GSD is a 
prime index of risk to the descendants of a population from diagnostic radiology and the 
definition as well as the assumptions and considerations that it is based on, are discussed in 
detail. 
During the early days of radiological experience, there was no precise unit of radiation 
measurement that was suitable either for radiation protection or for radiation therapy. 
When X-rays interact with matter, energy is absorbed mainly by the process of ionisation 
and this principle provides a very good method for radiation measurement. It is a feature of 
ionisation radiation that the energy absorption in the body and its distribution in specific 
organs and tissues can be determined either by measurement or calculation. Various units 
and quantities that are applicable to this project, are reviewed in Chapter 3. 
X-rays were used medically almost immediately after their discovery in 1895 for a 
multitude of purposes that involved some necessity for visualising the interior of the human 
body. Biological harmful effects of X-rays were already noted in 1896 in some of the early 
X-ray workers. According to Mould (1980), Edison for example reported in March 1896 
that his eyes were sore after experimenting with X-rays and radiation bums to hands were 
reported by Stevens on 18 April 1896. The Rontgen Society (Mould, 1980) appointed a 
committee in April 1898 to collect data on the harmful effect of X-rays. Aspects 
investigated by this committee included nature of injurious effect, duration of effect, nature 
of radiographic investigation, condition of subject, type of apparatus used, distance of 
patient from the tube, number and duration of each exposure. This could be perhaps 
considered as a first step in the direction of the radiation protection programs that followed 
later. 
Albers-Schonberg was the first person to realise that there was a possibility of an adverse 
effect of ionising radiation on biological reproductive systems when he discovered in 1903 
that X-rays were capable of sterilising guinea pigs without any other obvious change in the 
well-being of the animals (Albers-Schonberg, 1903). In spite of these early discoveries of 
deleterious effects the idea of setting up "safe" exposures for radiation workers was only 
developed in the 1920's. The biological effects and radiation protection standards are 
discussed in Chapter 4. 
The International Commission on Radiological Protection (ICRP) determines the policy 
regarding radiation safety internationally. Although no hereditary abnormalities have been 
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observed in human beings, hereditary changes as a result of either high or low doses are of a 
major concern to the ICRP (ICRP, 1982). This does not implicate that somatic changes are 
of minor concern (it is not dealt with in this project, however). The South African Forum 
for Radiation Protection thus recommended that a research project to determine the 
genetically-significant dose (GSD) from diagnostic radiology for the South African 
population should be carried out. Due to the limited available manpower and budgetary 
constraints it was recommended that it should be mainly a theoretical study. 
The genetically-significant dose is an index of the presumed genetic impact of radiation 
exposure on the whole population. This quantity, with particular reference to medical 
diagnostic radiology, has been determined in various countries. The main details of survey 
methods in sixteen countries and some large districts, between 1958 and 1986, are presented 
in Chapter 5. 
New procedures, techniques and data processing that were relevant to the current project 
had to be developed because the available information and conditions are unique to South 
Africa. The task was set to find a model in order to draw the best representative sample of 
the population who had undergone X-ray examinations. It was decided to make use of the 
so-called Dollar Unit Sampling (DUS) method since it appeared to provide definite 
advantages above other sampling methods. A sample of 27 institutions out of a possible 
292 (9%) was thus drawn which represented 25.8% of all examinations per week. 
Survey forms were designed for distribution to the various institutions that finally agreed to 
participate. Distribution of the forms started in July 1990. The survey was done during one 
week of the second semester of 1990 or the first semester of 1991 for all X-ray units at a 
specific institution. Data was requested for 96 diagnostic examinations of which 30 were 
chosen for inclusion in the calculation of the GSD. These 30 were considered as most 
likely to make an appreciable contribution to the gonad doses on the basis of the number of 
exposures associated with an examination and the gonad dose associated with each 
exposure. 
The "RADCOMP Entrance Skin Exposure Software Program" of Nuclear Associates was 
used to produce parametric free air exposure (FAE) tables (Nuclear Associates and 
Zamenhof, 1990) that were applied to determine skin entrance doses. A computer program 
was obtained from the FDA, US Department of Health and Human Services, in the USA 
(Peterson and Rosenstein, 1989) m order to calculate the gonad doses 
(Table 8.6). 
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The nwnber of examinations, N kb in the various age-gender-race groups (k) that underwent 
an examination of type f was obtained from the database and the population data (Figures 
8.1 and 8.2) was obtained from the Central Statistical Service (Population Census 1991, 
1992). Child expectancy for people in different age groups was obtained by means of the 
total fertility nwnbers for the different races and of the data of Darby et al., (1980). These 
quantities, namely the gonad doses, the N kt values, child expectancies and the population 
data were used in Chapter 9 to calculate the GSD for the various groups. 
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Chapter 2 
THE CONCEPT OF GENETICALLY-SIGNIFICANT DOSE 
A possible consequence of exposure of the human population to low doses of ionising 
radiation is an adverse effect on the population of the future. This might occur if 
deleterious mutations (change in the structure of DNA) to the gametes were caused by the 
radiation exposure of people and was put in the gene pool, i.e. transmitted to the 
descendants. This study is primarily concerned with doses to the reproductive cells due to 
medical X-ray examinations. These doses will make no contribution to genetic effects in 
subsequent generations when received after completion of a person's reproductive cycle. 
The "genetically-significant dose" is therefore obtained by multiplying the estimated doses 
of the individuals with a weighting factor, namely the child expectancy of the patient. 
Doses thus obtained for different countries vary by a factor of almost ten. 
2.1 The genetic effects of radiation 
The substance, DNA ( deoxyribonucleic acid), cames within its structure the 
hereditary information that determines the structure of proteins. The instructions that 
direct cells to grow and divide are encoded by DNA as well as the messages that 
cause the differentiation of fertilised ova into many specialised cells that are 
necessary for the successful functioning of higher plants and animals. Heredity is 
transmitted through ovum and sperm. 
2.1.1 Basic genetic terms and principles 
In all cells, excluding bacteria, the inner cellular mass is partitioned into a 
membrane-bound, spherical body, the nucleus, and an outer surrounding, namely the 
cytoplasm. The DNA is located in the nucleus in the form of coiled rods known as 
chromosomes. All the information that specifies a particular human being with his or 
her individual characteristics are carried in code form by the chromosomes. 
The fundamental unit of DNA is at present considered to be two intertwined 
polynucleotide chains, i.e. a multichained molecule or a double helix. Sugar-
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phosphate backbones are on the outside of the DNA molecules and the purine and 
pyrimidine bases are on the inside, oriented in such a way that they can form 
hydrogen bonds to bases on opposing chains, i.e. a purine on one chain is always 
hydrogen-bonded to a pyrimidine on the other chain. This implies that the area 
occupied by the paired bases would always be the same throughout the length of the 
DNA molecule, therefore it is a very regular-appearing structure despite the irregular 
sequence of bases on any one chain.· Further, the two purines, adenine and guanine, 
do not unselectively bond to the two pyrimidines, thymine and cytosine. Adenine 
(A) can pair only with thymine (T) and guanine (G) can bond only with cytosine (C). 
Each of these pairs possesses a symmetry that permits it to be inserted into the 
double helix in two ways, namely A-T and T-A as well as G-C and C-G (Figure 
2.1); thus along any given DNA chain, all four bases can exist in all possible 
permutations of sequence (Watson et al., 1992). 
H H 
H \ / 
Hydrogen 
bond -c 
\ 0 ... / /H 
Thymine C - C/ ... ··············· .. H - N Adenine 
H......_C/ \ \ /N' H c_c ~c/ 
\ N -H ····· / ~ N C / ···············N1 \_ / 






Cytosine / H··················· 
C -c ··· o Guanine 
H......_C/ \ \ /N' H 
C-c ~c/ 
\N C/N..... H-/ \ / 




Figure 2.1 Bonding between the adenine-thymine and guanine-cytosine base pairs. 
The gene is a finite segment of DNA specified by an exact sequence of bases, i.e. the 
portion of DNA transcribed to ultimately result in the synthesis of a protein is known 
as a gene. Genes occur along chromosomes in linear order like beads on a string, 
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and the position of a gene is referred to as its locus. In the case of humans, every 
normal cell has 46 chromosomes where 23 were derived from the mother and 23 
from the father. Each chromosome of a pair usually has the same genes for given 
characteristics, is lined up in the same sequence and it is said to be homologous. The 
pair of chromosomes that determine the gender are XX in the female and XY in the 
male. The two chromosomes for the male do not contain parallel genes and are said 
to be heterologous. Some genes, dominant genes, express themselves when they are 
present in only one copy, whereas other genes, recessive genes, require two copies 
for expression. 
An example to illustrate this is that the gene for blue eyes is recessive, while that for 
brown eyes is dominant. The Y sex chromosome in humans appears to have a few 
other genes except for those that determine maleness. The X chromosome, however, 
has many genes. If a mother carries a recessive mutant (see next paragraph) gene on 
the single X chromosome that she donates to her son, there will be no matching gene 
from the father, and consequently the recessive gene will be expressed. If the 
descendant is a daughter, there may well be a dominant gene on the X chromosome 
supplied by the father, which would suppress the expression of the recessive mutant. 
The daughter could transmit the mutant gene to her sons, in whom it would be 
expressed. The characteristics that are due to recessive genes on the X chromosome, 
so that they are expressed almost exclusively in male children, are said to be sex-
linked. The most common examples are colour blindness and hemophilia. Most 
characteristics are, however, the result of an interplay in the expression of many 
genes. 
Radiation does not result in genetic effects that are new but only increases the frequencies 
of the same mutations that already occur spontaneously or naturally in that species. 
Radiation-induced genetic changes, like mutations caused by any other agent, may be a 
consequence of a gene mutation or chromosomal changes. 
2.1.2 Gene mutations 
A gene mutation is a change in the structure of DNA. This may involve either the 
base composition, the sequence, or both. An alteration even so small that it involves 
the substitution, gain, or loss of a single base can be the cause of significant 
inheritable changes. Because they usually are small and do not involve large 
segments of the genome, they are known as point mutations. A very good example is 
sickle cell anaemia, which results from the substitution of only one base and where a 
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dominant gene mutation is expressed in the first generation after its occurrence. A 
large number, namely 736, such conditions have been identified with certainty, and 
an additional 753 are less well established. Examples in this regard are polydactyly, 
Huntington's chorea and retinoblastoma (Hall, 1988). 
Recessive mutations, unless sex-linked, require that the gene be present in duplicate 
to produce the trait, i.e. the mutant gene must be inherited from each parent; thus it 
could be expressed for the first time after many generations. Five hundred and 
twenty one recessive diseases are known and another 596 are suspected. Examples 
of this are sickle cell anaemia, cystic fibrosis, and Tay-Sachs disease (Hall, 1988). 
The best known examples of sex-linked disorders are hemophilia, colour blindness, 
and a severe form of muscular dystrophy. Altogether there are 80 well established 
and 60 probable conditions of this sort (Hall, 1988). Males have only one X 
chromosome and a sex-linked recessive mutation can thus be expressed if only a 
single gene complement is present. 
The possible adverse effect on the population of the future from low doses of 
ionising radiation, has occupied the thought and concern of many people. These 
adverse effects could occur if radiation exposure of people living now causes 
significant numbers of deleterious mutations in their gametes and those mutations 
were put in the gamete pool, i.e. transmitted to descendant generations. A possible 
consequence, therefore, of the use of ionising radiation to benefit people living today 
might be an injury to people yet to be born - and a shortening of the average life 
expectancy of future populations. The use of ionising radiation is widespread, at 
least in the so-called "developed nations" of the world, and is thus considered as a 
problem of considerable potential importance. 
Exposure to ionising radiation increases the mutation frequency. It must be stressed 
that radiogenic mutations are not unique and do not differ from those that occur 
spontaneously. Mutations enter the gene pool spontaneously at low rates. For 
humans this number is in the region of l0-5/gene/generation, i.e. in a human 
generation (about 30 years) the chance that any given gene will mutate is about 1 in 
100000. There are, however, many thousands of genes in every cell and many cells 
in every body, so the chance of a few mutations occurring within a generation is 
good. The rate of entry and elimination are, in undisturbed populations, about equal 
(in equilibrium). The equilibrium therefore implies that more or less a constant but 
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small fraction of the pool being mutant. This fraction is called the population's or 
gene pool's mutation burden or load. 
The increase in mutation frequency resulting from diagnostic radiation procedures is 
estimated to be approximately l0-7/gene/cGy for human beings (Pizzarello & 
Witcofski, 1982). Gonadal exposure of one cGy would then increase the mutation 
frequency with an extremely small fraction of the spontaneous mutation frequency, 
i.e. by 1% or a relative risk of 0.01. 
The following aspects need special reference, however. 
(a) Mutations per cGy. The above-mentioned estimation of l0-7/gene/cGy implies 
that a GSD of 94.6 µGy (the overall South African value, this work) will result in 
an extremely small mutation induction frequency. It is true, however, that the 
actual increase in mutation frequency from such GSD's remains uncertain because 
there are a number of unanswered or unsatisfactorily answered questions about 
the relationship between radiation dose and mutation frequency. An ad hoc 
committee of the National Academy of Sciences reported in 1974 that a wide 
variety of biologic end points, including mutation, studied over an extensive dose 
range, showed a linear-quadratic relationship (Figure 2.2). 
·················································· 
Dose 
~-- Quadratic portion 
······················· ... 
Figure 2.2 The relationship between mutation frequency and radiation dose. 
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The important factor, however, from the point of view of the population, is not 
necessarily how much the mutation frequency is increased by the GSD, but that it 
is low and not increasing continuously. 
(b) Doubling dose. The 1980 BEIR Report gave a doubling dose for mutations as 50 
to 250 cGy (National Research Council-BEIR III, 1980). A later report, based on 
an analysis of the survivors of the atomic explosions at Hiroshima and Nagasaki, 
suggested that the doubling dose should be at the upper end of the above-
mentioned scale and fixed at 156 cGy for acute exposures (Schull, Otake and 
Neel, 1981). 
( c) Dose rate. Differences in the frequency of the mutations are observed when the 
rate at which radiation is delivered, is altered. The increase in mutation 
frequency is affected to a degree by the stage of the germ cell maturation at which 
irradiation occurs. It appears, however, that the lower the rate of radiation, the 
less the increase in mutation frequency for a specific dose. These results were 
obtained from animal experiments. 
It has been postulated that mutation is at least a two-step process and that all steps 
in the process must occur before a true mutation exists. The first of these steps, 
"premutational" change or damage, is supposed to be reversible or reparable. If 
more steps follow this phase before the change is either reversed or repaired, a 
mutation will occur. During irradiation at low doses, all the premutational 
changes can be repaired or reversed so that no mutation will occur. Increasing 
dose rate will result in events taking place so closely that no reversal or reparation 
will occur. Larger numbers of mutations, per unit dose, will therefore be 
produced at high rather than at low dose rates. 
Low-LET radiation have a smaller expectation of bringing about several changes 
within a given molecule than high-LET radiation. For low doses, low-LET 
radiation may produce a relatively large number of premutational changes in most 
nuclei. Only a few mutations will be produced if the changes are reversible. At 
higher doses, the probability that several ionisations will occur in a given 
molecule is high since the number of low-LET radiations to which cell nuclei are 
exposed, is larger. Low-LET radiation, therefore, have a good chance of 
producing premutational as well as any additional events that must take place for 
subsequent mutations. 
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( d) Time. In order to minimise the transmission of mutations into the gene pool, it 
has been suggested that after testicular inadiation men wait about three months 
before attempting conception. It can be explained as follows. Germ cells in the 
late stages of maturation, spermatids and spermatozoa, have about twice the 
probability of mutation induction as do earlier, less mature forms (National 
Research Council-BEIR III, 1980 and Searle, 1974), but they are quite resistant to 
being killed by ionising radiation (Pizzarello & Witcofski, 1982). The chances of 
males transmitting mutations is thus the highest directly after gonadal inadiatiort. 
The immature, premeiotic forms (spermatogonia) are radiosensitive, but those 
swviving radiation are less susceptible to mutation induction than mature forms. 
Sperm appearing after about three months are produced from immature 
premeiotic fo1ms which have survived radiation, and will have relatively low 
mutation content. 
No data is available directly from inadiated women regarding the probability of 
inducing mutation in ova. Experiments with mice showed that no mutations were 
transmitted when conception was delayed two months or longer following 
inadiation (National Research Council-BEIR III, 1980 and Searle, 1974). It is 
uncertain, however, whether the mouse data can be extrapolated to humans. 
(e) Cancer. The induction of cancer from ionising radiation was always considered 
as a stochastic effect, i.e. the probability of occurrence depends on the dose 
received. It was generally agreed that any dose, no matter how small, carries 
some risk without any threshold. 
The contemporruy VIew of cancer is that a malignancy originates from the 
transf01mation of the genetic material of a normal cell, followed by successive 
mutations, ultimately leading to uncontrolled proliferation of progeny cells. 
Despite the large amount of data that is available, it is still unknown how many 
mutations are required for the pathogenesis of a specific tumour. There is, 
however, no evidence at this stage that gene mutations in germ cells lead to 
cancer in future generations. 
The work that was done by Renan (1993) in this regard, is veiy significant. He 
used as a starting point the mathematical models based on the work of Nordling 
and of Armitage and Doll. The models are in essence the same and they are 
represented by the function 
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11.(a) = kam-l (equ. 2.1) 
where A( a) represents the age-specific incidence rate and a the age of an 
individual. The constant, k, represents the product of the probabilities of each of 
m somatic alterations in the DNA of the progenitor tumour cell. A malignancy 
appears as a clinical entity only after the requisite set of m sequential alterations 
has occurred in the cell (Nordling, 1953; Armitage and Doll, 1954). 
The model provides a useful framework and has met with some success. 
Armitage and Doll obtained a reasonably good straight line in a plot of the log of 
death rate vs. the log of age. Regression coefficients varied between 4.97 and 
6.48 for the various examinations (Armitage and Doll, 1954). The statistics 
available at that time were not sufficiently reliable, however, for a detailed 
analysis. The mortality rates for individuals with age less than 25 could not be 
analysed at all, and the contributions of sub-populations with different 
predispositions were not considered. 
Renan addressed some of the deficiencies in this work. He used a much more 
extensive database, namely the Atlas of Cancer Mortality for US Counties: 1950-
1969 (Mason et al., 1975). Statistics for 28 different tumour types were analysed 
in detail. This database made it possible to consider the contributions of different 
sub-populations. The log of the age-specific mortality rate (per 100,000 of the 
population) against the log of age in years were plotted for 28 different 
malignancies. Best-fit linear regression coefficients were determined from these 
figures for each tumour type (Renan, 1993). 
The results indicated that approximately 8 mutations are required for a cell to 
become malignant with the actual values for the various sites of the primary 
cancers varying between 3 and 12 (Renan, 1993). X-rays from diagnostic X-ray 
examinations can cause mutations, so that it is theoretically possible that if there 
are already 7 mutations present, the radiation dose could lead to the 8th mutation 
and consequently to a malignancy. The development of the malignancy may also 
depend on the number of cells with the 7 mutations that might undergo further 
mutation. The higher the dose, therefore, the greater the probability that a 
particular mutation can be induced in more than one cell and thus the possibility 
of cancer induction . 
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2.1.3 Chromosome aberrations 
Cells may contain too many or too few chromosomes in individuals. Mongolism, for 
example, results from an extra chromosome. An incorrect chromosome number, 
either a deficiency or an excess, results mostly in embryonic death. It is estimated 
that at least 40% of spontaneous abortions that occur from the fifth to the twenty-
eighth week of pregnancy and about 6% of stillbirths are associated with 
chromosomal anomalies (Hall, 1988). This kind of chromosome error is believed not 
to be strongly influenced by radiation, particularly at low doses. Chromosome 
breakage appears less frequently than aberrations among spontaneous instances of 
severe human anomalies, but radiation is much more effective at breaking 
chromosomes than in causing errors in chromosome distribution. 
Chromosomes that are broken may rejoin in various ways. A translocation involves 
the reciprocal exchange of parts between two or more chromosomes and is not 
necessarily harmful so long as both rearranged chromosomes are present and contain 
the full gene complement. Children of a person with a translocation often receive 
only one of the rearranged chromosomes, and their cells are therefore genetically 
unbalanced. The harm to the individual ranges from rather mild to very severe, 
depending on the extent of the abnormality. If the chromosome imbalance does not 
cause the death of the embryo, it typically leads to physically abnormalities and is 
usually accompanied by mental deficiency. 
2.1.4 Genetically-significant dose 
It is only the fraction of medically-given doses of radiation absorbed in gonads of 
people who subsequently reproduce, that will have genetic impact or significance. 
Gonads receive probably some radiation during every medical procedure - either in 
or outside the collimated beam. The genetically-significant dose (see definition in 
paragraph 2.2) will only be a fraction of the total dose and would be absorbed in the 
gonads of persons who produce children. Only mutations produced in gametes 
which are placed in the gene pool, are of significance to the population of the future. 
If the gonad dose in persons with childbearing expectancy is continuously increasing, 
it is reasonable to assume that mutation frequency and mutation load may also be 
increasing. It must be kept in mind too that the genetically-significant dose is an 
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index of the presumed genetic impact of medical radiation on the whole population. 
It is not applicable to any individual or to his or her unborn children. 
The gene pool consists of all the genes placed in it by any generation. Therefore, a 
situation may exist where some people put many mutations in the pool and others 
only a few. It has the same effect on the population or pool in the situation in which 
everyone contributing to the pool puts in an equal number. This concept is used in 
determining the GSD. 
The GSD measures genetic impact of medical irradiation, but it does not measure or 
estimate the actual increase in mutation frequency as a result of the GSD. The GSD's 
that have been determined are small and, presumably, increase mutation frequency 
by only a small amount, but the actual increases are unknown. 
2.2 Definition of the genetically-significant dose 
The genetically-significant dose (GSD) is defined as "the dose which, if received by 
every member of the population, would be expected to produce the same total genetic 
injury to the population as do the actual doses received by the various individuals" 
(UNSCEAR 1972). This annual dose is the weighted population dose commitment 
from a year of radiological practice. 
This definition is based on the following assumptions and considerations: 
2.2.1 The relevant tissue dose is that accumulated by the gonads; 
2.2.2 The dose-effect relationship is linear without threshold; 
2.2.3 The rate of delivery of radiation can be neglected; 
2.2.4 Differences in sensitivity of the gamete with age and sex are ignored. 
(UNSCEAR 1972) 
The following mathematical expression has been derived for the GSD: 
IINktpktDkt 





where N kt is the number of individuals in the kth age-sex-race group who underwent an 
examination of type f during the year in question; 
Pkt is the child expectancy of an individual in the kth age-sex-race group who 
underwent an examination of type f; 
Dkf is the mean gonadal dose received by an individual in the kth age-sex-race group 
from an examination of type f; 
N k is the number of individuals in the kth age-sex-race group in the population; · 
and Pk is the child expectancy of an individual in the kth age-sex-race group. 
(Darby et al., 1980) 
The child expectancy of an individual will generally not be independent of the type 
of examination. Ce11ain types of examinations, for example, will be carried out only 
on individuals who are thought to have diseases which reduce fertility. In practice 
the determination of Pkt will present great difficulties, however, and approximations 
have to be applied. A great variation could be obtained for Pkb since it would be 
seriously effected by the condition of the patients in the above-mentioned cases. It 
must be assumed therefore that Pkt= Pk (Darby et al., 1980). 
An individual may undergo an examination of type f more than once a year. If the 
repeat had to be conducted on a different patient, its contribution to the total genetic 
injury would have been the same. Such an examination is therefore to be considered 
as an examination on an additional individual in the N krgroup. 
2.3 Comments on the definition 
One of the assumptions on which the definition is based, states that "the dose-effect 
relationship is linear without threshold". This assumption therefore implies that the 
term "significant" in the definition of the GSD refers to any value bigger than zero, 
although according to A Dictionary of Statistical Terms an effect is said to be 
significant if the value of the statistic used to test it lies outside acceptable limits. A 
test of significance is one which, by use of a test statistic, endeavours to provide a 
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test of the hypothesis that the effect is absent (Kendall & Buckland, 1971 ). The term 
"significant" could therefore be considered as not relevant in the definition of the 
GSD. Since the definition refers to the dose that is accumulated by the gonads, 
multiplied by a weighting factor (the child expectancy), an appropriate heading for 
this definition could be the "weighted gonad dose" or "genetically-weighted gonad 
dose" or just "genetically-weighted dose. 
The word "significant" in this expression is, however, not used in the strict statistical 
sense but rather, as in the more common dictionary definition, as a synonym for 
"relevant" or "signifying". It is the gonad dose weighted in such a way as to make it 
relevant for predicting the likely genetic injury to future generations. 
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Chapter 3 
RADIATION QUANTITIES AND UNITS 
3 .1 The history of X-rays and radiation units 
W.C. Rontgen, a professor in Physics at the University of Wurzburg, found in 1895 
that some photographic plates, kept carefully wrapped in his laboratory, had become 
fogged. Instead of merely throwing them aside, he set out to find the cause of the 
fogging. He traced it to a gas-discharge tube that he was using with a low pressure 
and high voltage. This tube appeared to emit radiation that could penetrate paper, 
wood, glass, rubber, and even aluminium a centimetre and a half thick. Rontgen 
could not find out whether the radiation was a stream of particles or a train of waves 
- Newton had the same problem with light - and he decided to call it X-rays. Within 
a month of his paper describing the new rays, a radiograph of a weld had been 
published, and by the end of 1896 the number of applications of X-rays that had 
already been described was remarkable. 
We now regard X-rays as waves, similar to light waves, but of much shorter 
wavelength: about 1 o-s cm, or 1 angstrom. They are produced when fast electrons 
strike a target, such as the walls or anode of a low-pressure discharge tube. In a 
modem X-ray tube there is no gas, or as little as high-vacuum technology can 
achieve: the pressure is about 10-5 mm Hg. The electrons are provided by 
thermionic emission from a white-hot tungsten filament. From the a.c. mains, 
transformers provide about 10 volts for heating the filament and about 20 kV to 150 
kV for diagnostic X-ray machines for accelerating the electrons. 
Radiation dosimetry originated at the end of the nineteenth century. The newly 
discovered X-rays were put to almost immediate medical use. Both the successes, 
like that of the first recorded tumour treatment in 1899, and the failures of the early 
attempts underlined the necessity for some quantitative measurement of the radiation 
emanating from an X-ray tube. Most of the earlier workers used photographic 
fluorescence methods for measuring X-ray intensities. Chemical methods were also 
tried and early as 1897 a measurement was made of the heat produced by the 
complete absorption of an X-ray beam in a metal. These early physical techniques 
were eventually displaced by ionisation methods due to a lack of sensitivity, 
unreliability or of unwanted quality dependence. The rontgen (R) was adopted as an 
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internationally accepted method of defining a measuring and X-ray dose at the 
Second International Congress of Radiology in Stockholm in 1928. 
Prior to 1928 the principles on which dose-measurement of X-rays were based were: 
(i) Blackening of photographic film. Ki en bock used in 1905 as the basis of his X-
unit the ability of radiation to blacken silver bromide film. Rollins in 1902 and 
Tousey in 1921 applied the same principles. 
(ii) Change in colour and chemical reactions. Sabouraud and Noire (1904) used a 
small capsule of platino-barium cyanide. The Pastille unit is the most well 
known radiation unit depending upon a chemical colour change subsequent to 
exposure to radiation. The Sabouraud Radiometer consisted simply of a booklet 
containing platino-barium cyanide pastilles and two standard tints, namely Tint 
A (unexposed) and Tint B (the Epilation Dose). Tint B was found empirically. 
The colour of the pastille can be measured in terms of fractions and multiples of 
Tint B by means of the Lovibond Tintometer. Similar principles applied for the 
H-unit and the Bordier-unit. Units defined with regard to the quantity of a 
chemical substance deposited during an exposure, are the Kalom and I-unit. 
Holzknecht developed his chromoradiometer which was a mixture of salts that 
changed from yellow to green when irradiated. The change was calibrated in 
Holzknecht (H) units and it is more or less the same as the unit that is presently 
being used for dose, namely the Gy (Thames and Hendry, 1987). 
(iii) Tube current. Such an indirect method was clearly not satisfactory. 
(iv) The uranie. Butcher defined in 1905 the uranie-unit as "the quantity of 
radiation given out by one gram of uranium" stating "a gram of radium may be 
roughly said to give one million uranies" and that the output from an X-ray tube 
is in the range I08 to 1010 uranies (Mould, 1980). 
(v) Temperature variation. Dr Kohler of Wiesbaden suggested the measurement of 
the quantity of X-rays by the variation of temperature in the X-ray tube. This 
was recorded using a thermometer placed in a depression in the wall of a tube. 
(vi) Fluorescence. The most widely used unit based on the fluorescent effect 
produced by X-rays was suggested by Guilleminot in 1907. He used as his 
standard a radium source of activity 50 000 (A pure radium source has about 
2000000 times the activity of an equal weight of uranium. Its activity is thus 
said to be 2000000. A radium source with activity of 50000 is thus a source 
with activity that is only 50000 times that of an equal weight of uranium.) and 
quantified the X-ray tube output by placing the tube at a distance from the 
platino-cyanide screen that gave an equal illumination, when compared with 
that given by his radium standard behind the screen. His unit was denoted by 
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M and defined as "the quantity of X-rays falling on one square centimetre of 
the surface during one minute". X-ray intensities at different distances were 
calculated using the inverse square law. 
(vii) The erg per cm3. The idea of a quantity to specify the amount of energy 
deposited by the radiation per unit mass (or volume) was proposed by Christen 
in 1912, but it was not until 1953 that the quantity absorbed dose, and its 
relevant unit the rad, was adopted. A few similar units were also proposed in 
the intervening time. 
(viii) Selenium cell measurement. A dose rate unit, the F per minute, was proposed 
by Furstenau (1915), and based on the change in electrical resistance of a layer 
of selenium caused by exposure to X-rays. The F/min was not a reliable unit. 
(ix) The skin erythema dose. It was fairly quickly recognised that X-rays could 
produce a bum if used long enough and at sufficiently high intensity. This bum 
was called erythema, and the amount of radiation exposure that was sufficient 
to cause such skin reddening was called the erythema dose. The tolerance of 
the skin to radiation was also the limiting factor in determining the fractionation 
of the radiation dose and Holfelder, for example, defined 1 S.E.D. (skin 
erythema dose)= 500 rand Quimby gave the conversion of T.E.D. (Threshold 
Erythema Dose) to radium gamma-rontgen as: 1 T.E.D. = 1 000 ry (Mould, 
1980). The T.E.D. and S.E.D. are essentially the same. 
(x) Biological units. Biological material such as rabbit muscle, ascan eggs, 
drosphilia eggs and tadpoles were used for radiation experiments. Biologically 
based units were impractical, however, since they were too indefinite and 
required too many tests for each measurement. There was therefore never any 
idea of developing units from biological material by most investigators. 
(xi) Ionisation units. Villard is credited as being the first to suggest the use of an 
ionisation chamber as a dosemeter and a quantitative unit based on the 
ionisation effect (1908). The Villard unit was defined as "that quantity of x-
radiation which liberates by ionisation one e.s:u. of electricity per cm3 of air 
under normal conditions of temperature and pressure" (Mould, 1980). It was 
essentially the same as the first definition of the rontgen unit, denoted by r, in 
1928. It remained largely unused for several years, until it was readopted by 
Kronig and Friedrich in 1918 as the e-unit, and later modified by Behnken in 
1924 to become the R-unit. 
(xii) However, in 1928 at the Second International Congress of Radiology, 
Stockholm, an absolute unit of X-ray dose was internationally accepted. This 
replaced the earlier e and R units and finally an acceptable international unit 
was defined as the "quantity of x-radiation which, when the secondary electrons 
are fully utilised and the wall effect of the chamber is avoided, produces in 1 cc 
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of atmospheric air at 0°C and 7 6 cm of mercury pressure such a degree of 
conductivity that 1 esu of charge is measured at saturation current". This unit 
was called the rontgen and was denoted by the small letter r to avoid confusion 
with the Solomon and Behnken R-units (Mould, 1980). 
In 1934 the International Commission on Radiological Units could still not bring 
itself to recommend that the rontgen (r) be accepted as an appropriate unit for both X 
and gamma rays. The recommendation had to wait until 1937 when the rontgen was 
defined slightly differently than in 1928 as "The rontgen shall be that quantity of X-
or y-radiation such that the associated corpuscular emission per 0.001293 gram of air 
produces, in air, ions carrying 1 electrostatic unit of quantity of electricity of either 
sign" (ICRU, 1954). 
3.2 Quantities and units in X-ray monitoring 
During the early days of radiological experience, there was no precise unit of 
radiation that was suitable either for radiation protection or for radiation therapy. 
Various principles for radiation measurement were discussed in the previous section. 
When X-rays interact with matter, energy is absorbed mainly by the process of 
ionisation and this principle provides a very good method for radiation measurement. 
It is a feature of ionisation radiation that the energy absorption in the body and its 
distribution in specific organs and tissues can be determined either by measurement 
or calculation. 
3.2.1 Exposure 
Exposure is a measure of the ionisation caused by the absorption of X- or 
gamma-rays in a specified mass of air - at the point of interest. A quantity of 
X-rays can be specified either in the presence or the absence of a patient. The 
unit for exposure is the rontgen and the definition is given at the end of 
paragraph 3 .1. This unit was originally denoted by the small letter "r". In the 
1960's, the International Conference on Weights and Measures decided that 
the use of the small "r" was out of keeping with their system of terminology 
and to replace it with the large "R" that is still in use. 
The new SI unit of exposure has no historical name. It is a measure of the 
photon flux, and it is related to the amount of energy transferred from the X-
ray field to a unit mass of air. One exposure unit is therefore defined as that 
quantity of X- or gamma radiation that produces in air, ions carrying 1 
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coulomb of charge (of either sign) per kg air. The unit is therefore expressed 
as "C kg-1 ". The exposure unit is based on ionisation of air because of the 
relative ease with which radiation induced ionisation can be measured. The 
rontgen corresponds to the production of ions ( of one sign) carrying a charge 
of 2,58 x l0-4 coulombs per kilogram (C kg-1) of air or 1 C kg-1 is equivalent 
to 3876 R. 
Exposure (X) was defined by the ICRU in 1968 as "the quotient of dQ by dm 
where the value of dQ is the absolute value of the total charge of the ions of 
one sign produced in air when all the electrons (negatrons and positrons) 
liberated by photons in air of mass dm are completely stopped in air" (ICRU, 
1980). 
X = dQ (C kg-1) 
dm 
(equ. 3.1) 
The ICRU (1980) has pointed out that a number of factors need to be 
considered as regards exposure. 
(a) Bremsstrahlung is emitted by the liberated electrons. The ionising arising 
from this radiation is, however, not to be included in dQ. Exposure, as 
defined above, is therefore the ionisation equivalent of the air kerma 
(definition section 3.2.2), except for the contribution of the 
bremsstrahlung, which is significant only at high energies. 
(b) It is difficult to measure exposure when the photon energies involved are 
~ 3 MeV or below 12 keV. 
( c) It is often required to refer to a value of exposure or exposure rate at a 
point inside a material different from air or in free space. The value thus 
obtained will be that which would be determined for a small quantity of 
air placed at the point of interest. 
( d) The mass of the ionisation chamber should be so small that its 
introduction does not appreciably disturb the photon field. In some cases 
an appropriate correction must be applied. 
( e) When transient charged-particle equilibrium exists, the numerical value of 
the exposure in rontgens is approximately equal to the numerical value of 
the absorbed dose in rads to air, water, or soft tissue. It does not hold, 
however, when SI units are used. The air kerma, expressed in gray, would 
be useful in this regard. An even better approximate numerical equality 
may exist between it and the absorbed dose to air, water, or soft tissue, in 
gray, under transient charged-particle equilibrium conditions. 
(ICRU, 1980). 
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The exposure rate, X, is the quotient of dX by dt, where dX is the increment 
of exposure in time interval dt. 




In the SI-system the rontgen can also be replaced by the quantity "air kerma", , 
kerma being an acronym for Kinetic Energy Released per unit MAss. Air 
kerma can be taken to have the same value as the absorbed dose in air in 
diagnostic radiology and can be used to describe the radiation field either in 
the presence or the absence of a patient. 
"The kerma, K, is the quotient of dEtr by dm, where dEtr is the sum of the 
initial kinetic energies of all the charged ionising particles liberated by 
uncharged ionising particles in a material of mass dm" (ICRU, 1980). 
K = dEtr 
dm 
The unit ofke1ma is J kg-I with the special name of gray (Gy). 
(equ. 3.3) 
In the case of kerma, the ICRU has again indicated a number of factors that 
need to be considered. 
(a) The sum of the initial kinetic energies of the charged ionising particles, 
liberated by the uncharged ionising particles, also includes the energy of 
those charged particles that have been produced by Bremsstrahlung. The 
energies of any charged particles are also included when these are 
produced in secondary processes occurring within the volume element, 
like Auger electrons. 
(b) Kerma or kerma rate may often be referred to, for a specified material, at a 
point inside a different material or in free space. Such a value would be 
obtained if a small quantity of the specified material is placed at the point 
of interest. Therefore, one can speak, for example, of the air kerma at a 
point inside a water phantom. 
( c) The mass of the ionisation chamber should be so small that its 
introduction does not appreciably disturb the field of the uncharged 
ionising particles, especially if the material for which kerma is measured, 
is different from the ambient medium. In some cases, an appropriate 
correction must be applied. 
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( d) It may be convenient to describe the field of indirectly ionising particles in 
terms of the kerma rate for a suitable material. The material could be air 
for electromagnetic radiation of moderate energies, pertinent tissue 
composition for all indirectly ionising radiation applied in medicine or 
biology, or any relevant material for studies of radiation effects. 
The kerma rate, K, is the quotient of dK by dt, where dK is the increment of 
kerma in the time interval dt. 
· dK K = - (J kg-1 s·l or Gy s·l) 
dt 
(equ. 3.4) 
3.2.3 Absorbed dose 
Radiation damage depends on the absorption of energy from the radiation, and 
is approximately proportional to the concentration of absorbed energy in 
tissue. For this reason, the basic unit of radiation dose is expressed in terms 
of absorbed energy per unit mass of tissue. 
The energy imparted, E, by ionising radiation to matter in a volume, as well 
as the mean energy imparted, E, need to be defined at first. 
The energy imparted, E, by ionising radiation to matter in a volume is: 
(equ. 3.5) 
where 
Rin = the radiant energy incident on the volume, i.e., the sum of the energies 
(excluding rest energies) of all those charged and uncharged ionising 
particles which enter the volume; 
Rout= the radiant energy emerging from the volume, i.e., the sum of the 
energies ( excluding rest energies) of all those charged and uncharged 
ionising particles which leave the volume; 
and L Q= the sum of all changes ( decreases: positive sign, increases: negative 
sign) of the rest mass energy of nuclei and elementary particles in any 
nuclear transformations which occur in the volume. 
(ICRU, 1980). 
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Two points are imp01tant, namely that (a) E is a stochastic quantity (see 
section 4 .1 ), and (b) the expectation value of E , termed the mean energy 
imparted, e, is a non-stochastic quantity (see section 4.1). 
The absorbed dose, D, was introduced in 1953 by the ICRU and was defined 
as "the quotient of de by dm, where de is the mean energy imparted by 
ionising radiation to matter of mass dm" (ICRU, 1980). 
D = dE (J kg-I or Gy) (equ. 3.6) 
dm 
The absorbed dose rate, D, is the quotient of dD by dt, where dD is the 
increment of absorbed dose in the time interval dt. 
· dD D = - (J kg-1 s·l or Gy s·l) 
dt 
(equ. 3.7) 
Before the universal adoption of the SI units, radiation dose was measured by 
a unit called the rad (Radiation Absorbed Dose). 
One rad is an absorbed radiation dose of 100 ergs per gram. 
Since 1 J = 107 ergs, and since 1 kg = 1 000 g, 
1 Gy = 100 rad. 
Although the gray is the newer unit, the rad nevertheless continues to be 
widely used. 
3.2.4 The relation between kerma, absorbed dose and the rontgen 
The kerma decreases continuously with increasing depth in an absorbing 
medium because of the continuous decrease in the flux of the indirectly 
ionising radiation. The absorbed dose, however, increases with increasing 
depth as the density of the primary ionising particles and the secondary 
particles that they produce increases, until a maximum is reached, after which 
the absorbed dose decreases with continuing increase in depth. The maximum 
dose occurs at a depth approximately equal to the maximum range of the 
secondary ionising particles. The relation between kerma and dose which 
holds for both photon and fast neutron irradiation, is illustrated in Figure 3 .1. 
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Depth in absorbing medium 
Figure 3 .1 Relationship between kerma and dose. 
In diagnostic radiology, the close approximation of absorbed dose to air and 
air kerma for X-rays is due to the secondary electron range being much less 
than the mean free path of the primary photons. Charged particle equilibrium 
is thus easily achieved, while bremsstrahlung losses (which affect the 
absorbed dose but not the ke1ma) are negligible. Either absorbed dose to air 
or air kerma can be used to describe the radiation field in the presence or 
absence of a patient. 
Since an exposure of 1 R results in an energy deposition of 0.00873 J kg-1 in 
air (see Johns and Cunningham, 1983) and the rad is defined as an energy 
deposition of 0.01 J kg-1, it follows that 1 R gives an absorbed dose of 
0.00873 _ O 873 d . . ---- . ra m air. 
0.01 
An air kerma in air of 1 Gy represents a transfer of 1 J of energy from the X-
ray beam to air per kg of air. An exposure of 1 R corresponds thus to an air 
kerma of 8.73 mGy (8.69 mGy in air per R previously). 
For X-rays used in diagnostic radiology, soft-tissue kerma is approximately 
equal to air kerma and for the purposes of radiation protection they can be 
considered equal. Thus the value of the air kerma is interchangeable with that 
of the absorbed dose in soft tissue, as was the case previously for the exposure 
measured in rontgen and the absorbed dose measured in rad ( an exposure of 
1 R gives an absorbed dose of 0.96 rad in tissue, i.e., for practical purposes 
the same numerical value). 
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3.2.5 Equivalent dose 
The fundamental dosimetric quantity in radiological protection is the absorbed 
dose, D. Absorbed dose is defined in terms that allow it to be specified at a 
point, but it is often used to mean the average dose over a tissue or organ 
(ICRP, 1991). The use of the average dose as an indicator of the probability 
of subsequent stochastic effects depends on the linearity of the relationship 
between the probability of inducing an effect and the dose - a reasonable 
approximation over a limited range of dose. The dose-response relationship is 
not linear for deterministic effects (see section 4.1), so the average absorbed 
dose · is not directly relevant to deterministic effects unless the dose is fairly 
uniformly distributed over the tissue or organ. 
The probability of stochastic effects is found to depend also on the type and 
energy of the radiation causing the dose. Provision is made for this by 
multiplying the absorbed dose with a weighting factor which is determined by 
the quality of radiation. Therefore the ICRU (1962) and the ICRP (1966) 
have introduced the concept of dose equivalent (H), i.e., a dose at a point, 
which is evaluated by multiplying the dose in rads by certain factors. Thus 
H (rem)= D (rad) x Q x DF1 x DF2 x ... (equ. 3.8) 
where Q is a quality factor (see section 3.2.7) and DF1 , DF2, etc. stand for 
various distribution factors. When isotopes, for example, are ingested and 
deposited, the spatial distribution of the isotopes is not uniform and result in 
high dose regions. Abnormally large biological effects may be produced and 
therefore the distribution factor (DF) may be set at some value greater than 
1.0. The unit of dose equivalent is the rem. 
The most recent principles in this regard are stated in the ICRP Publication 
60. "In radiological protection, it is the absorbed dose averaged over a tissue 
or organ (rather than at a point) and weighted for the radiation quality that is 
of interest" (ICRP, 1991). The weighting factor to be used for this purpose is 
called the radiation weighting factor, roR, selected for the type and energy of 
the radiation involved. Since this is strictly a dose, the ICRP decided to call it 
again equivalent dose, using the symbol HT. The equivalent dose in tissue T 
is given by the expression 
HT =LroR.DTR (Jkg·1 orSv) 
R , 
(equ. 3.9) 
where DT,R is the average absorbed dose over the tissue or organ T and due to 
radiation R. The radiation weighting factors are given in Table 3.1. These 
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weighting factors are different to those used in the previously used equation of 
dose equivalent. It is shown on page 25 that 1 Gy = 100 rad and by inspection 
of equations 3.8 and 3.9, it follows that the equivalent dose in tissue (HT) in 
sieve1t = 100 x dose equivalent (H) in rem. 
Table 3.1 Radiation weighting/actors. 
Type and energy range 
Photons 
Electrons and muons, all energies 
Neutrons, energy < 10 ke V 
10 keV to 100 keV 
> 100 keV to 2 MeV 
> 2 Mevto 20 MeV 
> 20MeV 
Protons, other than recoil protons, energy > 2 Me V 














The equivalent dose rate in tissue T, HT, is the quotient of dHT by dt, where 
dHT is the increment of equivalent dose in the time interval dt. 
. dHT 
HT = -- (J kg-ls-1 or Sv s-1) 
dt 
(equ. 3.10) 
3.2.6 Effective dose 
The ICRP introduced the concept of effective dose equivalent in 1977 in the 
ICRP Publication 26. It is based on the principle that the risk of a stochastic 
effect per unit effective dose equivalent should be equal whether the whole 
body is unif01mly inadiated or whether the radiation dose is non-uniformly 
distributed. The effective dose equivalent, HE, is given by 
(equ. 3.11) 
where WT is the weighting factor for tissue T, tabled in the ICRP Publication 
26, and HT is the dose equivalent to tissue T. 
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The ICRP considered the term "effective dose equivalent", however, as 
unnecessarily cumbersome and therefore decided to change it to effective 
dose, E, in the ICRP Publication 60. It is given by the expression 
E = LCOr.Hr (equ. 3.12) 
T 
where HT is the equivalent dose in tissue or organ T and cor is the weighting 
factor for tissue T. The new factors of coT are the result of a re-estimation for 
radiation induced cancers resulting from the recent ( 1986) follow-up studies 
on the Japanese sub-populations. The effective dose can also be expressed as 
the sum of the doubly weighted absorbed dose in all the tissues and organs of 
the body. The tissue weighting factors, published in the ICRP (1991), are 
given in Table 3.2. 
Table 3.2 Tissue weighting/actors. 
Tissue or organ 
Gonads 



























* The remainder is composed _of the following tissues and organs: adrenals, brains, upper 
large intestine, small intestine, kidney, muscle, pancreas, spleen, thymus and uterus. Some 
organs in the list are known to be susceptible to cancer induction and if other tissues and 
organs subsequently become identified as having a significant risk of induced cancer, they 
will then be included either with a specific ro T or in this additional list constituting the 
remainder. The latter may also include other tissues or organs selectively irradiated. 
(ICRP 60, 1991). 
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Exposure conditions that are not dealt with by means of the radiation and 
tissue weighting factors, are dealt with by using different values for the 
coefficients relating effective dose and the probability of stochastic effects. 
This method is prefeITed above the possibility of using additional weighting 
factors in the definitions of the quantities. 
Both equivalent dose and effective dose are quantities intended for use in 
radiological protection. Only the probability of stochastic effects can be 
estimated by means of these two units. The absorbed doses must be well 
below the threshold for deterministic effects. It will sometimes be better, 
however, to use absorbed dose and specific data with regard to the relative 
biological effectiveness of the radiation involved and the probability 
coefficients relating to the exposed population for the estimation of the likely 
consequences of an exposure of a known population (ICRP 60, 1991). 
3.2.7 Relative biological effectiveness (RBE) 
The Quality Factor (Q) weights the absorbed dose for the biological 
effectiveness of the charged particles producing the absorbed dose. The term 
RBE was fo1merly used to describe the factors Q x DF (ICRP, 1955). This 
practice is no longer recommended, since it is felt that the RBE should be 
used solely to describe the results of radiobiological experiments and should 
not be used for radiation protection (Johns and Cunningham, 1974). 
One physical parameter which describes the quality of a beam, is the linear 
energy transfer (LET). The LET, expressed in ke V per micron, gives the rate 
at which an ionising particle deposits energy along its track. 
When comparing the relative toxicity, or damage-producing potential of 
various radiations, comparison is being done on the basis of equal amounts of 
energy absorption. Generally, the higher the the rate of linear energy transfer 
of the radiation, the more effective it is in damaging an organism. The ratio of 
the amount of energy of 250 kVp X-rays required to produce a given effect to 
the energy required of any radiation to produce the same effect, is called the 
relative biological effectiveness of the radiation (Hall, 1988). The RBE of a 
specific radiation depends on the exact biological effect on a given species of 
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organism under a given set of experimental conditions. The RBE is thus 
restricted to radiation biology. 
For health physics purposes, a conservative upper limit of the RBE for the 
most important effect due to radiation other than the reference radiation (250 
kVp X-rays) is used as a normalising factor in adding doses from different 
radiations. This normalising factor, which is called the quality factor (Q), is 
related to LET as shown in Table 3.3. 
Table 3.3 Relationship between Q and LET. 
LET 
keV/µm in water 
3.5 or less 
3.5 - 7.0 
7.0 - 23 
23 - 53 







5 - 10 




X-rays were used medically almost immediately after their discovery in 1895 for a 
multitude of purposes that involved some necessity for visualising the interior of the human 
body. Biological harmful effects of X-rays were already noted in 1896 in some of the early 
X-ray workers: Edison reported in March 1896 that his eyes were sore after experimenting 
with X-rays; radiation burns to hands were reported by Stevens on 18 April 1896; Gilchrist 
reviewed 23 cases of X-ray injury which had been reported in the literature before January 
1897; in May 1897 Scott reviewed 69 reports of X-ray injury and the Rontgen Society 
appointed a committee in April 1898 to collect data on the harmful effect of X-rays. 
Aspects investigated by this committee included nature of injurious effect, duration of 
effect, nature of radiographic investigation, condition of subject, type of apparatus used, 
distance of patient from the tube, number and duration of each exposure. This could be 
perhaps considered as a first step in the direction of the radiation protection programs that 
followed later. 
Albers-Schonberg was the first person to realise that there was a possibility of an adverse 
effect of ionising radiation on biological reproductive systems when he discovered in 1903 
that X-rays were capable of sterilising guinea pigs without any other obvious change in the 
well-being of the animals (Albers-Schonberg, 1903). In spite of these early discoveries of 
deleterious effects the idea of setting up "safe" exposures for radiation workers was only 
developed in the 1920's. 
4.1 Historical background for radiation protection 
It was fairly quickly recognised that X-rays could produce a burn if used long 
enough and at sufficiently high intensity. This burn was called erythema, and the 
amount of radiation exposure that was sufficient to cause such skin reddening was 
called the erythema dose. Investigators and practitioners quickly became careful to 
avoid the sufficiently high exposures necessary to produce this particular effect. 
Indeed, the first actual experimental effort in the United States to determine whether 
X-rays were injurious was provided by Elihu Thomson, an American, in November 
1896 when he exposed one of his fingers to X-rays for several days and noted injury 
over a week later. Within several years other and more unpleasant long-term effects 
of this new type of irradiation became apparent among those who had used it most 
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extensively. These included cancerous sores of the skin as well as other more deep-
seated cancers, principally of bone in the extremities. It can be stated that most of 
the physicians who worked extensively with X-rays in the early days, eventually 
developed cancers and in many cases suffered amputations. 
There is today no way to do an accurate estimation of the doses to which people 
were exposed during those early days. However, according to one estimate annual 
exposures to medical practitioners prior to 1930 in the United States may have been 
greater than 100 R as compared with present averages of much less than 5 R~ another 
estimate of 2000 R was also stated (Herny, 1969). One of the reasons for the variety 
of doses was the technical fact that the early X-ray tubes were of the cold-cathode 
type, similar to the Crooke's tube, which gave useful results only under limited 
ranges of air pressure and voltage that were interdependent. Since the pressure 
inside the sealed tubes changed with use and time, wide variations also occurred in 
the voltages and exposure times and consequently in the total exposures necessary to 
produce a desired and useful result. It was not until the development in the 1920's of 
the hot-cathode X-ray tube invented in 1913 by W.D. Coolidge, an American 
physicist, that easily reproducible exposures could be produced (Henry, 1969). 
Almost all of this early medical work was fluoroscopic, which, because of the 
comparatively long viewing time and the necessity for the viewer to be at least pai1ly 
within the direct X-ray beam during exposures, resulted in much higher exposures 
than does the photographic work that comprises most of the current work. In 
addition, each user had his own manipulation techniques and variations in the 
respective planned or unplanned shielding had unknown effects on their exposures. 
By about the time of World War I, it was recognised that X-rays could exert 
deleterious effects and there was increasing insistence on inf01mation concerning 
safe exposure limits and methods of determining them. The wai· itself had two 
effects of interest. First, the need for infonnation obtainable only with X-rays in 
treating battle casualties pushed considerations of safety into the background, and 
second, more physicians and other individuals became acquainted with the aI1. Thus 
the con'ling of peace in late 1918 pennitted fmther attention to be given to the matter 
of limiting exposure. 
However, the general acceptance of protection procedures was too late to prevent 
radiation injuries to superficial tissues, blood and internal organs of some of the early 
workers in the radiation field - Mutscheller (1925), Barclay and Cox (1928), 
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Glaser (1932). In 1936 the Gennan Rontgen Society erected a monument for the X-
ray and radium "martyrs". This memorial originally contained 169 names from 15 
different nations, but by 1959 the total had risen to 360. Rontgen is not among them, 
probably because his experiments were mainly photographic and his X-ray tubes 
were housed within a metal box (Mould, 1980). 
4.2 Biological effects 
The biological effects of ionising radiation have been studied since about 1900. 
These effects may be classified in various ways. Radiation energy initiates physical 
and chemical reactions, resulting in biological changes. Some diagnostic X-ray 
equipment (for example fluoroscopy) is capable of delivering radiation doses that 
may be high enough to produce cellular reactions which will be manifested as acute 
radiation reaction or injmy. In properly conducted diagnostic X-ray examinations, 
however, these acute radiation effects do not occur because the radiation doses are 
well below the threshold for such effects. Neve11heless, there may be no lower limit 
of dose for the limitation of some deleterious biological changes. Even small doses 
of radiation may increase the risk of development of neoplasia and small doses of 
radiation absorbed in the gonads may induce mutations or chromosomal changes 
leading to heredita1y effects. The lCRP introduced the tenn "stochastic", i.e., only 
the probability of occmTence of the effect depends on the dose of radiation absorbed 
whereas the severity of the effect is independent of dose. 
Cancer induction and heritable effects are the principal stochastic effects of 
iITadiation. It is generally assumed that it is caused by injmy to one or a small 
number of cells. The probability that such an effect will occur, increases with the 
number of cells at 1;isk and the nature of the effect depends on the particular change. 
Although the dose may be ve1y small, there is always a finite probability for the 
effect to occur, since it is assumed that only a single cell need to be affected. The 
conclusion, namely that there is no threshold, could therefore be derived from this 
argument. There exists therefore no dose for a stochastic effect below which it 
cannot possibly occur. 
The result of exposure to a carcinogen or a mutagen is an increase in the probability 
of the occmTence of the effect. The increase in the probability is directly 
prop01tional to the magnitude of the dose (Figure 4.1 ). People can develop cancer 
whether or not they are exposed to carcinogenic agents. Exposure to a carcinogen, 
however, increases the likelihood of cancer; and the greater the exposure the greater 
100 
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is the increased likelihood. At no time, regardless of the size of the exposure, is it 
certain that cancer will result from exposure to a carcinogen. The best that we can 
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Figme 4.1 Dose-response curves. Curve A is the characteristic shape for a biological effect 
that exhibits a threshold dose (point a). The shape of the curve, from the threshold 
at a until the 100% response is thought to be due to "biological variability" around 
the mean dose, point c, ·which is called the 50% dose. Curve B represents a zero-
threshold, or linear re!>ponse; point b represents the 50% dose for the zero-threshold 
biological effect. 
(Cember, 1983) 
When frequency of occutTence of a stochastic effect is plotted against size of dose, a 
linear dose-response relationship is observed rather than the sigmoid curve that is 
characteristic of agents associated with a threshold response. The biological model 
that is compatible with this straight line dose-response relationship and with our 
knowle.dge of molecular biology predicts that cancer can be initiated or a genetic 
change can be wrought by altering the genetic infonnation coded in DNA. Thus, 
carcinogenesis and mutagenesis are merely different manifestations of the same basic 
molecular phenomenon. In this context, cancer can be initiated by damaging DNA 
of a somatic cell, whereas a genetic change may be caused by damage to the DNA of 
a genn cell. On the basis of this model, no threshold should exist for a stochastic 
effect, and even the smallest amount of the carcinogen or mutagen - a single 
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molecule in the case of chemicals or a single photon in the case of X-rays - can 
produce the effect. For these reasons, stochastic effects are often called linear, zero-
threshold dose-response effects (Figure 4.1, curve B). 
Most biological effects fall into the categmy of deterministic effects or as it was 
previously called, non-stochastic effects. Detenninistic effects are considered to be 
types of damage resulting from collective injmy to substantial numbers of cells. A 
given number or prop01tion of cells must therefore be affected so that there will be a 
threshold dose below which the number of cells affected is insufficient for the 
specific injmy to occur. The level of injmy would increase for any increase in dose 
above the threshold and effects that are "all or none", such as death, may also occur. 
These effects are characterised by three qualities: First, a ce1tain minimum dose 
must be exceeded before the paiiicular effect is observed. Additionally, the 
magnitude of the effect increases with the size of the dose. Fmthe1more, there is a 
clear causal relationship between the exposure to the noxious agent and the observed 
effect. When the magnitude of the effect or the proportion of individuals who 
responded at a given dose is plotted as a function of dose to obtain a quantitative 
relationship between dose and effect for such non-stochastic effects, a curve like A 
in figure 4.1 is obtained. Non-stochastic effects are also called threshold effects 
because of the minimum-dose that must be exceeded before the effect is shown by an 
individual. 
This type of effect is characterised by a severity that increases with dose above some 
clinical threshold. Although the initial cellular changes are essentially random, the 
lai·ge number of cells involved in the initiation of a clinically observable, non-
stochastic effect gives the effect a deterministic character. For this reason the ICRP 
now calls such effects "dete1ministic" effects. 
Examples of detenninistic effects include bone maITow damage, gonadal injuiy 
leading to impai1ment of fe1tility, and lung damage leading to impaired function. 
Injuries are attributed to damage that was caused in the individual cells resulting in 
the loss of their reproductive capacity. Hulse and Mole pointed out in 1982 that it is 
the nature of the damage to cells that dete1mines whether the final injuiy is stochastic 
or dete1ministic, since events that cause injuries to individual cells, occur at random 
(Field and Upton, 1985). An example to illustrate this statement, is the fact that 
neither malignant nor heredita1y effects can result if the cell is killed. 
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The ICRP consider certain concepts of risks as follows: The detrimental effects 
against which radiation protection is required, are known as hereditary if they affect 
the exposed individual's descendants and somatic if they manifest themselves in the 
exposed individual (ICRP, 1982). 
4.2.1 The somatic effects of radiation 
Acute whole body overexposure affects all the organs and systems of the 
body. Not all the organs are equally sensitive to radiation, however. The 
pattern of response, or disease syndrome, in an overexposed individual 
therefore depends on the magnitude of the dose. 
(a) Early radiation effects 
Early effects are those which occur in the period from a few hours up to a few 
weeks after an acute exposure, that is, a large dose received over a few hours 
or less. The effects are due to major depletion of cell populations in a number 
of body organs due to cell-killing and the prevention or delay of cell division. 
The main effects are attributable to bone maITow, gastrointestinal or 
neuromuscular damage depending on the dose received. Acute absorbed 
doses (whole body) above about 1 Gy give rise to nausea and vomiting. This 
is known as radiation sickness and it occurs a few hours after exposure as a 
result of damage to cells lining the intestine. Absorbed doses above 2 Gy may 
lead to death, usually 10 to 15 days after exposure. 
There is no well defined threshold dose below which there is no risk of death 
due to acute doses. Below about 1.5 Gy the risk of early death would be very 
low. Similarly, there is no well defined point above which death is certain, 
but the chances of surviving an acute dose of about 8 Gy would be very low. 
For doses of up to about 10 Gy, death is usually due to secondary infections 
because of depletion of the white blood cells which normally provide 
protection against infection. The range of doses from 3 to 10 Gy is often 
called the region of infection death. For doses above about 10 Gy survival 
time drops abruptly to between 3 - 5 days. Gross damage occurs in the lining 
of the intestine. This is called the region of gastrointestinal death. 
At much higher doses, survival times become progressively shorter. From 
animal experiments, the symptoms indicate some damage to the central 
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nervous system; hence the region is called the region of CNS (central nervous 
system) death. However, it is found that death is not instantaneous even in 
animals irradiated with doses in excess of 500 Gy. 
Another effect which shows up soon after an acute over-exposure to radiation 
is e1ythema, that is reddening of the skin. An exposure of about 3 Gy of low 
energy X-rays will result in e1ythema and larger exposures may lead to other 
symptoms such as changes in pigmentation, blistering and ulceration. 
(Ma11in and Harbison, 1979). 
Although changes in blood have been seen m individuals with gamma-ray 
doses as low as 140 mGy, they usually do not appear until doses of 250 - 500 
mGy are experienced. Beyond 500 mGy, blood changes are almost ce11ain to 
appear (Cember, 1983). 
The blood consists of about 55% (by volume) of plasma and about 45°/o of 
fo1med elements, including leucocytes, e1ythrocytes and platelets. The white 
blood cells, which number about 7 OOO/mm3 of blood in the average adult, 
function as a major line of defence against bacterial invasion. An infection 
anywhere in the body stimulates the production of leucocytes in order to 
combat the infective organisms. Several major types of leucocytes are found: 
the granulocytes and the lymphocytes, each with ce11ain specialised functions. 
Under normal conditions, the relative prop011ions of each of these remain 
approximately constant - the granulocytes f01m about 70 - 75o/o of the white 
blood cells while the lymphocytes account for about 25 - 30%. The 
granulocytes are produced in the bone marrow, and circulate for about 3 days 
before their death and destruction, while the lymphocytes are produced in the 
lymph nodes and spleen and remain in the peripheral blood for years. The red 
blood cells are the most abundant of the f01med elements; their concentration 
in the blood is about 5 million per cubic millimetre. The main function of the 
red blood cells is to transp011 oxygen from the lungs to the cells in the body 
and to cany the carbon dioxide waste from the cells to lung. The e1ythrocytes 
are f 01med in the bone marrow, and survive in the circulating blood for about 
90 - 120 days. The platelets, which number about 200000 - 400000 / mm3 
blood, are concerned with the clotting of the blood. They are manufactured in 
the maITow, and have a useful lifetime of about 8 - 12 days. 
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After an acute whole body radiation exposure in the sub-lethal range (<±2.0 
Gy), there is a transit01y sharp increase in the number of granulocytes 
followed within a day by a decrease which reaches a minimum several weeks 
after exposure, and then retums to n01mal after a period of several weeks to 
several months. The number of lymphocytes drops sharply after exposure, 
and remain depressed for a period of several months. In contrast to the very 
rapid response of the white cells to radiation overexposure, the red blood cell 
count does not reflect an overexposure until about a week after exposure. 
Depression in the e1ythrocyte count continues until a minimum is reached 
between 1 to 2 months after exposure, followed by a slow recove1y over a 
period of weeks. The platelet count falls steadily until a minimum is reached 
about a month after exposure; recove1y is ve1y slow, and may take several 
months. In all cases, the degree of change in the blood, as well as the rate of 
change, is a function of the radiation dose. 
(b) Late effects 
It became clear in the early part of the twentieth centmy that groups of people 
such as radiologists and their patients, who were exposed to relatively high 
levels of radiation, showed a higher incidence of ce11ain types of cancer than 
groups not exposed to radiation. More recently, detailed studies of the 
populations exposed to radiation from atomic bombs, of patients exposed to 
radiation therapy, and of groups exposed occupationally, particularly uranium 
miners, have confomed the ability of radiation to induce cancer. 
Cancer is an over-production of cells in the body. It is thought that cancer 
may result from damage to the control system of a single cell, causing it to 
divide more rapidly than a normal cell. The defect is transmitted to the 
daughter cells so the population of abnormal cells builds up to the detriment of 
the n01mal cells in the organ. The estimation of the increased risk of cancer is 
complicated by the long and variable latent period, from about 5 to 30 years or 
more, between the exposure and the appearance of the cancer. The possibility 
cannot be ruled out that there is a threshold dose below which there is no risk 
of radiation-induced cancer. This is impossible to demonstrate, however, and 
it is generally agreed that the only practicable basis for radiological protection 
is to assume that any dose, no matter how small, caITies some risk (Ma11in and 
Harbison, 1979). 
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Although any organ or tissue may develop neoplasia after overexposure to 
radiation, certain organs and tissues seem to be more sensitive in this respect 
than others. Radiation-induced cancer is observed most frequently in the 
hemopoietic system, in the thyroid, in the bone, and in the skin. Leukaemia, 
especially acute myelogenous leukaemia, and to a lesser extent chronic 
myelogenous or acute lymphocytic leukaemia, are among the most likely 
forms of malignancy resulting from overexposure to total body radiation. 
Chronic lymphocytic leukaemia does not appear to be related to radiation 
exposure. Radiologists and other physicians who used X-rays in their practice 
before strict health physics practices were common, showed a significantly 
higher rate of leukaemia than did their colleagues who did not use radiation. 
Historically, occupational radiation-induced cancers of the bone and of the 
lung are important in emphasising the carcinogenicity of internally deposited 
radioisotopes (Cember, 1983). 
Ionising radiation may also be the cause of cataracts. The incidence rate of 
cataracts among physicists in cyclotron laboratories whose eyes had been 
intermittently exposed for long periods of time to relatively low radiation 
fields, showed that chronic overexposure of the eyes could lead to cataracts. 
The incidence rate of cataracts among atomic-bomb survivors whose eyes had 
been exposed to a single high radiation dose, however, showed that acute 
overexposure of the eyes could also lead to cataracts. Radiation may injure 
the cornea, conjunctiva, iris, and the lens of the eye. In the case of the lens, 
the principal site of damage is the proliferating cells of the anterior epithelium. 
This results in abnormal lens fibres after the differentiation of the damaged 
epithelial cells. These fibres eventually disintegrate to form an opaque area, 
or cataract, that prevents light from reaching the retina (Cember, 1983). 
The cataractogenic dose to the lens is in the order of 5 Gy of beta or gamma 
radiation and cataracts have been reported after a dose of 2 Gy from mixed 
gamma and neutron irradiation (Cember, 1983). The annual recommended 
limits for the lens of the eye was set by the ICRP as 150 mSv for radiation 
workers and 15 mSv for members of the public (ICRP, 1991). From patients 
who suffered irradiation of the eye in the course of X-ray therapy and 
developed cataracts as a consequence, the cataractogenic threshold is 
estimated at about 2 Gy. In cases either of occupationally or therapeutically 
induced radiation cataracts, a long latent period, in the order of several years, 
usually elapsed between exposure and the appearance of the lens opacity. 
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It had been observed among groups of experimental animals that large 
radiation doses may shorten the life span by increasing the rate of 
physiological ageing. The exact cause of death among these animals cannot 
be uniquely attributed to radiation; the causes of death are those that are 
expected among an animal population. Although this life-shortening effect 
has been clearly demonstrated in animals, no similar clear-cut effect has been 
seen among man. Comparison of the duration of life among medical 
specialists who used X-rays in their work with other medical practitioners who 
did not use radiation in their work gives conflicting conclusions. While some 
of the data suggests an increased death rate from non-specific causes among 
users of X-rays, other data shows no statistically significant difference in life 
expectancy between these two population groups (Cember, 1983). It is 
therefore clear that radiation exposure at the levels encountered by 
radiologists and other X-ray users among physicians is not high enough to 
accelerate the ageing process to the degree that will cause a statistically 
significant shortening of life span in reasonably large sample sizes. 
4.2.2 The hereditary effects of radiation 
The heredita1y effects (also regarded as a stochastic effect) of radiation result 
from damage to the reproductive cells. This damage takes the form of 
alterations (mutations) in the heredita1y material of the cell. This aspect has 
already been discussed in Chapter 2, paragraph 2. 1. 
Examples of the hannful somatic effects of radiation are the depression of the red 
blood cell count, the production of eye cataracts (a detenninistic effect) and the 
induction of a number of malignant conditions such as leukaemia (a stochastic 
effect). The severity of many somatic effects, rather than the probability of their 
occmTence, may depend on the dose of radiation received, the duration of the 
in-adiation, whether the dose is delivered as a number of fractions spread over a 
period of time, and the total volume of tissue iITadiated. As an example, if the hand 
is given a single sh011 duration dose of 5 Gy the skin will react soon after the 
hTadiation and tum red. If the same dose is given in separate fractions spread over a 
long period there may be no obvious effect. If, alternatively, the whole body is 
iITadiated with a dose of 5 Gy there is a high probability that death will shortly 
ensue. 
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The main difference between genetic effects and somatic effects is that somatic 
effects affect only the in-adiated individual whereas genetic effects do not affect this 
person but may appear in future generations, possibly many generations after the 
itTadiation. At the dose levels met with in radiation protection, genetic effects are 
regarded as stochastic effects and are treated as though their incidence is 
propmtional to dose. 
It is sometimes argued that genetic effects are not necessarily ha1mful and may in 
fact be beneficial since new and "better" types of species may be produced. This is 
unlikely to be the case since mutations occur spontaneously and natural selection has 
tended to weed out those mutants which are poorly adapted to survive. Although the 
spontaneous mutation rate is not high, during the many generations that man has 
existed the species has tended to become more adapted to its environment and 
radiation induced mutations are therefore likely to be deleterious (Lovell, 1979). 
4.3 The genetically-significant dose (GSD) 
Genetic effects consist of mutations in the reproductive cells that affect later 
generations. Since genetic effects occur only when reproductive cells are iITadiated, 
the gonads should be shielded during X-ray studies when possible. 
The GSD due to an exposure depends on the dose to the ovaries and testes as well as 
the age of the individual, which dete1mines the probability of that person becoming a 
parent in subsequent years. Thus X-raying women over 50 years old, who normally 
have little chance of having offspring, contributes ve1y little to the GSD of the 
population. Exposure of the reproductive organs of children results in the maximum 
contribution to the GSD of the population, since their potential for producing 
offspring is at maximum. In the United States, X-raying young men results in a 
major contribution to the GSD. An X-ray that includes the testes, which have little 
shielding tissue, results in a larger genetic dose than a similar X-ray that includes the 
ovanes. On the other hand, it is easy to shield the testes without losing any 
diagnostic infmmation, while this is not true for the ovaries. The 1972 BEIR repmt 
estimated that in the United States the GSD due to medical X-rays could be reduced 
by 50% by proper limitation of the beam and use of gonadal shielding (Cameron and 
Skofronick, 1978). 
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4.4 Radiation protection standards 
Generalised radiation protection measures were eventually adopted. A British X-ray 
and Radiation Protection Committee was formed in 1921. The basic responsibility 
for providing guidance in matters of radiation safety has been assumed by the 
International Commission on Radiological Protection (ICRP). This organisation was 
established in 1928 by the Second International Congress of Radiology as the 
International X-ray and Radium Protection Committee in 1928. In 1950 it was 
restructured and renamed. The first consideration by a national protection 
organisation of the principle of maximum tolerance dose of X-rays was by the US 
Advisory Committee on X-ray and Radium Protection in 1934. This dose was 
derived essentially from a 1921 recommendation that representative protective 
measures could be gleaned from the working conditions of a number of experienced 
radiologists who had escaped injwy and were enjoying normal health at that time 
(Mould, 1980). 
At its establishment and for many years afterwards, the main concern of the ICRP 
was the safety aspects of medical radiology. Its interests in radiation protection 
expanded with the widespread use of radiation outside the sphere of medicine, and in 
1950 its name was changed to the ICRP in order to more accurately describe its area 
of interest. The policy adopted by the Commission in preparing recommendations, 
was to deal with the basic principles of radiation protection. The responsibility of 
introducing the detailed technical regulations, recommendations, or codes of practice 
best suited to the needs of the individual countries, was left to the various national 
protection committees (ICRP, 1964). 
The maximum permissible doses at various points in time were traced. In the 1958 
Recommendations of the ICRP (1959) the maximum permissible total dose 
accumulated in the gonads, blood-forming organs and lenses of the eyes at any age 
over 18 years was determined by the relation 
D = 5(N-18) (equ. 4.1) 
where D is the tissue dose (rem} and N is the age (years). A maximum dose of 
8 rem/13 weeks for the skin, limited to 30 rem per year; and 20 rem/13 weeks for the 
hands and forearms, feet and ankles, limited to 75 rem per year, were 
recommended. For the exposure of internal organs other than the thyroid, gonads 
and blood-forming organs a maximum dose of 4 rem/13 weeks, limited to 15 rem 
per year, was recommended. 
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The suggested maximum dose to the population was 5 rem per year. All the above-
mentioned limits did not include any medical exposure or exposure to natural 
radiation. Background radiation is more or less 0.1 µSv per hour. 
In order to prevent detenninistic (non-stochastic) effects the 1977 Recommendations 
of the ICRP (1977) for radiation workers recommended an annual dose-equivalent 
limit of 0.5 Sv (50 rem) to all tissues except the lens, for which 0.3 Sv (30 rem) was 
recommended. To prevent stochastic effects for whole body radiation, the 
recommended limit was set at 50 mSv (5 rem). The annual dose-equivalent limit to 
individual members of the public was set at 5 mSv (500 mrem). 
The te1m "effective dose equivalent" (Section 3.2.6) was introduced by the 1978 
Stockholm meeting of the ICRP and changed to "effective dose" in the 1990 
recommendations. The latest recommendations by the ICRP (1991) is an effective 
dose limit of 20 mSv per year, averaged over 5 years, for occupational exposure. A 
fmther provision is that the effective dose should not exceed 50 mSv in any single 
year. The limit for public exposure is 1 mSv per year. In special circumstances a 
higher effective dose could be allowed, provided that the average over 5 years does 
not exceed 1 mSv per year. 
In the ICRP Publication 60 ( 1991) the latest recommendations regarding radiological 
protection are published. Like all its predecessors, these recommendations of the 
ICRP are concerned only with protecting man from ionising radiation. The 
recommendations are an extension of those made in ICRP Publication 26 in 1977 
and the aims are the same: to prevent detrimental non-stochastic effects (now called 
dete1ministic effects) and to reduce the stochastic effects of cancer and hereditary 
diseases to acceptable levels. As before, this is to be achieved by a system of 
protection that requires justification of a practice to ensure it produces a net benefit, 
optimisation of protection to keep exposures as low as reasonably achievable 
(ALARA) and the protection of individuals by imposing either dose limits or controls 
on the risks from potential exposures. 
4.4.1 The basic framework of radiological protection 
The basic framework is intended to prevent the occunence of dete1ministic 
effects, by keeping doses below the relevant thresholds, and to ensure that all 
reasonable steps are taken to reduce the probability of stochastic effects. 
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Most decisions about human act1v1t1es are based on an implicit form of 
balancing benefits against costs and disadvantages, leading to the conclusion 
that a pa11icular course of action or practice is, or is not, wmthwhile. It is also 
recognised that the conduct of a practice should be adjusted to maximise the 
net benefit to the individual or to society. This may often be a difficult goal 
to obtain since the objectives of the individual and society may not coincide. 
It is possible, however, to fmmalise and quantify procedures that could be 
helpful in reaching these decisions. Under these conditions attention has not 
only to be paid to advantages and disadvantages for the society as a whole, 
but also to the protection of individuals. 
Three classes of radiation exposure can be distinguished: occupational 
exposure, which occurs at work and principally as a result of work; medical 
exposure which can principally be attributed to diagnostic examinations and 
therapeutic treatment; and public exposure which comprises all other 
exposures. 
It is usually possible to apply controls at three points m the control of 
occupational exposure: at the source by fixing its characteristics, shielding 
and containment; in the environment, by ventilation or additional shielding; 
and at the individual, by requiring working practices and the use of protective 
clothing and equipment. 
These controls also apply at the three points in medical exposures, but mainly 
as part of the prima1y function of diagnosis or treatment, rather than as part of 
a separate system of protection. The controls should be applied at the source 
in public exposure. If it cannot be made effective, controls should be applied 
to the environment or to individuals. 
The appropriate control measures also depend on whether they are to be 
applied to practice causing exposures or to intervention aimed at reducing 
exposures. In the case of a new practice, there is the option of accepting the 
practice, as proposed or with modifications, or of rejecting it outright. 
Existing practices can be reviewed in the light of new information or changed 
standards of projection and, at least in principle, can be withdrawn. Any 
fmther changes then require intervention. Accidents give rise to situations 
which make some fonn of intervention unavoidable. It will often be vi1tually 
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certain in practices and in intervention that exposures will occur and their 
magnitude will be predictable, although with some degree of uncertainty. 
4.4.2 The system of radiological protection 
According to ICRP Publication 60 ( 1991) the system for proposed and 
continuing practices is based on a number of general principles. 
(a) Radiation should be adopted only if produces sufficient benefit to the 
exposed individuals or to the society to offset any detrimental effects it 
may have. 
(b) With respect to any radiation source, the magnitude of individual doses, 
the number of people exposed, and the likelihood of incun-ing exposures 
where these are not ce11ain to be received, should all be kept as low as 
reasonably achievable, taking cognisance of the economic and social 
factors. Any procedure involving radiation is subjected to certain 
restrictions, namely in dose, in risk, and in optimisation of protection. 
' 
(c) All individuals who are exposed to radiation should be subjected to dose 
limits or to some control of risk in the case of potential exposures. No 
individual should be exposed to radiation risks that in n01mal 
circumstances are judged to be unacceptable. 
(ICRP, 1991) 
The rep011 (ICRP, 1991) also addresses those principles to be followed during 
intervention (intervention is the decrease of exposures to radiation). 
(a) It should do more good than hmm. The reduction in detriment resulting 
from the reduction in dose should be sufficient to justify the harm and the 
costs, including social costs, of the intervention. 
1 
(b) The form, scale, and duration of the intervention should be optimised so 
that the net benefit of the reduction of dose should be maximised. 
Dose limits do not apply in the case of intervention. There will be, however, 
some level of projected dose above which, because of serious dete1ministic 
effects, intervention will almost always be justified. It is also stressed that 
any system of protection should include an overall assessment of its 
effectiveness in practice. This should be based on the distribution of doses 
achieved and on an appraisal of the steps taken to limit the probability of 
potential exposures. No one part should be taken in isolation, for example 
mere compliance with the dose limits, is not a sufficient demonstration of 
satisfact01y perfonnance. 
47 
Radiation protection is considerated today at the technical, political and international 
fronts. Many research projects are undertaken and are cmTently in progress to 
determine various aspects of radiation and its effects on the human body and its 
various organs. It includes studies of animals, theoretical estimates of radiation 
effects, data froin anthropomorphic phantoms, and a review of human data such as 
the results of radiation therapy to tenninally ill cancer patients. In addition to 
observations of actual measurable injuries in people and animals, estimates and 
theories of radiation injmy have been proposed. Much attention has also been given 
to an individual and his descendants. 
As imp011ant as the generation of data is, so is the interpretation thereof by various 
national and international scientific groups and others who have continued with the 
dete1mination and estimation of pe1missible exposure limits. These have 
subsequently been published and are widely used as bases for action. 
Professional organisations are also involved. Just after the invention of X-rays, the 
American Roentgen Ray Society and the Radiological Society of North America 
were organisations with membership primarily among physicians who used X-rays 
regularly; similar organisations were instituted in other countries as well. During 
World War II other disciplines, particularly physics, became veiy strongly involved 
in this subject. Hence the tenn "health physics" has been used essentially as a 
synonym for radiation protection and those engaged in radiation protection activities 
identify themselves as health physicists. Their activities culminated in 1955 in the 
fo1mation of the professional Health Physics Society in America and the 
establishment of the International Radiation Protection Association some ten years 
later. 
Large research and development organisations have produced more useful and 
sensitive radiation detem1ination and measuring devices. Methods have been 
developed for increasing the accuracy with which actual radiation exposures can be 
measured, and analytical procedures for bioassay dete1minations of potential 
exposure have been refined. 
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Chapter 5 
GENE TI CALLY-SIGNIFICANT DOSE SURVEY METHODS 
In many countries, medical exposure of patients represents the greatest man-made 
contribution to the population dose. The genetically-significant dose is an index of the 
presumed genetic impact of radiation exposure on the whole population. This quantity, 
with particular reference to medical diagnostic radiology, has been determined in various 
countries. The main details of survey methods in sixteen countries and some large districts, 
between 1958 and 1986, are presented in the following sections. 
5.1 Federal Republic of Germany, Bavaria (1956-1958) 
Statistical data regarding the admission of patients to hospitals in Bavaria were 
obtained in 1956. The classification by type of examination, age and sex was 
obtained for a population of 0. 75 million. Gonad-dose measurements were made on 
1759 patients in 10 different types of hospitals and private practices. Some 705 
measurements on children and 700 on adults were also carried out at the University 
of Munich. The gonad doses of adult females were measured in the vagina and for 
female children in the rectum. The national child-expectancy figures were used in 
the calculation of the GSD (UNSCEAR 1972). 
5.2 Yugoslavia: Slovenia (1960-1963) 
The total number of radiographic and fluoroscopic examinations was determined 
during 1960 for all the institutions in Slovenia. Information on a 25 percent sample 
of these examinations was obtained in terms of age, sex and type of examination. 
The gonad-dose survey was biased towards those examinations which contribute 
most to the GSD. The centres to be visited were deduced on the basis of the 1960 
workload. Some 2000 gonad-dose measurements were made. The gonad dose was 
measured at the scrotum for male patients and at the iliac crest for female patients. 
The data from the British survey and some additional data were used to convert the 
iliac crest doses to ovary doses. The child-expectancy figures were derived from 
national statistics. For examinations unconnected with pregnancy, the foetal 
contribution was taken into account, by assuming the proportion of pregnant women 
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of a particular age group in the population and reducing this by a factor of 0.75 to 
take into account the reluctance of the staff to subject women known to be pregnant 
to X-ray examination (UNSCEAR, 1972). 
5.3 Finland (1963-1964) 
All medical institutions, hospitals and private physicians were asked to supply details 
of all radiological examinations carried out during four weeks in 1963, together with 
the total number or estimated total number, of X-ray examinations during 1963. A 
second survey was instituted to complete the required information. The frequency of 
dental examinations was estimated from film consumption. A total of 2. 7 million 
examinations plus 80000 dental examinations were done in 1963. One hundred and 
forty three thousand examinations were recorded in the study period, i.e. 5.1 %. 
Gonad dose measurements were obtained by using 1960 fluoroglass dosemeters sent 
to 124 hospitals. In the case of males, fluoroglass rods were in contact with the 
testes; in females the dosemeter was placed on the back, near the ovaries. The ovary 
dose was obtained by phantom measurements using a calibration factor dependent on 
the type of X-ray unit used. National child-expectancy figures were used in the 
calculation of the GSD. Six per cent of the women examined were assumed to be 
pregnant and a foetal dose equal to the female gonad dose was assumed (UNSCEAR, 
1972). 
5.4 United Kingdom: Sheffield (1964) 
The frequencies of the examinations in the Sheffield area (population 4.5 million) 
were collected in all the X-ray departments during a one-week period. Gonad doses 
were measured using ionisation chambers placed at the scrotum in males and at the 
level of the iliac crest in females. Over 2000 measurements on 800 patients in 30 
hospitals were made. The ovary dose was calculated using the conversion data 
measured on a phantom in the 1957 British survey. The same child expectancies, 
based on national statistics, that were used in the earlier survey, were utilised in the 
later one (UNSCEAR, 1972). 
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5.5 United States: 1964 and 1970 national surveys 
In the 1964 National Survey in the United States the survey was conducted on the 
basis of interviews of 9653 households. The sampling plan followed a multistage 
probability design which pe1mitted a continuous sampling of the civilian population 
of the United States. The first stage of this design consisted of drawing a sample of 
357 geographically defined primary sampling units (PSU's) from the 1900 units into 
which the United States had been divided. A PSU was a county, a group of 
contiguous counties, or a standard metropolitan statistical area (Gitlin et al., 1966). 
Within the PSU's there were ultimate stage units called segments. Each segment 
consisted of a cluster of neighbouring households or addresses and was defined to 
contain an expected nine households. A random sample of approximately 90 
segments were drawn each week and members of the approximately 800 households 
were interviewed concerning factors related to health (Gitlin et al., 1966). 
Since the household members interviewed each week were a representative sample of 
the population, samples from successive weeks could be combined into larger 
samples. Thus, the design pe1mitted both continuous measurement of characteristics 
of high incidence or prevalence in the population and, through the larger 
consolidated samples, more detailed analysis of less common characteristics and 
smaller categories. For this study, 13 weeks of interviewing (from April to June 
1964) provided a sample of 10029 households that included 94 refusals and 282 
households in which no one could be found at home during repeated calls. The 9653 
completed households included 31289 persons of whom 4525 had had an X-ray 
examination during the previous three months (Gitlin et al., 1966). 
The 1970 study was designed to provide data directly comparable to the previous 
study. The first stage of the sampling consisted again of drawing 357 PSU's from 
approximately 1900 geographically defined PSU's. This study, 26 weeks of 
interviewing (from April through September 1970), provided a sample of 22500 
households. The 21500 completed households that were ultimately interviewed 
included approximately 67000 persons for whom X-ray visit data and other survey 
information were obtained (US Dept. of Health, 1973). 
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The follow-up for both surveys consisted of an approach to each clinic or hospital 
where a selected person had had an X-ray examination with requests for details on 
the examination together with a film from which the X-ray quality and the field size 
could be determined. The gonad doses were determined on the basis of these 
exposure factors by processing the results of comprehensive scatter measurements 
made on a phantom. These were checked by in vivo thermoluminescent dosemeters 
applied to 360 patients undergoing a variety of examinations. Child-expectancy 
figures were derived from national statistics (US Dept. of Health, 1976 and 
UNSCEAR, 1972). 
5.6 Russian Republic (1964) 
The results of the surveys at the Moscow X-ray Radiology Research Institute 
concluded that 65 million X-ray examinations were carried out annually on the 82 
million people in the Russian Republic (14 million radiographs, 36 million 
fluoroscopies and 15 million chest photo-fluorographs). Measurements of the skin 
dose, gonad dose and the integral dose were made for a number of X-ray 
examinations. Ninety one per cent of the total integral dose was from fluoroscopy, 
6 per cent from photofluorography and 3 per cent from radiography (UNSCEAR, 
1972). 
5.7 United States: Other local surveys 
Four surveys have been completed in local areas: New York City (1962); New 
Orleans (1962-1963); Johns Hopkins Hospitals (1965); and in Texas (1963). Each of 
these surveys have had to depend on the national child-expectancy figures. In the 
New York survey 68 out of 234 institutions took part and each reported the annual 
number of X-ray examinations and a breakdown by age and type for a period of a 
few days. Physicians' offices reported over a four-week period. In New Orleans 262 · 
X-ray units and 144 physicians' offices, 73 per cent of those in the area, reported data 
for a six-month period and the details of the exposure of 8000 patients comprising 
9000 examinations and 18000 projections were collected and used to derive the 
gonad doses using relevant phantom data. The Johns Hopkins survey was based on 
the radiographic examinations of 100000 patients. The 220000 examinations at the 
hospitals of the University of Texas over a 30-month period were used together with 
gonad and skin dose measurements to derive the GSD (UNSCEAR, 1972). 
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with phantom measurements. The average gonad doses were derived from the 
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5.8 Czechoslovakia, Bohemia (1965-1966) 
The survey covered three out of the 11 regions of the Czechoslovak Socialist 
Republic (population 4341000 or 30.5 per cent of the country total). The number of 
examinations carried out in all radiological" and fluoroscopic units over a period of 
one year was collected, together with those carried out during a three-month period 
in all mass chest survey units and during two one-week periods in 219 out of 570 
dental X-ray departments. The breakdown by age was obtained for 253853 
examinations, i.e. for 6.4% of the annual number. Central-axis skin-dose and gonad-
dose measurements were can-ied out on 5602 patients in 70 departments at 28 
industrial and agricultural localities. To obtain the ovary dose, phantom 
measurements were carried out on each machine immediately following an 
examination on the specific machine (UNSCEAR, 1972). 
5.9 Netherlands (1967) 
The radiological examinations cmied out in one year on 4.9 million people covered 
by 53 insurance companies were used to derive the annual total number of 
examinations. A subsample of nine companies which covered 1 million people was 
used to obtain the breakdown by age and sex. Both samples, i.e. the sample to derive 
the annual total number of examinations as well as the sub-sample to obtain the 
breakdown, were geographically scattered. The gonad doses were obtained from 
measurements done on patients and on a phantom. National child-expectancy figures 
were used, except for the examinations of pregnant women (UNSCEAR, 1972). 
5.10 United States: Puerto Rico, Southern and Western regions (1968) 
The average number of· patients radiographed per week over the year 1968 was 
presented from all hospitals in these two regions of Puerto Rico. These statistics 
were broken into types of examinations. An earlier investigation had been carried 
out in the western region in 1967. The majority of dosimetric work was carried out 
on one unit. Thermoluminescent dosemeters and ionisation chambers were used for 
a limited number of in vivo dose measurements at one centre and agreed reasonably 
with phantom measurements. The average gonad doses were derived from the 
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returns from the 47 facilities with one or more X-ray units in the Southern region and 
from 65 facilities in the Western region. The child-expectancy figures were derived 
by the Department of Health but not published (UNSCEAR 1972). 
5.11 Japan (1969) 
The frequencies of examinations were obtained during 30 consecutive days from a 
number of hospitals of various sizes with regard to number of beds and from 1000 
physicians. Answers giving the numbers of examinations and the physical conditions 
used, were received from 60 per cent of the hospitals approached. Gonad doses were 
measured on four phantoms using X-ray units from differ~nt manufacturers operating 
at the particular conditions used for each examination type in the various hospitals 
included in the survey. The phantoms represented 8-month, 5-year and 10-year old 
children and the adult. The output of 54 X-ray generators was surveyed to obtain a 
mean output per unit. The child expectancies were derived from national statistics 
(UNSCEAR 1972). 
5.12 New Zealand (1969) 
A survey in which details of 40000 radiological examinations were collected and 
analysed, sampled 3.5 per cent of the annual number of examinations. A field survey 
was conducted in which the gonad or skin doses were measured in 1400 
examinations and 2460 technique forms were used to derive the gonad dose. The 
male measurements were carried out directly and the ovary dose was calculated from 
the data used in the British national survey of 1957. Child expectancies were derived 
from national statistics (UNSCEAR, 1972). 
5.13 Thailand (1970) 
The total number of patients radio graphed in. all centres was requested for January 
1970 and the 56 per cent return represented some 45 per cent of the estimated 
number of examinations carried out. A very low frequency of 30 examinations per 
year per 1000 persons was reported. Gonad-dose measurements were made in one 
hospital during fluoroscopic procedures using thermoluminescent dosemeters placed 
on the scrotum of male patients and in the vagina of female patients. Phantom 
measurements were undertaken in five hospitals utilising the exposure data of 
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patients. As data was insufficient to make an accurate estimate of the GSD, a "most 
possible" value was derived. The female child-expectancy data derived in 1966 by 
the Ministry of Public Health was used and the male fertility was deduced from it, 
using as a basis the relationships observed in New Zealand (UNSCEAR, 1972). 
5.14 Great Britain (1977) 
5.14.1 Selection of the sample 
Every National Health Service (NHS) hospital in England completed an annual 
return giving details of the workload of its various departments. For radiology 
departments the workload was given using a system of radiography units in which 
each unit represented approximately one minute of a radiographer's time. At the time 
the sample was selected the most up-to-date information available was from the 1974 
returns, with a total of about 211 million radiography units (Table 5.1). A standard 
stratified sampling technique was used and it was estimated that about 7% of the 
hospitals was enough in order to make an estimation of the total numbers of 
examinations with sufficient accuracy. The returns were stratified into nine 
workload ranges as shown in Table 5 .1. The single returns with a workload of over 2 
million units were automatically included in the survey. Thus, 78 institutions in 
England were allocated to the individual strata as shown in Table 5.1 and the 
institution with radiography units larger than 2000000 was automatically included to 
bring the total to 79 (Kendall et al., 1980). 
Wales used the same radiography workload unit system as England. For 1974 a total 
of 15 million units were recorded for 131 hospitals. From these, five were selected 
on an informal basis. This sample comprised one large, two medium-sized, and two 
small hospitals. 
The Scottish system of radiography workload units was not identical with that for 
England, although similar, and the Scottish sample was chosen along similar lines to 
the English one. Information was available for 1976 when a total of 43 million units 
were recorded for 151 hospitals. The two hospitals with recorded workloads of over 
2 million units were included in the survey, while the remaining were stratified using 
the same eight workload ranges as used for England. From these hospitals 26 were 
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selected using the same allocation procedure as was used for England with individual 
hospitals selected within each stratum, i.e. the workload ranges (Table 5.1), with 
probability proportional to the recorded workload. The total sample for Scotland 
therefore consisted of 28 hospitals (Kendall et al., 1980). 
Table 5.1 Structure of the sample for England. 
Radiography units Number of NHS hospital Numbers NHS 
returns in England for Hospitals included in 
1974 sample 
<20 000 307 4 
20 000 - 49 999 226 4 
50 000 - 99 999 154 5 
100 000 - . 199 999 123 7 
200 000 - 299 999 109 6 
300 000 - 499 999 102 11 
500 000 - 999 999 102 28 
1 000 000 - 1 999 999 25 13 
~2 000 000 1 1 
1 149 79 
5.14.2 Data collection 
Among the hospitals contributing to the 79 English hospital returns initially selected 
for this survey, 54 consented to take pati, including the three hospitals which 
submitted a joint return (~2000000). The five Welsh hospitals all consented to 
taking pa1i in the survey, as did 22 of the 28 Scottish hospitals. Each of the 81 
consenting hospitals was then sent a supply of fmms to be completed and asked to 
record details of all radiological examinations caITied out during the week beginning 
13 June 1977, before returning the completed fmms to the NRPB. The details 
included the sex and age of the patients and the types of examination, as well as 
technical factors like the number of films used, the fluoroscopic screening time, and 
the extent of gonadal shielding. The overall response rate in the survey was 68%. 
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The first step in the processing of the completed forms was the coding of 
examination types and data was then transferred to a computer. 
The first stage in the analysis was the generation of summarised information for each 
hospital. At this stage, further plausibility checks were carried out and it was 
necessary to introduce some assumptions about incomplete or incorrect information. 
A number of errors were detected when the data was first entered into a computer. 
During the course of the analysis further checking was carried out on certain 
examinations, and some fmther errors were corrected. Although the residual error 
rate cannot be stated with ce1tainty, it was believed to be below 1 %. This was 
considered acceptable since the standard error due to sampling is never less than 5% 
of the estimated overall total. The identification and correction of errors was found 
to be a very time-consuming process. Additional to the wide variety of transcription 
errors which could be introduced, there was the problem of different interpretations 
of those originally completing the forms (Kendall et al., 1980). 
5.14.3 The gonadal dose survey 
To derive a value for the GSD it is necessary to establish accurate values for the 
gonadal doses delivered by only those types of examinations which make a 
significant contribution to GSD. These are likely to be examinations of the lower 
abdomen, where the ovaries and testes will be in the X-ray beam or close to its edge, 
or examinations that occur very frequently and consistently make a large contribution 
to the population dose even if the individual gonadal doses may be low. 
Consequently, 13 examination types were selected which, between them, were likely 
to contribute at least 95% to the GSD. 
The number of patients included in the survey for each examination type was 
necessarily a compromise between the time and effort available and the desired 
accuracy in the measurement of the mean gonadal dose. It was also recognised that a 
large number of measurements would be needed at each hospital if any forms of 
inter-hospital comparisons were to be made. In practice, large variations were found 
to occur in the same hospital. 
Separate samples were required, not only for each examination type, but also for 
each category of patient that might be considered to have its own peculiar dose 
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distribution. It was found that at least four different patient categories were required: 
male and female, child and adult, but it was not realistic to expect to be able to 
measure doses on 50 patients from each categ01y for the 13 selected examinations at 
every hospital in the survey. For any one hospital therefore, there were only two 
patient categories, male and female, and the intention was to gather data on at least 
50 patients of each sex for the more common examination types. This proved to be 
possible within a peiiod of one or two months for all but the smallest hospitals in the 
survey. For the less frequent examination types as many measurements as possible 
were made during the survey period. 
A dosimetry system had been developed that was based upon small sachets, 
approximately 4 mm x 4 mm, of lithium borate the1moluminescent powder that could 
easily be attached to the patients to measure directly the skin dose received during X-
ray examinations. These sachets were stuck directly on to the patient. At the end of 
the examination and after removal from the patient it remained sufficiently adhesive 
to stick to a form on which were entered the relevant details concerning the patient 
and the examination technique. Technique factors that were unlikely to vary from 
patient to patient such as the X-ray tube filtration and the film/screen combinations 
were recorded separately when the surveys were being initiated to avoid unnecessary 
duplication on the individual patient fonns. 
For male patients the sachets were positioned on the inside of the thigh level with the 
testes and left there throughout the examination. The dosemeter reading was 
consequently taken as a direct indication of the gonadal dose for male patients. If 
gonadal shields were used the radiographers were instructe_d to shield the dosemeters 
to the same extent as they shielded the gonads. For female patients, the entrance skin 
dose at the level of the ovaries was measured by attaching the sachets to the lower 
abdomen at the level of the anterior-superior iliac spines on the side of the body on 
which the X-rays were incident. For non-fluoroscopic examinations a separate 
dosemeter was attached to the patient for each projection whilst for fluoroscopic 
examinations, like barium enemas, where the projection, field size and beam position 
constantly change, four dosemeters were attached to the patient throughout the 
examination. They were positioned one at the front , one at the back and one at each 
side at the level of the ovaries, so that the entrance dose was monitored for all 
projections. 
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For chest X-rays an elastic belt was attached around the hips containing six lithium 
borate sachets on the anterior midline and a further six on the posterior midline. 
Since the absorbed dose at the level of the gonads from radiography of the chest was 
too low to be measured accurately with TLD's for single examinations, the same belt 
was used repeatedly to integrate the dose for up to 100 patients. The mean dose 
recorded for each batch of six sachets was used as an indication of the amount of 
leakage and scattered radiation reaching the level of the gonads. Different factors 
were then applied to convert these mean doses into ovarian and testicular doses. 
Factors for converting entrance skin doses to ovary doses have been derived by 
exposing a Rando standard-man phantom to a range of diagnostic X-ray fields, with 
lithium borate dosemeters located on the skin and at the sites of the ovaries (Wall et 
al., 1980). 
5.14.4 The genetically-significant dose 
The annual GSD was then calculated using the formula: 
(equ. 5.1) 
where d kit' is the estimated mean dose received among persons in age-sex group k1 who 
undergo examination type R 
ek
1
t is an estimate of the total number of future children expected by persons in 





is the estimated child expectancy of an individual in the k2 th subdivision of 
the k1 th age-sex group 
N ki k
2 
is the 1977 mid-year population of Great Britain in the k2 th subdivision of 
the k1 th age-sex group. This will include a category for the number of 
foetuses in utero estimated from the number oflive births in 1977. 
The estimate of GSD calculated in this report is subject to a number of different 
types of uncertainty. These are mainly due to the fact that the frequency data was 
collected at only a sample of hospitals rather than at all hospitals which carry out 
diagnostic radiology, and that the estimates of gonadal doses received from the 
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various categories of radiological examination were based on relatively few 
measurements. The sampling error in the estimated GSD from these two sources can 
be approximated, using detailed results from the frequency survey and the values for 
the gonadal doses and their standard errors. 
This method of calculating the sampling error ignores sources of error such as 
inaccuracies in the data collection and measurement procedures. Bias due to 
hospitals not responding to requests to take part in the project and the fact that data 
for the frequency survey were collected during a single week which may not have 
been typical of the year as a whole were ignored. There will also be some error 
introduced by the assumption that the child expectancy of an individual is not related 
to the type of examination he or she undergoes, and by the use of child expectancies 
for 1974, rather than 1977. However, the estimate of GSD can be shown to be 
relatively insensitive to small changes in child expectancies. In spite of these 
deficiencies the sampling error calculated in this way should be useful as a rough 
guide to the interpretation of this estimate of GSD (Darby et al., 1980). 
5.15 France (1982) 
A national survey was undertaken in 1982 in France to establish the collective 
effective dose and the genetically-significant dose associated with the main types of 
radiological examinations ( excluding nuclear medicine, CT scans, dental radiology 
and mass chest screening) performed annually in France. 
5.15.1 The national survey 
The survey was conducted in two separate phases: (i) About 500 radiology 
departments, private clinics and offices practising diagnostic radiology were initially 
selected throughout the country by a stratified sampling procedure (average sample 
rate of 1~ ). The stratification was based on a rough evaluation of their annual X-ray 
film consumption. All the necessary information about the provision of staff and 
facilities for diagnostic radiology, in terms of numbers of radiologists, radiographers 
and X-ray units available, was finally gathered in 386 public hospitals and private 
practices that actually participated in the survey. 
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(ii) In order to estimate the total number of X-ray examinations annually being done 
in France, a questionnaire was sent to a sub-sample selected among the X-ray units 
(549 out of 1372) that equipped the 386 radiological departments mentioned above. 
The questionnaire was broken down by age and sex of patients and technical data 
about each of 13000 X-ray examinations, such as the number of films, the 
fluoroscopic screening time, the X-ray beam projection, the applied potential (kVp), 
the tube current (mA) and the exposure time (s), were collected over a specified one-
week period in June 1982. It was estimated that a total of 45.4 million X-ray 
examinations were performed in France in 1982 by extrapolating the weekly figures 
and taking into account the seasonal radiological activity variations. 
5.15.2 Dosimetry 
Measurements were performed either on an anthropomorphic phantom or directly on 
the patient by using thermoluminescent dosimeters (lithium borate). These 
dosimeters were previously calibrated with a standard source of Co-60. 
(i) Adult phantom dosimetry 
Three major problems had to be solved. The first one was the selection of 
parameters to be used in the experimental measurements. There were almost 1500 
configurations expressed in terms of combinations of physical and anatomical 
parameters such as kVp, mAs, film size, X-ray beam projections and centring point 
position observed in the survey. This number was reduced to 37 configurations by 
considering either the relative low frequency or the low contribution to the collective 
population dose. 
The second problem to be addressed was the selection of a representative X-ray table 
on which dosimetry measurements were to be performed. Seventeen different X-ray 
tables, installed in five hospitals which participated in the dosimetry survey, were 
selected. Free-in-air exposure variations were checked as a function of kVp, mAs 
and quality of the detector (standard film and rare earth screen film) by using 
ionisation chambers and TLD's. Finally, the selected X-ray table, having the closest 
values of technical parameters as compared to the average was a model made by 
Compagnie Generale de Radiologie. 
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The third problem was the method of the organ dose assessment. Dose 
measurements were done inside the Rando-man phantom for particularly 
radiosensitive organs. It must be kept in mind that the objective of this study was to 
evaluate the equivalent dose and not the GSD only. Two different procedures were 
followed in measuring organ doses: 
(a) For lenses (6 TLD's), lungs (57 TLD's), testes (6 TLD's), ovaries (9 TLD's), 
mammary glands (9 TLD's) and thyroid (3 TLD's ), TLD's were inserted into the 
corresponding organ positions and systematically irradiated 30 times to obtain 
significant dose values, especially at different points outside the primary beam. 
Three TLD's were also attached to the smface of the phantom at the centre of 
each X-ray field to dete1mine the entrance skin dose (Maccia et al., 1988). 
(b) For red bone marrow, bone surface and the "remainder" organs, the estimation of 
doses was mainly based on the entrance skin dose measurements, carried out for 
each radiograph. These organ doses had been obtained through Monte Carlo 
calculations using standardised X-ray field size and positions, corresponding to 
37 configurations. A mathematical phantom (MIRO) was used to represent the 
patient. To validate this procedure, the organ doses obtained from a Rando 
phantom and the MIRO had been compared and reasonable agreement was 
obtained (Maccia et al., 1988). 
(ii) Children 
Some in-vivo measurements were also performed on a sample of young patients (less 
than 10 years old) for a limited number of X-ray examination types, namely pelvis, 
intravenous urography, abdomen, lumber spine and barium meal. Measurements 
were carried out by using TLD's attached to the patient's skin. Thyroid, gonads ( only 
for boys) and lung doses were estimated directly from skin dose measurements: one 
TLD over the thyroid, one TLD over the testes and two TLD's respectively on the 
front and back of the thorax. Doses for other organs were, as in the case of the adult 
patients, deduced from measurements of entrance skin dose using Monte Carlo 
conversion factors adapted to a paediatric phantom (Maccia et al., 1988). 
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5.15.3 The genetically-significant dose 
The results of both frequencies and gonadal doses associated with each examination 
type in this survey were combined with child expectancy of the patients to obtain the 
GSD. It was recognised that many of the X-rayed individuals may have had life and 
child expectancies quite different from the general population because of the effect 
of their medical condition. Due to a lack of specific data on this subject, it was 
assumed that persons who underwent radiological examinations had the same future 
child expectancy as the general population. 
5.16 Spain (1985 - 1986) 
The Medical Physics Group at the School of Medicine of the Complutense 
University of Madrid initiated a study of radiation doses in relation to diagnostic 
radiology in the area of Madrid in 1986 in co-operation with the Department of 
Health and Consumer Affairs and several Madrid hospitals as well as some 
outpatient centres. Many of the results and conclusions could be extrapolated to the 
rest of Spain. A second phase of the study was however designed in co-operation 
with the Department of Health to involve sampling throughout Spain in order to 
obtain the required results without extrapolation. A first assessment and in some 
cases making use of preliminary figures and a few indirect estimations, was 
published in Janmuy 1989 in The British Journal of Radiology. 
5.16.1 The survey 
The National Health Service (NHS) through the National Institute of Health (NIH) is 
responsible for the health of approximately 96% of the population of Spain. Each 
person affiliated to the NHS has a card which entitles his/her family to receive health 
care in the NHS network. Radiological examinations are performed mainly in 
hospitals and outpatient centres. Private diagnostic radiology is used by the 
remaining population, excluding those served by military hospitals, and by patients, 
although they have access to NHS services, prefer the private sector. Data was 
available from all the Autonomous Communities through the Directorate General of 
the NIH. The Communities Andalucia and Catalu:fia were excluded, but the available 
data still amounted to 67% of the population in Spain. The effect of the exclusion 
would not be significant, since its average characteristics should be close to that of 
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the whole population. Data had also been supplied by national, regional and local 
health institutions including the Nuclear Safety Council (NSC). 
A partial analysis of different diagnostic radiology sectors was made to estimate the 
annual number of radiological examinations. There are three well differentiated 
types of diagnostic radiology practice : (i) hospitals belonging to the Department of 
Health network ( or to the Department of Health of the Autonomous Communities, as 
in the case of Andalucia and Catalufia); (ii) outpatient centres (also depending on 
the corresponding department); and (iii) the private sector (private hospitals, clinics 
and offices). The diagnostic radiology performed in any of the 36 centres of the 
Department of Defence or in local administration centres is not included. It was 
found to be difficult to obtain data from the private sector. Information reflected in 
the Department of Health and Consumer Affairs internal reports, namely that about 
20% of the total radiographic film sold annually in Spain is used in private radiology, 
led to the assumption that 26% of the examinations were performed in the private 
sector. 
5.16.2 Frequency of some examinations 
Data from the San Carlos University Hospital was used for analysing the frequency 
of hospital radiological examinations. This centre was a good representation of the 
functioning and patient population in Spain during the year of the analysis (1986). 
The hospital had also a very good data-processing centre which enabled some of the 
data obtained to be compared by using different methods of analysis. The following 
information was available for the San Carlos Hospital during the year of the survey: 
• 18 radiodiagnostic rooms 
• 13 portable X-ray machines (excluding the catheterisation room or dental 
equipment) 
• 141578 radiological examinations (ultrasound examinations excluded) 
• 414265 radiographs were taken 
• 2. 86 films per examination 
• total of 265990 patients (26348 patient admissions; 191355 outpatient visits and 
72898 emergency admissions) 
• 0.53 radiological examinations per attended patient. 
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Data from a national insurance company and of one private centre in Madrid was 
analysed for the private sector. The results from 16 additional private centres, 
comprising 43 rooms and 96320 annual examinations were also used. Table 5.2. 
refers to an estimation of the frequency of the radiological examinations in Madrid 
and the whole of Spain. Values for Spain as a whole were extrapolated from the 
frequency distribution of examinations in Madrid. 
Table 5.2 Estimate of the frequency of radiological examinations. 
Number of examinations (per 1000 inhabitants per year) 
Examination Madrid Whole of Spain Whole of Spain 
% 
Skull 18 15 3.1 
Spine 110 97 19.8 
Chest 154 128 26.0 
Mammography 17 14 2.9 
Abdomen 53 45 9.2 
GI tract 45 40 8.2 
Urography 15 13 2.6 
Hip and pelvis 18 15 3.1 
Extremities 90 75 15.3 
CT 10 7 1.4 
Other 50 41 8.4 
Total 580 490 100.0 
(Vafi6 et al., 1989). 
5.16.3 Dose measurement · 
Not all the necessary dose values for the different examinations were obtained during 
the first year of the project. It was possible, however, to obtain technical information 
for more than 60000 hospital examinations of the technique factors, operator and 
65 
equipment involved, place where perfonned, patient sex and age, as well as a smaller 
number of examinations perf01med in outpatient centres. 
Exposure measurements were made at skin level using mean values of parameters 
like kVp, mAs, screening time, etc. The measurements were done in several rooms 
of the different centres and for a large number of examination modes. Calibrated 
Victoreen Radcheck ion chambers were used for this pwpose. Measurements of the 
area-exposure-product for some complex examinations ( digestive tract, intravenous 
urography, etc.) were also made by using a Diamentor (PTW Freiburg) transmission 
ionisation chamber. 
Measurements in urography of the absorbed dose (in muscle) at the point of entry 
were done directly on patients. TLD-100 dosemeters from Harshaw were used for 
this purpose. Organ dose measurements were conducted on a Remab phantom from 
Alderson which was specially designed for diagnostic radiology. Between 40 and 50 
TLD-100 chips were used in each radiological examination for dose estimations. 
Results had been obtained for digestive tract examinations, chest, conventional chest 
tomography, computed tomography and urology. 
5.16.4 The genetically-significant dose 
At the time of the rep01t it was possible to perfo1m a more detailed analysis of the 
chest and urographic examinations so that the GSD in these cases could be 
calculated. The report of the National Institute of Statistics made it possible to 
analyse the population of the different Autonomous Communities. It was therefore 
possible to derive the child expectancy as a function of age from their age 
distribution and number of descendants. This was assumed to be identical for the 
whole of Spain and thus the GSD could be calculated. 
An evaluation of all the above-mentioned survey methods will be done in the 
discussion in Chapter 10, namely with special reference to the properties that an 
acceptable sample and sampling procedure should comply with. The sampling 




In the present investigation of the GSD in South Africa, the format of the sample to be 
drawn to assess the value of the GSD depended on the available infonnation. It is required 
by the Directorate: Electromedical Devices and Radiological Health, Department of 
National Health, that records of patients receiving therapy or diagnostic examinations 
should be kept. In addition to the prescribed information to be included in the patients' 
medical records, registers are also kept or in some cases the infotmation is stored in a 
computer. Registers usually include some basic inf01mation such as the name of the 
patient, date of bitih, gender and type of X-ray examination. 
Letters were written to all private radiologists during the third quarter of 1989 with the 
request to supply total number of exposures, total number of examinations and total number 
of patients for 1987 and 1988. The best response was obtained regarding the total number 
of patients for 1988. Summaries of the workload of all government aided hospitals were 
obtained from the four provinces (Natal Provincial Administration, 1987/88; Orange Free 
State Provincial Administration, 1988; Provincial Adminish·ation of the Cape of Good 
Hope, 1987/88 and Transvaal Provincial Adminish·ation, 1987/88). In two of the four 
provinces, namely in the Cape and in the Orange Free State, only the number of patients 
who underwent X-ray examinations, was available. In Natal, however, both the number of 
patients and examinations for the years 1986, 1987 and 1988 were available. It was 
therefore possible to calculate an average factor of the ratio of the number of X-ray 
examinations to the number of patients in Natal, namely 1.265. The number of patients 
examined in all the government aided hospitals, clinics as well as in the private practices, 
where the number of examinations was not available, was multiplied by a factor 1.265 in 
order to obtain the number of X-ray examinations. A total of 5576235 examinations were 
thus obtained for South Africa. It was assumed that the frequency of examinations 
during this period would be the same as that at the time of the actual survey (1990-
1991 ). 
Statistical information from a total of 292 institutions, i.e., the complete total of private 
practices, government aided hospitals and clinics, was thus obtained (a few other 
institutions, discussed on pages 174 and 175, were omitted since their contributions were 
believed to be negligible). It was therefore considered necessa1y to present the data more 
visually in order to dete1mine a suitable method of sampling. 
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6.1 Stem-and-leaf display 
In order to decide what process could be used to draw a random and representative 
sample, it was necessary to get more clarity on aspects like the following: 
(i) The symmetry of the sample distribution. 
(ii) The extent of the range of examinations of each participant in the survey. 
(iii) Whether a few values were far removed from the rest. 
(iv) Whether there were concentrations of data. 
(v) Whether there were gaps in the data. 
A stem-and-leaf display (Hoaglin, Mosteller and Tukey, 1983) provides answers to 
all the above aspects and is similar to a histogram. By using the digits of the data 
values themselves instead of merely enclosing area, this display offers advantages in 
some situations. The median and other summaries can be readily found on the 
ordered batch. Two problems with histograms are that they are somewhat difficult to 
construct and that the sense of what the actual sample points are within the respective 
groups, is often lost. It can be of help to see the distribution of data values within 
each interval, as well as patterns in the data values. 
An example of the stem-and-leaf display is represented in Figure 6.1. A line exists of 
a stem and one or more leaves, the stem just left of the ve11ical line and the leaves at 
the right. Line number 10, for example, has a stem with value 4 and three leaves 
with values 50, 80 and 55. Since a unit represents 100 in this representation, a leaf 
with value 50 represents 5000. The number 45000 is thus represented on the line 
with stem 4 and by the leave with number 50. 
The choice of the number of lines in a stem-and-leaf display involves the number of 
data values in the batch and the range to be covered. The maximum number of lines 
can be calculated according to the equation 
L = [10xfog 10n] (equ. 6.1) 
where n is the number of data values. According to this rule, it was experienced in 
practice that values of L between 20 and 300 were obtained (Hoaglin, Mosteller and 
Tukey, 1983). 
Since n is the number of data values, it represents the number of institutions (292) in 
this model. Thus for n = 292, the maximum number of lines calculated according to 
equation 6.1 was L = 25. The range of the batch (R) was obtained by subtracting the 
smallest number of examinations from that of the largest. The actual largest value 
was ignored, however, since it was considered to be an outlier with a value nearly 
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double that of the second largest one. In order to determine the interval width, the 
range is divided by the maximum number of lines, i.e. 
R = 233400 = 9336. 
L 25 
Rounding to the nearest power of 10 gave the value 10000 as the interval width. 
Since the first line was too crowded (having too many leaves on the line) it was 
necessary to split lines and repeat each stern. Leaves from O to values <5000 were 
put on the* line and from 5000 to values <10000 on the• line. 
In Figure 6.1, the first column on the left refers to the total number of institutions in 
the survey and the second column refers to the government aided hospitals and 
clinics only. The third column represents the interval widths, i.e. the stems, and the 
numbers to the right of the vertical line in italic/bold refer to the private practices. 
A data value can be assigned a rank by counting in from each end of the ordered 
batch ( columns one or two). When the total number of examinations are considered 
in Figure 6.1, the number with stem 6 and leaf 99 (i.e. 69900) has rank 271 when 
counting up from 300 (first item, first row, top, left) and rank 22 when counting 
down from 390400. If the government aided hospitals and clinics only (all numbers 
excluding the italic/bold numbers) are considered only, 65200 has rank 225 when 
counting up from 300 and rank 15 when counting down from 390400. The depth of 
the data value is the smaller of the two ranks for each of the columns, namely 22 and 
15 respectively. 
Except for one middle line (indicated with a number in brackets), the number in the 
depth column is the maximum depth associated with data values on that line. Thus 
the depth of 35700 is 40 for the total number of institutions and 28 for the hospitals 
only. The "middle line" includes the median, and the depth column shows in 
parentheses the number of leaves on this line. 
6.2 Sampling method 
The stem-and-leaf display made it possible to organise numbers graphically in a way 
that directed attention to various features of the data. The properties of the sample 
distribution were well identified in conespondence with the aspects mentioned in 
Section 6.1. The task was therefore set to find a model in order to draw the best 
representative sample of the population and it was obtained in a very unique way. 
The parameters required in the sample were the numbers of examinations in the 
various age-gender-race groups as well as the technique factors regarding the various 
examinations, namely screening time (min.), receptor size (cm), view (AP, PA, LAT, 
Oblique), tube voltage (kV), workload (mAs) and FFD (cm). 
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It was decided to make use of the so-called Dollar Unit Sampling (DUS) method 
after the data in the stem-and-leaf display was subjected to each one of the guide-
lines enunciated in Section 6.1 and arguments in favour of this method considered: 
(i) The annual usage data is skewed to the small numbers (Figure 6.1 ). The Dollar 
Unit Sampling method is especially applicable to such circumstances. This 
method is a special case of probability proportional to size sampling (PPS 
sampling). All institutions with an annual examination number larger than 
200000 were included (Section 6.3.3) and the other institutions were 
proportionally and effectively randomly drawn. 
(ii) Figure 6.1 clearly indicates how spread out the range of examinations of each 
pru1icipant was in the survey. Prop011ional sampling is, however, a safe way to 
conduct a sampling procedure, since every class-size has an equal opportunity 
to be drawn. 
(iii) It can easily be observed that a few values are far removed from the rest, that 
there are concentrations of data and that there are gaps in the data. Proportional 
sampling is again a reliable way to conduct a sampling procedure, however, 
since it does not matter whether any or all of these conditions occur, every 
class-size has still an equal oppo11unity. 
This demonstrates why the stem-and-leaf display was considered to be an essential 
aid in the process to make a decision on the sampling method to be implemented. 
6.3 Dollar Unit Sampling (DUS) 
In this section it is not the intention to compare several methods of sampling. 
Proportional to size sampling appears to be an effective way, however, to deal with 
data like this and the Dollar Unit Sampling is thus an obvious choice. This section is 
therefore a representation of the historical development and theory of the DUS (not 
all the theoretical principles mentioned are applicable to this study but reveal the 
necessruy background) as well as its application to South African conditions. 
6.3.1 Non-standard mixtures 
The Dollar Unit Sampling method originated with the analysing of non-standard 
mixtures of distributions in auditing. A number of people were concerned about the 
fact that there were no appropriate statistical methods available for certain non-
standru·d distributions. Statistical methods have only recently begun to be developed 
for analysing this non-standru·d type of data. The first significant contribution was 
that of Aitchison (1955), with the larger number of contributions after 1972 (Guthrie, 
1989). 
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Figure 6.1 Stem and leaf display of radiological examinations in government aided 
hospitals, clinics, and private practices for 1987 /88. 
Interval width: 5000 
n (total) = 292 n (hospitals)= 239 
DEPTHS 
Total Hospitals (Unit= 100 examinations) 
o* 00 00 00 00 01 01 01 01 01 01 01 01 01 02 02 02 02 02 02 02 
03 03 03 04 04 04 04 05 05 05 05 05 05 06 06 06 07 07 08 08 
08 08 09 09 09 09 10 10 10 10 10 10 10 10 10 11 11 11 12 12 
13 13 13 13 14 14 14 14 14 14 15 15 15 16 16 17 17 17 17 18 
143 (137) 18 18 18 18 19 19 19 19 19 20 20 20 21 22 22 23 25 25 25 25 
26 26 26 26 26 27 28 2829 29 30 30 31 31 32 33 33 34 35 35 
36 38 38 40 40 40 40 40 40 41 41 43 44 44 45 45 45 45 45 46 
46 47 48 
(36) 102 o. 50 52 52 53 54 54 57 58 59 59 59 59 60 60 62 62 63 63 70 
70 72 74 74 75 76 80 82 83 84 84 85 86 88 88 90 94 ; 
113 69 1* 01 02 06 09 10 13 13 14 17 17 17 19 19 20 22 23 23 27 31 
31 32 33 34 39 40 41 47 
86 54 le 51 52 61 63 70 74 76 81 82 82 85 89 96 97 
72 44 2* 00 06 15 17 21 21 31 31 32 33 41 
61 36 2. 52 54 56 58 62 65 65 80 87 92 93 
50 32 3* 03 05 16 22 23 23 38 41 42 42 
40 28 3. 57 60 79 84 94 
35 25 4* 21 25 30 38 42 
30 21 4. 50 55 80 
27 19 5* 26 
26 18 5. 53 
25 17 6* 01 47 
23 15 6. 52 99 
7* 
21 14 7. 64 88 
19 13 8* 18 20 
17 8e 60 
16 9* 11 29 43 
13 11 9. 50 73 
11 9 10* 29 
10 8 10. 55 97 
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Figure 6.1 (cont.) 
DEPTI-IS 
Total Hospitals (Unit= 100 examinations) 
8 11* 38 





6 14* 01 






4 4 11. 75 (King Edward VIII Hospital) 










2 2 23* 34 (Groote Schuur Hospital) 
23. 
1 1 39* 04 (Baragwanath Hospital) 
Note: The bold numbers refer to private practices. 
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The terminology "mixture of distributions" usually refers to a situation in which the 
jth of k underlying distributions is chosen with probability p j,j = 1, ..... , k. The 
selection probabilities are usually unknown and the number of underlying 
distributions k may be fixed or random. The special case of two underlying 
distributions, with probabilities p and p-1, is an important classical problem. There 
are many examples of models that are best described as mixtures of two or more 
other models in the above sense. A probability model for the heights of 16 year old 
children would probably best be described as the mixture of two unimodal 
distributions, one representing the model for the heights of girls and one for the boys. 
Similar mixtures of distributions are mixtures of normal distributions, mixtures of x 2 
distributions, mixtures of exponential distributions and mixtures of binomial 
distributions. 
The literature contains very few papers that provide and deal with special "non-
standard" mixtures that mix discrete and continuous distributions. The word mixture 
refers in general to a convex combination of distributions of random variables. 
Suppose X and Y are random variables with distribution functions F and G, 
respectively. If O ~ p ~ 1, then H = pF + (1- p )G is a distribution function that may 
be called a mixture of F and G. The function H represents a model in which the 
distribution F is used with a probability p while G is used with a probability 1-p 
(Guthrie, 1989). His therefore a model of observation Z that is obtained as follows: 
With probability p observe X having distribution F, and with probability 1-p observe 
Y having distribution G. This may be interpreted as the outcome of a two-stage 
experiment: In the first stage, a population is randomly selected and in the second 
stage, an observation is made from the chosen population. Every distribution may be 
expressed as a mixture in infinitely many ways, however, when mixture models are 
formulated reasonably, they can provide useful tools for statistical analysis. 
This same type of non-standard model has applications in many quite different 
applications covering almost all other disciplines, for example, medicine and 
engineering (Guthrie, 1989). The descriptions of the following applications are brief 
and somewhat simplified. Fundamental differences do occur, however, since in 
some of the applications the mixtures are distinguishable in the sense that one can 
tell from which population an observation has come, whereas in others the mixtures 
are indistinguishable. 
(a) A particular service, for example a specific medical care, may not be utilised by 
all families in the community and those who subscribe to it, do so in varying 
amounts. The distribution of the consumption of the service may be represented 
by a mixture of zeros and positive values. 
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(b) In the mass production of certain components, some components may fail on 
installation (zero life lengths). The other components will have a life length that 
is a positive random variable whose distribution may take different forms. The 
overall distribution of lifetimes which includes the non-functional ones is a non-
standard mixture. 
( c) Genetic birth defects. Children can be characterised by two variates: (i) a 
discrete or categorical variable to indicate if one is not affected, affected and 
stillborn, or affected and born alive; and (ii) a continuous variable measuring the 
survival time of affected children born alive. The conditional distribution of 
survival time given this first variable is undefined for children who are not 
affected, a mass point at O for children who are affected and stillborn, and non-
trivial for children who are born alive. 
( d) The last application to be considered is the measurement of the physical 
performance scores of patients with a debilitating disease such as multiple 
sclerosis. Frequent zero measurements would be observed from those giving no 
performance and many observations with graded positive performance. 
6.3.2 Implementation of the Dollar Unit Sampling method 
Since the late 1950's, Kenneth Stringer began to investigate the practicality of 
incorporating statistical sampling into the audit practices of his firm, Deloitte, 
Haskins & Sells. It was not until 1963, however, that some results of his studies 
were communicated to the statistical profession (Stringer, 1963). 
Two pieces of information, the book (reco!ded) amount and the audited ( correct) 
amount, are produced by an item in an audit sample. The difference between the two 
is called the error amount. It is not uncommon to observe only a few items with 
errors in an audit sample. An audit sample may not yield any non-zero error 
amounts. For those samples in which most observations are zero, the classical 
interval estimation of the total error amount based on the asymptotic normality of the 
sampling distribution is not reliable. 
Alternatively, one could use the sample mean of the audited amount to estimate the 
total mean audited amount for the population. The value obtained, is then multiplied 
by the known number of items in the population to estimate the population total. 
This method is referred to in the audit profession as mean-per-unit estimation. (This 
method was implemented in this work in order to calculate radiological average 
technique values). 
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The mean-per-unit estimation is imprecise, however, because of the large variance of 
the audited amount that may arise in simple random sampling. A further result, 
however, is when the sample does not contain any item in error. The difference 
between the estimate of the total audited amount and the book balance must be 
interpreted as the sampling error. Assuming a population with no error in it, Stringer 
(1963) stated that statistical estimates of total error for each of the possible distinct 
samples of a given size that could be selected from it, would result in a different 
estimate and precision limit under this approach. Otherwise, however, all samples 
which include no errors should result in identical evaluations (Stringer, 1963). 
Stringer therefore reported in the same presentation that he, in collaboration with 
F.F. Stephan, had developed a new statistical procedure in auditing that was not 
dependant on the normal approximation of the sampling distribution. It could also 
provide a reasonable inference for the population error amount when all items in the 
sample are error-free (Stringer, 1963). This procedure is apparently the original 
implementation of the dollar unit sampling and it is one of the first workable 
solutions proposed for non-standard mixtures in accounting. The procedure is 
described in more detail in the following section, as well as how it was ·implemented 
for the present study. 
6.3.3 Definitions and notation 
In accountancy an account is considered as a population of individual accounts. The 
constituent individual accounts, when used as audit units, are defined as line items. 
Yi and Xi denote the book (recorded) and the audited ( correct) amount respectively 
for the ith line item of an account of N line items. Book and audited balances of the 
account are respectively 




called the population audited amount. The error amount is defined as 
D-=Y-X. 





When D i > o, it is known as an overstatement and if D i < o, an understatement. If 




is called the tainting ( or just the taint) of the ith item and 
Di =TiYi. 
The error of the book balance of the account is thus 
N N 





A large proportion of items in an audit population will likely be error-free, therefore 
Di= 0 for many values of i (Guthrie, 1989). 
Aitchison (1955) was the first to consider an inference problem for such a population 
(Di = 0 for many values of i). The error d of an item randomly chosen from an 
accounting population may be represented by 
d = { z with probability p 
0 with probability (1-p) 
(equ. 6.8) 
where p is the proportion of items with errors in the population and z =t:- 0 is a random 
variable representing the error amount. The variable z may depend on the book 
amount. 
· A useful sampling design for statistical auditing is to select items with probability 
proportional to book values. A process that can be applied, is the so-called Dollar 
Unit Sampling (DUS) or Monetary Unit Sampling (MUS) since the sampling design 
is modelled in terms of use of individual dollars of the total book amount as sampling 
units. (Neter, Wasserman and Whitmore, 1988; Guthrie, 1989). Similar populations 
are common in many disciplines, for example the cases described Section 6.3.1 
numbers (a), (b), (c) and (d). Such a sampling method is very appropriate for the 
present project. 
In the above-mentioned case of the books, the book amounts of the N items could be 
taken to be cumulated sequentially to a total of Y dollars. One may then choose 
systematically n dollar units at fixed intervals of I (= Y/n) from the cumulative total 
dollars. The items with book amounts exceeding I dollars, and hence items that are 
certain to be sampled, are separately examined. For the purposes of this project, the 
total number of X-ray examinations (Y) was considered. A table was constructed of 
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all the institutions as well as the cumulative number of examinations at every 
institution (Table 6.1). The fixed interval (I) was taken as 200000 examinations and 
27 institutions (n) were drawn in this way. This implies, therefore, that all 
institutions where more than 200000 examinations were done during the period ( one 
year) for which the statistics was obtained, were included automatically in the 
sample. In this case 100000 could be chosen for example for the fixed interval (I), 
but the amount of data that would have been obtained, would be difficult to 
manipulate. It is a sampling technique that results in a sample proportional to size, 
i.e. the larger the volume of X-ray examinations of the hospital or private 
radiological practice, the larger the likelihood to be included into the final sample. 
Table 6.1 Sample selection of institutions performing radiological investigations. 
Institution Number of examinations Cumulative number of 
examinations 
1 3019 3019 
2 4560 7579 
3 390415 397994 
4 7047 405041 
5 5711 410752 
6 10280 421032 
7 8610 429642 
8 7455 437097 
' 9 108 437205 
10 32309 469514 
11 2068 471582 
12 1802 473384 
13 246 473630 
14 55382 529012 
15 2091 531103 
16 68739 599842 
17 2275 602117 
18 850 602967 
etc. 
Intervals of 200000 were chosen in order to draw the samples. Institution number 3 
was the first institution that fell in an interval that is a multiple of 200000 and was 
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chosen. The next interval is 400001 to 600000 and institution number 4 is the first 
institution to fall in it. Thus number 4 was chosen. The next interval is 60000 l to 
800000 and institution number 17 is the first institution to fall in it and was therefore 
chosen. The whole process was thus completed this way. It can also be mentioned 
that the entries in the table were not entered by means of a statistical random method. 
It was entered in the same order as supplied in the provincial annual reports and in the 
order received from the various private radiologists in the four provinces. This would 
have no effect on the sample, however, since it was ensured that institutions were 
drawn in a random way by means of the Dollar Unit Sampling method. 
This method differs from that used for example in the UK and France as was 
discussed in Section 5.14. l and Section 5.15.1 respectively. In the UK the drawing of 
the sample was based on a system of radiography units, while in France their annual 
X-ray film consumption was considered during _a first phase and a sub-sample of X-
ray units during the second phase. A sample of 27 institutions out of a possible 292 
(9%) was drawn in the local survey, in comparison with the 386 out of a possible 4958 
(8%) public hospitals and pdvate practices and clinics in France (Maccia et al., 1988) 
and 112 out of a possible 1431 (8%) hospitals in Great Britain (Kendall et al., 1980). 
With the resources available, it was possible to successfully draw the sample. In the 
theoretical discussion, Section 6.3.3, one could choose systematically n units 
(institutions) at fixed intervals of I from the cumulative total Y according to the 
formula I = Y/n. In the South African smvey the fixed interval I was chosen 
systematically and an inte1val of 200000 examinations se1ved this purpose very well, 
resulting in a manageable number of institutions and automatically included the few 
extremely large ones. A sample of adequate size was obtained according to the 
discussions in the previous paragraph and in Section (a) of Chapter 10. 
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Chapter 7 
THE PROCESS OF DATA COLLECTION 
In Chapter 6 the procedure of how the sample was selected, was described. Letters were 
written to all the hospitals and private practices (27 in number) that were drawn in the 
sample, requesting them to participate in the survey. The initial response was poor 
(approximately 50% of the institutions did not respond). A second letter was written before 
the end of May i 990 and sent to hospitals and private practices reluctant to participate in 
the survey. In July 1990, all the institutions that had not responded to the two requests to 
take part in the survey were visited. Survey forms were handed out during these visits to 
people who seemed willing to help, and in some cases an agreement was reached on the 
format of the available information that could be supplied. A 100% response was obtained 
in this way. The sample distribution is represented by Figure 7.1. 
represent regions and not institutions. 
Figure 7.1 Sample distribution (examinations per year). 
655134 examinations per year e 74 622 examinations per year 
481 585 examinations per year @ 45 a50 examinations per year 
304 479 examinations per year @) 43 855 examinations per year 
203 511 examinations per year 2 275 examinations per year 









Krrysna Port Elizabeth 
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7.1 Design 
7.1.1 Longitudinal versus the cross-sectional approach 
A problem may be investigated in a variety of different ways. To decide upon 
a method of approach, it is necessary to understand the types of studies that 
might be done, and two were considered for this project. 
A longitudinal study collects information on study units, for example a 
cohort, over a specified time interval. A cross-sectional study collects data on 
study units at some fixed time (Fisher and van Belle, 1993). 
The difference is illustrated Figure 7 .2. The longitudinal study might collect 
information on the six new examinations appearing over the specified time 
interval. The cross-sectional study would identify the nine available 
examinations at the fixed time point. The cross-sectional study will have 
proportionately more examinations with a long duration. 
The GSD is a dose allocated to the population over a period of one year by 
definition so that a longitudinal study over a period of one year would be 
appropriate· for its determination (see section 2.2). However, for the present 
study, the cross-sectional approach was used with the fixed time being one 
week during which the survey was done at the various units. 
There were two reasons for using the cross-sectional approach. 
Firstly, it was considered to be too much of a burden for those radiographers 
involved should the survey continue for longer than one week. Secondly, 
differences exist between the respective X-ray units regarding certain 
technical aspects. There are also variations in technique in the various 
institutions as well as within X-ray departments. Since fewer units could be 
involved in a longitudinal study, the contribution of certain units that were not 
representative as regards physical properties of the unit as well as · the 












































Figure 7.2 Illustration of a longitudinal and a cross-sectional study of 
examinations (Fisher and van Belle, 1993). 
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The principal disadvantage of the cross-sectional approach is the fact that a 
limited number of cases are observed for short periods only with no 
quantification for the interim periods. Conclusions have to be made in many 
instances· without taking into account the contributions of events such as 
accidents or public disturbances. It is ~lso difficult to compensate for events 
like holidays which may cause an increase in the workload at certain 
institutions and a decrease at others. 
7.1.2 Data acquisition 
Survey forms were designed for dish·ibution to the various institutions that 
finally agreed to pat1icipate. Senior radiography personnel of the academic 
hospitals in the Western Cape and the Directorate: Electromedical Devices 
and Radiological Health were consulted in the planning of a survey form and 
the list of radiological examinations. Two types of forms as detailed in 
Appendix A were designed and finalised in June 1990. One form made 
provision only for the general info1mation and some technical information 
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(short form). The other form was designed to provide all the information 
necessary to do the required calculations for the skin-entrance doses and 
gonad doses ( detail form). Ninety six different examinations were selected, 
and a code was allocated to each examination (Appendix A). This 
information was distributed with the survey forms. 
The information required to determine the GSD can be divided into two 
categories: 
(a) General information. This category of information is relevant in the 
calculation of the GSD. The type of examination, age, gender and race 
were essential in order to do the calculations. The race must be known 
as there is a difference in the child expectancies of the different races 
(Health trends in South Africa, 1993; Demographic trends (1950-1990), 
1994). Although the mass was included, it was not required for the 
calculation of the GSD and was often left out by the participants. 
(b) Technical information. This data is required for the calculation of the 
skin-entrance doses and subsequently, the gonad doses. The technique 
factors for each examination, namely the view (for example AP, PA and 
LAT), tube voltage (kV), tube current (mA), workload (mAs), focal-film-
distance (FFD) and whether the unit was automatic or not, were essential 
for the calculations. The other factors involved were the screening time, 
cassette sizes, number of exposures (or CT cuts) per examination and 
retake views. Although information regarding the use of gonad shields 
was also requested, the information supplied was incomplete. 
It was initially planned that the average values under the heading "Technique" 
should be calculated for age-sex-view groups for all examinations. These 
values could then be imputed into corresponding records of the short form, as 
well as for the missing data on the detail form. This would have been a 
lengthy task and it was decided in preference to calculate average values and 
standard deviations. It would then be possible to calculate the skin entrance 
and gonad doses from these average values for all the examination types for 
the age-sex-projection groups. 
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7.1.3 Procedure 
The "detail" fo1ms were distTibuted to those institutions who responded 
initially in a positive manner. The remaining institutions were supplied with 
the "sh011" fonns. Radiation control officials of the Directorate: 
Electromedical Devices and Radiological Health are familiar with working 
conditions in the various hospitals and private practices under their control 
and were also consulted before a decision was made regarding the type of 
f01ms to be distributed. 
Distribution of the fo1ms staited in July 1990. The distribution in the Cape 
Province and in the Orange Free State was undertaken personally. The 
assistance of some of the senior personnel of the Directorate: Electromedical 
Devices and Radiological Health was obtained in this regard for Natal and the 
Transvaal. Their involvement was greatly appreciated since their personal 
contact with the personnel in charge at the institutions ensured the co-
operation of the institutions involved and that reliable data could be obtained. 
The survey was done during one week of the second semester of 1990 or the 
first semester of 1991 for all X-ray units at the specific institution. A typical 
week had to be chosen tluoughout all sections of the X-ray and allied 
departments. It was prefened that all the units be done. during the same week. 
If it was not possible, the survey was split, for example, unit A during the 
third week of September 1990, units B and C during the first week of 
October, etc. Therapy units (kV units and linear accelerators) were not 
included in the survey. 
7.2 Problems experienced 
The problems experienced during the progress of the survey were never of such a 
nature that it put the continuation of the project in danger at any time. Problems that 
were experienced were as follows: 
(a) The project had been delayed because of serious illness of key personnel who 
were responsible for the distribution of the forms in the Transvaal. To ensure 
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that accurate and reliable information was obtained, as well as the co-operation 
of those persons who were initially not willing to take part in the survey, the 
assistance of the above-mentioned workers was essential. 
(b) The political upheaval and stay-aways in the country at the time, as well as 
dissatisfaction amongst certain groups of radiographers regarding problems in 
their profession also contributed to a delay in the return of the survey forms. In 
some_ cases only a small number of radiographers was available for duty and 
under these circumstances, it was difficult to obtain the co-operation of the 
senior people. It was also impossible to enter certain areas to deliver the 
survey forms and to explain the completion of the forms. Arrangements had to 
be made to deliver , and later to collect the forms, elsewhere. 
(c) Supplementing and transferring of data into the computer started in July 1991. 
The extent of the task to transfer the raw data to a computer database was not 
fully realised previously. A need thus arose for financial aid in order to employ 
people for this task. An amount was made available shortly after the request 
which made it possible to complete this aspect in March 1992. 
7.3 Return of information 
The responses from the various institutions, could be classified into six categories, 
namely 
(a) Detail form (10 institutions)· 
(b) Short form (7 institutions) · 
( c) Register ( 4 institutions) 
( d) Computer printouts (2 institutions) 
(e) Detail form and register (1 institution) 
(f) Short form and register (3 institutions) 
Due to a shortage of staff or a heavy workload or both, it was not possible for some 
of the institutions to handle the extra burden of completing the survey forms. It was 
possible for other institutions to complete the survey forms during the day, but not 
after hours. These institutions were therefore willing to supply copies of their 
registers or computer printouts. This explains why registers and registers together 
with forms were supplied. 
84 
7.4 Database 
The software package used was Microsoft® Excel version 4.0 which was used and 
run on a 486 DX personal computer. The database ultimately consisted of 43100 
records. It was found that in some instances it was difficult to extract data for entry 
into the database due to the format in which the raw data was supplied by the 
institutions. 
7.4.1 Data processing 
Data supplied by means of photostatic copies, and often data supplied on the 
standard forms, needed to be checked and edited before it could be transferred 
to the computer (for example the allocation of codes to the various 
examinations). Instructions and other information to assist the persons who 
were involved with the transfer of the data and to interpret it correctly are 
given in Appendix B. 
Due to a shortage of staff, some institutions completed the standard forms 
only during the day. Copies of the registers were obtained and compared 
with the available completed forms. By means of a thorough investigation of 
the forms and registers, it could be decided what patient information did not 
appear on the forms and needed to be entered on the database. These 
decisions were based on information such as birthdays, types of examinations, 
and in some cases the date and time indicated on the copy of the register. 
In some instances during the transfer of data, the original records were found 
to be incomplete or unclear. These were marked and the data was later 
supplemented before entry into the database. · 
7.4.2 Imputation of missing data 
Item non-response imputation and adjustment procedures. When there 
was a failure by a patient to respond to an item, there was still some 
information available from the completed form. Two possible non-response 
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imputation and adjustment procedures as described by Madow, Nisselson and 
Olkin (1983) were applicable to this survey. 
(a) The Hot-deck imputation procedure. The individuals included in the 
survey were divided into categories and an initial value was determined 
for each category based on available data. The category to which each 
individual belonged, was determined as the new data was processed. If 
the form that was processed was complete, then that individual's 
response replaced the responses stored in the relevant category of the hot 
deck. When a form was encountered with a missing item, the response 
in the same cell of the hot deck was imputed for the missing response. 
When all forms were processed and the missing data imputed, the means 
and variances were again computed in the usual manner. 
(b) The Weighting-class imputation procedure. Basically, the weighting-
class adjustment procedure assigns sample members to various classes, 
based on information available for both respondents and non-
respondents. Within these classes an adjusted sampling weight can be 
assigned to each individual. 
The size of the database, however, hampered the implementation of the 
above-mentioned types of imputation to the extent that they could not be 
used. It was therefore necessary to resort to more simple types of imputation. 
Since standard film sizes and divisions are used, for example, in various types 
of examinations, a deterministic imputation could be applied in cases where 
film sizes and divisions were omitted. When the gender was omitted for 
example, a probability imputation was applied. The imputation that was done 




In order to calculate the gonad doses, it was decided to calculate the average values of the 
technique factors, with respect to the different age groups and views, for certain 
examinations. As mentioned previously, some results need to be imputed and these 
included age, gender, tube potential, tube current, exposure time and focal-film distance. 
The method used to calculate skin entrance and gonad doses is also described in the 
ICRP (1982). 
8.1 X-ray examinations 
Table 8.1 indicates the 96 diagnostic X-ray examinations for which data was 
requested. The table also lists the number of records in the database for the various 
examinations. Thirty of the 96 examinations were chosen for inclusion in the 
calculation of the genetically-significant dose as shown in Table 8.2. The 
examinations chosen were those that were considered as most likely to make an 
appreciable contribution to the gonad doses. This contribution was determined by 
the number of exposures in the sample associated with an examination (an 
indication was obtained from the number of records in the file) as well. as the gonad 
dose associated with each exposure. 
8.2 Age groups 
Four main age groups were distinguished in order to calculate the gonad doses, 
namely 0-0.5 years; >0.5-5 years; >5-15 years; and> 15 years. It was assumed that 
average prope1ties of the population such as weight and height, and therefore the 
average technique factors, could in an optimum way be represented by these four 
age groups. In order to calculate the GSD, these doses needed to be associated with 
the frequency of the X-ray examinations and that of the population distribution 
represented in the population census (Population Census 1991, 1992). The 
following procedure was followed: 
gonad doses in the 0-0.5 - age group were associated with the ( -1) - age group of 
the population; 
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gonad doses in the >0.5-5 - age group were associated with the (1 - 4) - age group 
of the population; 
gonad doses in the >5-15 - age group were associated with the (5 - 9) and (10 - 14) -
age groups of the population; 
gonad doses in the >15 - age group were associated with the ~15 - age groups of the 
population. 
8.3 Average technique factors 
From the above-mentioned file, tables were constrncted that comprised the average 
values of the technique factors, and are given in Table 8.2. Since these tables were 
arranged according to age and view, it was essential that these aspects had to be 
present in all records. The following replacements and imputations therefore had to 
be performed: 
(a) In some cases the age of patients were unknown and was either left blank or 
an indication was given like "U" for unknown, "A" for adult, etc. Except 
when there was reason to replace the vacancy or symbol with something else, 
a 30 was imputed. This was based on the principle that fewer X-ray 
examinations are being done on younger people. The child expectancy is also 
lower than at a younger age (Darby et al., 1980), with the result that it had 
minimal effect on the GSD. It must be stressed, however, that this was only a 
problem for a small number of the records, namely 1.4%. 
(b) It was apparent from the data supplied, as well as from consultation with 
workers active in this field, that in general the PA-view for fluoroscopy and 
AP for radiography are most often used. Missing values were therefore 
respectively imputed. 
( c) In some records the size of the film of the camera that was entered on the 
fo1m, i.e. 10 cm x 10 cm, had to be replaced with 18 cm x 24 cm. The 
computer program that was used to calculate gonad doses, makes provision 
only for the views AP, PA and LAT. It was therefore necessary to replace AP-
Oblique with AP and PA-Oblique with PA. 
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Table 8.1 · Diagnostic X-ray examinations. 
A. GENERAL EXAMINATIONS No. records No. records 
No. records TIB&FIB 364 L YMPHANGIOGRAMS 0 
HEAD ANKLE 375 
FOOT 279 JOINTS AND EXTREMITIES 
SKULL 674 PELVIMETRY 0 
SELLA TURCICA 9 ARTHROGRAM (SHOULDER) 10 
ORBITS 25 B. SPECIAL EXAMINATIONS ARTHROGRAM (ELBOW) 5 
SINUSES 342 ARTHROGRAM (HIP) 2 
FACIAL BONES 128 No. records ARTHROGRAM (KNEE) 0 
MASTOIDS 73 HEAD PERIPHERAL ARTERIO- 33 
ZYGOMATIC BONE 5 GRAM AND ANGIOPLASTY 
T-MJOINTS 10 ANGIOGRAM 13 (UPPER LEG) 
MANDIBLE 81 AIR ENCEPHALOGRAM 5 PERIPHERAL ARTERIO- 29 
ORTHOP ANTOMO- 45 MASTOID TOMOS IS GRAM AND ANGIOPLASTY 
GRAM (LOWER LEG) 
TEETH 14 SPINE LYMPHANGIOGRAPHY: 0 
TOTALLEG 
SPINE MYELOGRAM (CERVICAL) 6 VENOGRAPHY: LOWER LEG o. 
MYELOGRAM (THORACIC) 10 ARTEROGRAPHY:UPPER 0 
CERVICAL SPINE 530 MYELOGRAM (LUMBAR) 62 LEG 
THORACIC SPINE 207 DISCOGRAPHY 5 SCREENING OF EXTREMI- 36 
LUMBAR SPINE 709 SPINE TOMOGRAPHY 17 TIES FOR REDUCTION OF 
SCOLIOSIS X-RAYS 24 FRACTURES OR 
(FULL SPINE) CHEST DISLOCATIONS 
SCREENING UPPER LEG 5 
CHEST AORTOGRAM 6 (FEMUR) 
BARIUM SWALLOW 204 EXTREMITY TOMOGRAPHY 3 
LUNGS 6349 BRONCHOGRAM 5 
RIBS 99 MAMMOGRAM 196 
STERNUM 6 TOMOGRAPHY (LUNGS) 10 C. COMPUTER TOMOGRAPHY 
STERNOCLA VICU· 4 HEART CATHETERISATION 669 
LARJOINTS SCREENING OF DIAPHRAGM 4 No. records 
MASS-MINIATURE 2 BRAIN 336 
ABDOMEN ORBITS 13 
ABDOMEN FACIAL BONES I SINUSES 37 · 
AORTOGRAM 27 PETROUS BONE I AUDITORY 7 
ABDOMEN SURVEY 480 ARTERIOGRAMS: MESEN- 15 CANAL 
GALL-BLADDER VIEW 3 TERIC, RENAL, HEPATIC CERVICAL SPINE 8 
CHOLANGIOGRAM, 32 THORACIC SPINE 6 
PELVIS CHOLECYSTOGRAM LUMBAR SPINE 47 
RETROGRADEPYELOGRAM 55 LUNGS I MEDIASTINUM 66 
PELVIS 300 INTRAVENOUSPYELOGRAM 372 ABDOMEN· LIVER, 110 
SACRUM 22 EMBOLISATION, LITHO- 14 SPLEEN, KIDNEYS, VESSELS, 
COCCYX 8 TRIPSY, NEPHROSTOMY LYMPH NODES 
S-IJOINTS 19 BARIUM MEAL 434 PELVIS 15 
ECRP 23 EXTREMITIES (KNEE, ETC.) 6 
JOINTS AND EXTREMITIES KIDNEY TOMOGRAPHY 82 PITUITARY FOSSA 0 
SHOULDER GIRDLE 234 PELVIS 
HUMERUS 72 
ELBOW 187 CYSTOGRAM 107 
FOREARM 203 URETHROGRAM 18 
WRIST 253 SALPINGOGRAM 39 
HAND 384 BARIUM ENEMA 317 
HIP JOINT 201 HIP TOMOGRAPHY 0 
FEMUR NECK 16 HIP OPERATIONS 2 
FEMUR 204 BIFURCATION ARTERIO· 12 
KNEE 451 GRAMS/ ANGIOPLASTY 
Table 8.2 Average technique values/or diagnostic examinations. 89 
(mAs - workload; SD - standard deviation; kV - tube voltage; FFD - focus-film distance; 
SSD - source-skin distance; FicldX - X-ray field in x-direction at image receptor; FieldY -
X-ray field in y-direction at image receptor; Fluoro - screening time; 0/AP - overview/AP; 
AX - axial; 0/LAT - overview/lateral). 
CERVICAL SPINE 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 




AP 12.5 8.8 69.7 11.0 105.7 5.3 16.6 2.4 22.3 2.9 
>0.5-5 PA 
LAT 12.6 6.4 60.2 7.1 114.2 25.4 19.5 2.7 25.5 2.7 
AP 10.5 6.4 64.5 10.6 100.0 0.0 24.0 0.0 24.0 8.5 
>5-15 PA 
LAT 10.3 4.5 65.0 9.2 116.7 28.9 24.0 0.0 26.0 6.9 
AP 37.6 34.7 68.7 7.0 117.4 23.3 18.7 3.3 24.9 3.0 
>15 PA 45.7 14.1 65.8 8./ 105.7 13.4 17.6 1.3 23.6 1.6 
LAT 43.9 41.3 70.7 7.1 138.1 30.2 20.8 3.0 26.8 3.0 
THORACIC SPINE 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 







AP 6.0 0.0 57.0 0.0 180.0 0.0 20.0 3.5 26.0 3.5 
>5-15 PA 
LAT 
AP 88.6 71.2 70.4 8.6 107.6 16.1 19.1 5.1 39.5 4.7 
>15 PA 
LAT 282.7 284.7 67.3 11.4 114.7 21.8 19.9 5.2 39.0 5.3 
LUMBAR SPINE 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 





>0.5-5 PA 4.0 55.0 150.0 24.0 30.0 
LAT 
AP 148.0 33.9 66.5 5.9 110.5 7.2 22.6 4.3 36.4 6.0 
>5-15 PA 64.0 0.0 72.0 1.7 100.0 0.0 18.0 0.0 24.0 0.0 
LAT 173.6 99.0 74.7 8.5 117.2 24.6 22.0 4.9 33.6 7.9 
AP 130.1 80.3 76.5 9.3 103.2 8.0 22.8 5.2 35.9 6.2 2.0 
>15 PA 130.0 42.4 77.0 15.6 106.7 7.6 22.7 6.4 41.0 1.7 
LAT 194.2 127.6 86.9 10.7 103.3 10.7 21.5 5.2 33.5 7.6 
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SCOLIOSIS X-RAYS (FULL SPINE) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 






AP 106.7 24.6 72.0 5.3 140.0 46.2 37.7 4.1 73.7 30.0 
>5-15 PA 
LAT 122.5 3.5 75.0 2.8 180.0 35.0 0.0 93.0 2.8 
AP 99.1 47.9 70.7 9.3 148.6 35.8 32.0 6.3 52.5 25.2 
>15 PA 
LAT 114.0 72.6 76.0 11.8 140.0 43.8 30.3 6.8 52.1 28.5 
LUNGS 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 
AP 4.3 1.2 53.0 7.1 108.1 14.7 18.9 2.6 25.0 2.9 
0-0.5 PA 4.4 3.0 62.0 8.7 150.0 32.2 6.9 33.2 4.5 
LAT 6.4 3.3 62.6 9.7 124.6 27.2 21.8 5.6 28.4 6.6 
AP 5.3 4.0 61.4 9.0 118.7 29.3 22.3 3.4 28.4 3.6 
>0.5-5 PA 8.0 10.0 65.0 11.3 150.4 19.7 25.5 5.0 31.4 5.o-
LAT 6.8 5.7 76.8 15.4 142.5 30.7 22.5 4.7 28.8 5.3 
AP 9.6 16.2 66.2 12.1 138.3 35.9 27.3 4.5 34.7 5.2 
>5-15 PA 9.6 10.5 79.0 16.2 163.7 22.1 29.8 5.0 36.8 5.4 
LAT 19.6 21.7 90.2 20.6 164.3 27.6 29.3 4.8 37.1 5.9 
AP 8.4 13.6 89.3 28.8 143.2 30.0 34.7 2.0 41.0 3.6 
>15 PA 13.2 13.1 110.4 31.9 167.3 ]8.6 34.9 1.2 40.7 3.6 2.2 0.8 
LAT 21.4 22.8 123.5 26.9 167.3 18.3 33.0 2.8 41.6 2.1 
RIBS 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 








>5-15 PA 11.0 7.1 63.0 4.2 140.0 56.6 24.0 0.0 30.0 0.0 
LAT 
AP 53.6 36.2 70.0 12.7 130.5 32.1 32.5 3.0 40.9 2.8 
>15 PA 67.7 87.4 83.9 31.7 143.8 32.8 33.9 2.1 41.2 2.8 . 
LAT 19.3 8.7 102.2 22.6 156.0 37.8 31.0 2.2 40.6 1.3• 
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ABDOMEN SURVEY 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 
AP 35.6 99.9 51.7 1.7 104.0 5.2 18.6 1.9 24.7 1.9 
0-0.5 PA 
LAT 6.0 52.0 110.0 18.0 25.0 
AP 18.5 16.0 60.3 5.5 100.6 2.4 23.6 4.2 29.9 4.9 
>0.5-5 PA 
LAT 10.0 60.0 180.0 24.0 30.0 
AP 19.7 20.3 68.3 6.5 111.3 28.0 31.1 3.8 39.9 4.3 
>5-15 PA 
LAT 23.0 24.0 70.0 21.2 100.0 0.0 32.5 3.5 41.5 2.1 
AP 69.2 49.5 77.6 13.5 109.3 12.8 34.4 3.1 42.l 3.6 2.8 2.8 
>15 PA 31.5 26.2 105.0 26.l 118.8 25.6 34.6 1.4 41.8 2.7 16.0 
LAT 52.6 39.3 80.6 17.2 111.7 15.9 31.8 6.1 39.3 6.9 
PELVIS 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 




AP 28.0 6.8 58.8 5.0 102.0 2.7 20.4 3.3 26.4 3.3 
>0.5-5 PA 
LAT 
AP 52.6 42.2 67.2 6.8 101.0 2.1 31.2 4.3 40.1 5.3 
>5-15 PA 
LAT 
AP 78.2 54.8 70.9 7.7 33.7 3.6 41.1 4.3 
>15 'PA 241.6 353.7 78.0 19.1 100.0 0.0 38.0 0.0 27.1 4.3 28.0 5.1 6.2 6.2 
LAT 301.5 303.5 85.5 23.5 104.3 5.2 38.0 0.0 27.5 5.1 34.2 5.3 
SACRUM 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 







AP 175.0 215.8 61.7 2.0 103.3 5.2 28.7 5.4 36.0 6.7 
>5-15 PA 
LAT 332.6 351.4 64.8 6.6 104.0 5.5 25.0 7.5 32.2 8.9 
AP 105.0 7.5 21.0 3.2 27.0 3.2 
>15 PA 
LAT 135.0 105.8 86.2 5.1 102.5 6.1 18.9 2.3 24.9 2.3 
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HIP JOINT 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 
AP 3.0 48.0 100.0 18.0 24.0 
0-0.5 PA 
LAT 
AP 35.2 23.8 53.8 6.3 114.0 20.4 28.4 6.0 35.2 7.1 
>0.5-5 PA 
LAT 71.0 45.0 110.0 24.0 30.0 
AP 68.6 65.3 64.0 3.3 102.1 2.7 18.0 4.9 27.4 3.2 
>5-15 PA 
LAT 
AP 109.0 72.7 70.0 8.3 104.9 6.3 27.4 6.6 34.9 7.4 
>15 PA 73.0 7.2 75.0 2.4 87.0 2.7 24.0 0.0 30.0 0.0 4.7 
LAT 160.5 92.5 76.9 7.2 107.5 5.3 24.1 3.5 31.2 4.7 
FEMUR NECK 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 







AP 6.0 0.0 59.0 1.7 100.0 0.0 30.7 4.1 39.3 4.8 
>5-15 PA 
LAT 6.0 63.0 100.0 24.0 30.0 
AP 12.7 3.1 62.0 3.5 100.0 0.0 19.8 3.6 38.7 7.5 
>15 PA 12.3 2.2 62.0 3.6 100.0 0.0 25.0 0.0 25.0 0.0 
LAT 28.4 21.4 70.4 5.8 100.0 0.0 22.8 2.7 32.6 5.8 
FEMUR 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 
AP 5.0 50.0 100.0 18.0 24.0 
0-0.5 PA 
LAT 
AP 9.3 3.1 57.3 5.5 100.0 0.0 20.2 6.6 38.6 5.0 
>0.5-5 PA 
LAT 9.3 3.1 57.3 5.5 100.0 0.0 23.7 6.5 37.7 6.8 
AP 21.0 29.9 64.5 9.2 100.0 0.0 21.8 7.8 41.5 3.6 
>5-15 PA 
LAT 26.5 33.8 57.1 16.9 105.6 16.7 16.9 1.3 42.2 1.4 
AP 44.5 50.4 67.1 8.8 109.2 20.2 22.1 8.0 39.9 4.3 
>15 PA 11.0 0.0 57.0 1.8 100.0 0.0 25.0 0.0 25.0 0.0 
LAT 29.3 48.6 65.4 7.3 105.1 16.7 18.8 5.6 39.8 5.0 
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MYELOGRAM (LUMBAR) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 










AP 43.9 29.1 76.5 5.5 112.0 6.1 17.3 8.5 33.6 2.5 3.5 
>15 PA 34.6 20.0 81.2 6.7 77.8 13.9 38.0 0.0 16.5 5.9 30.0 0.0 4.1 1.9 
LAT 87.4 60.1 94.3 10.6 91.3 23.2 16.0 6.5 30.8 2.4 
BARIUM SW ALLOW 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 





>0.5-5 PA 800.0 0.0 96.0 0.0 68.0 0.0 38.0 0.0 20.6 5.6 30.0 0.0 2.2 0.7 
LAT 800.0 0.0 96.0 0.0 68.0 0.0 38.0 0.0 24.0 0.0 30.0 0.0 
AP 
>5-15 PA 800.0 0.0 109.0 0.0 68.0 0.0 38.0 0.0 12.0 0.0 30.0 0.0 2.0 
LAT 800.0 0.0 109.0 0.0 68.0 0.0 38.0 0.0 12.0 0.0 30.0 0.0 
AP 294.0 375.4 82.4 12.1 102.8 15.1 38.0 0.0 23.7 8.0 31.7 3.2 
>15 PA 389.2 368.2 107.8 17.4 72.2 9.1 39.9 2.4 13.9 5.6 31.3 2.7 3.1 2.9 
LAT 651.8 311.0 105.5 17.9 71.8 10.4 39.3 2.2 16.5 6.1 30.3 1.5 
HEART CATHETERISATION 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 











>15 PA 128.7 44.1 82.8 17.8 91.1 3.2 55.0 0.0 19.8 7.8 19.2 6.8 13.5 9.9 
LAT 118.0 41.7 92.4 22.9 91.2 3.3 55.0 0.0 20.3 8.0 19.7 7.0 5.8 6.6 
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AORTOGRAM (ABDOMEN) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 










AP 38.0 0.0 70.0 4.7 100.0 0.0 35.0 0.0 35.0 0.0 
>15 PA 37.7 13.2 70.3 6.6 88.1 12.1 38.0 0.0 25.0 1.6 27.0 2.6 3.6 2.8 . 
LAT 
RETROGRADEPYELOGRAM 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 










AP 40.0 0.0 80.2 3.6 109.7 1.8 34.7 1.7 42.7 2.0 
>15 PA 800.0 0.0 109.0 0.0 68.0 0.0 38.0 0.0 17.8 9.7 30.8 2.0 4.0 0.0 
LAT 
INTRAVENOUSPYELOGRAM 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 
AP 16.0 0.0 62.0 0.0 100.0 0.0 18.0 0.0 24.0 0.0 
0-0.5 PA 
LAT 
AP 25.0 0.0 60.0 0.0 100.0 0.0 21.6 3.1 27.6 3.1 
>0.5-5 PA 
LAT 
AP 88.6 JO.I 61.0 2.9 110.2 4.6 27.1 3.6 35.4 5.6 
>5-15 PA 
LAT 
AP 93.1 53.3 71.4 8.0 105.6 6.3 29.7 6.1 37.3 7.0 
>15 PA 94.8 83.7 80.1 27.3 122.5 27.6 35.0 0.0 43.0 0.0 
LAT 136.6 91.0 105.2 25.3 114.0 20.1 28.4 6.0 35.2 7.1 
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BARIUM MEAL 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 







AP 68.0 38.0 18.0 24.0 
>5-15 PA 401.6 207.4 96.0 0.0 71.8 10.6 38.0 0.0 21.1 7.1 26.6 8.6 3.1 2.1 
LAT 500.0 0.0 96.0 0.0 68.0 0.0 38.0 0.0 23.0 2.4 29.0 2.4 
AP 71.4 57.2 89.0 12.3 100.7 20.0 65.5 23.3 19.8 8.0 29.7 5.5 
>15 PA 77.3 146.3 96.5 15.4 68.7 5.3 41.8 6.2 15.7 6.8 24.7 7.7 4.9 2.2 
LAT 256.2 377.9 98.7 14.2 71.6 12.3 44.5 12.4 19.7 5.4 26.3 7.0 
KIDNEY TOMOGRAPHY 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 







AP 80.0 0.0 56.0 0.0 110.0 0.0 24.0 0.0 30.0 0.0 
>5-15 PA 
LAT 




Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (cm) (min.) (min.) 
AP 25.0 0.0 49.0 0.0 68.0 0.0 38.0 0.0 35.0 0.0 35.0 0.0 1.7 
0-0.5 PA 
LAT 
AP 28.5 3.7 50.0 1.0 68.0 0.0 38.0 0.0 35.0 0.0 35.0 0.0 4.0 1.9 





AP 84.6 32.6 77.0 11.8 76.6 18.2 54.1 22.4 30.3 6.6 32.7 4.4 2.2 1.8 
>15 PA 100.8 22.9 95.6 16.1 71.8 2.2 44.1 8.0 17.9 7.5 29.8 5.6 4.1 1.5 
LAT 400.0 85.3 13.3 73.0 43.0 31.3 6.4 33.3 2.9 
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URETHROGRAM 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro . SD 










AP 59.4 35.8 82.8 3.8 114.3 3.4 19.1 5.3 27.8 5.5 
>15 PA 
LAT 120.0 0.0 115.0 0.0 12.0 0.0 30.0 0.0 
SALPINGOGRAM 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 










AP 34.0 11.3 81.9 17.4 110.6 5.0 38.0 21.4 3.1 27.4 3.1 
>15 PA 11.6 7.3 113.0 6.1 69.5 2.3 38.9 2.0 22.2 2.8 28.2 2.8 3.4 1.1 
LAT 
BARIUM ENEMA 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 







AP 24.6 23.6 65.0 9.4 109.0 15.9 78.0 17.1 30.3 5.9 35.1 5.8 
>5-15 PA 69.3 42.6 90.l 15.1 83.5 18.8 52.7 18.4 22.7 9.3 33.3 4.8 6.7 7.4 
LAT 85.0 0.0 115.0 0.0 85.0 12.0 0.0 30.0 0.0 
AP 58.3 134.6 95.8 13.0 99.6 17.9 57.8 22.0 31.1 5.3 37.2 6.0 
>15 PA 139.6 /88.5 106.5 10.0 77.1 13.5 43.6 8.2 22.4 8.7 31.1 6.0 6.1 3.3 
LAT 291.4 356.6 111.8 10.9 80.0 15.5 43.5 10.6 24.8 4.3 30.8 4.5 
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BIFURCATION ARTERIOGRAMS I ANGIOPLASTY 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 










AP 38.0 0.0 69.0 0.0 68.0 0.0 38.0 35.0 0.0 35.0 0.0 
>15 PA 24.5 0.5 68.0 8.3 68.0 0.0 38.0 0.0 27.2 4.2 27.2 4.2 3.0 2.1 
LAT 
PERIPHERAL ARTERIOGRAM AND ANGIOPLASTY (UPPER LEG) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD FieldY SD Fluoro SD 








>5-15 PA 60.0 0.0 68.0 0.0 38.0 0.0 25.0 0.0 25.0 0.0 1.5 
LAT 
AP 38.0 0.0 56.4 8.0 68.0 0.0 38.0 0.0 20.8 6.5 25.8 4.2 
>15 PA 20.8 6.7 64.1 8.3 68.8 5.0 38.0 0.0 25.8 2.2 26.1 2.4 9.7 15.8 
LAT 
LUMBAR SPINE (CT) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD No. of SD Fluoro SD 





>0.5-5 AX 507.0 0.0 120.0 0.0 250.0 0.0 10.0 
0/LAT 
0/AP 320.0 120.0 1.0 
>5-15 AX 420.0 0.0 120.0 0.0 15.0 
Oil.AT 960.0 120.0 1.0 
0/AP 499.6 121.0 120.0 0.0 40.0 1.0 0.0 
>15 AX 552.6 103.8 125.1 5.0 311.4 48.9 26.6 13.2 
0/LAT 847.2 149.8 123.8 5.1 35.0 0.0 1.0 0.0 
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LUNGS / MEDIASTINUM (CT) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD No. of SD Fluoro SD 







0/AP 314.0 178.2 122.5 3.5 51.2 1.0 0.0 
>5-15 AX 411.0 36.2 121.2 2.1 250.0 0.0 22.7 14.2 
0/LAT 
0/AP 335.5 123.7 124.2 3.8 50.3 2.2 1.0 0.0 
>15 AX 336.3 73.6 124.5 4.6 295.5 51.0 14.3 4.9 
0/LAT 527.5 480.1 120.0 0.0 1.0 0.0 
ABDOMEN - LIVER, SPLEEN, KIDNEYS, VESSELS, LYMPH NODES (CT) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD No. of SD Fluoro SD 
(years) (cm) (cm) (cm) (cm) (cm) (cm) slits (cm) (min.) (min.) 
0/AP 24.0 120.0 1.0 





0/AP 440.0 125.0 51.2 1.0 
>5-15 AX 410.0 0.0 125.0 0.0 19.0 
0/LAT . 
0/AP 355.7 104.6 124.5 3.4 48.5 6.8 1.0 0.1 
>15 AX 394.2 47.5 123.5 3.4 319.5 72.9 21.2 8.3 
0/LAT 
PELVIS (CT) 
Age View mAs SD kV SD FFD SD SSD SD FieldX SD No. of SD Fluoro SD 




0/AP 380.0 120.0 25.0 1.0 





0/AP 234.4 84.3 122.0 2.7 28.7 5.4 1.0 0.0 
>15 AX 352.0 102.6 115.6 9.4 325.8 85.2 17.5 9.7 
0/LAT 
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8.4 The determination of skin entrance doses 
The following procedure was followed: 
(a) Two methods were available. The method described by McCullough and· 
Cameron (1970) involved the interpolation of tube potential values (kV) on a 
graph to obtain an exposure in mR/mAs. The "RADCOMP Entrance Skin 
Exposure Software Program" of Nuclear Associates was used, however, to 
produce parametric free air exposure (FAE) tables (Nuclear Associates and 
Zamenhof, 1990) based on doses from Table B.3, NCRP Report No. 102 
(1989). Additional information such- as the phase (single or three phase), Rad 
or Fluoro or Mammo, total filtration and focus-chamber-distance was also 
required by RADCOMP. The total filtration could be assumed to be 2.5 mm Al 
in all calculations according to the NCRP Report No. 54 (NCRP, 1977). It was 
assumed that all the units were three phase and different tables were drawn up 
for Radiography and Fluoroscopy. 
In Table B.3 ofNCRP Report No. 102 (1989), average air kerma rates produced 
by diagnostic X-ray equipment at certain distances from source to point of 
measurement are provided in centigray per 100 mAs. Since the FDA-program 
that was used to determine the gonad doses (see 8.3) requires that the FAE at 
skin entrance must be in mR, it was therefore necessary to convert the values in 
the above-mentioned Table B.3 to rontgen (see 3.2.4). The conversion is 
shown in Table 8.3. 
This method was therefore preferred above the one described by McCullough 
and Cameron since no relatively inaccurate interpolation on a graph was 
required. More reliable results could also be obtained by using Table B.3 in the 
NCRP Report No. 102 (1989) in order to obtain the free air exposure tables. 
This report contains recent information that is better applicable to the present 
technology. Nine such tables were produced, five for radiographic 
examinations with FFD 43 cm, 60 cm, 100 cm, 140 cm and 180 cm, and four 
for fluoroscopic examinations with FFD 43 cm, 60 cm, 100 cm and 140 cm. 
One such a table for the radiographic mode is represented by Table 8.5. 
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Table 8.3 Exposure rates produced by three phase diagnostic X-ray equipment. 
Distance from Tube Potential 
Source to Point kVp 
of Measurement 
50 60 70 80 90 100 110 120 130 140 
cm rontgen per I 00 mAs 
30 3.80 5.87 7.94 10.24 13.00 14.73 16.92 20.48 24.28 26.35 
45 1.73 2.65 3.57 4.49 5.75 6.56 7.48 9.09 10.82 11.74 
60 0.96 1.50 1.96 2.53 3.22 3.68 4.26 5.06 6.10 6.56 
100 0.34 0.53 0.71 0.92 1.15 1.27 1.50 1.84 2.19 2.42 
137 0.18 0.28 0.38 0.48 0.62 0.70 0.80 0.98 1.15 1.26 
183 0.10 0.16 0.21 0.28 0.34 0.39 0.45 0.55 0.66 , 0.71 
(b) Skin entrance doses were calculated for all the views in the various age groups for 
the chosen examinations and as shown in Table 8.6. Values from Table 8.2 were 
used to obtain these doses and a cmTent of 3 mA was used for screening. The free 
air exposure was calculated first at the image receptor and then by means of the 
inverse square law at the surface of the skin. In order to obtain the focus-skin-
distance, info1mation regarding average patient-thickness was required. It was 
obtained from practical measurements and from the literature (Rosenstein, 1988 and 
Rosenstein, Beck, Warner, 1979). These values are shown in Table 8.4. 
Table 8.4 Patient thickness. 
Age (years) View Patient thickness (in·cm) 
0- 0.5 AP 11.2 
LAT 12.4 
>0.5- 5 AP 15.0 
LAT 20.0 
> 5-15 AP 20.0 
LAT 25.0 
> 15 AP 24.0 
LAT 31.0 
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FAE - Free Air Exposure (mR) 
mAs 
l 2 3 5 10 15 20 25 30 40 50 60 80 100 120 140 
5 10 16 26 S2 78 104 130 156 · 207 259 311 415 S19 622 726 
7 IS 22 37 73 110 147 184 220 294 367 441 588 73S 882 1029 
10 19 29 48 96 144 192 240 288 385 481 577 769 961 1154 1346 
12 24 36 60 120 180 240 300 360 479 S99 719 959 1199 1438 1678 
14 29 43 72 145 217 289 362 434 578 723 868 1157 1446 1735 202S 
17 34 51 85 170 256 341 426 511 682 852 1022 1363 1704 2045 2385 
20 39 59 99 197 296 394 493 591 788 986 1183 1577 1971 2365 2760 
22 45 67 112 225 337 450 562 674 899 1124 1349 1799 2248 2698 3148 
25 SI 76 127 253 380 507 634 760 1014 1267 1521 2028 2535 3042 3549 
28 57 85 142 283 425 566 708 849 1132 1415 1698 2264 2830 3396 3962 
31 63 94 157 313 470 627 784 940 1254 1567 1881 2508 3135 3762 4388 
34 69 103 172 345 517 690 862 1034 1379 1724 2069 2758 3448 4137 4827 
38 75 113 188 377 565 754 942 1131 1508 1885 2262 3015 3769 4523 5277 
41 82 123 205 410 615 820 1025 1230 1640 2050 2459 3279 4099 4919 5739 
44 89 133 222 444 666 887 1109 1331 1775 2218 2662 3549 4437 5324 6211 
48 96 143 239 478 717 956 1196 1435 1913 2391 2869 3826 4782 5739 6695 
SI 103 154 257 S14 770 1027 1284 1541 2054 2568 3081 4108 5135 6162 7189 
55 110 165 275 550 824 1099 1374 1649 2198 2748 3297 4396 5495 6594 7694 
59 117 176 293 586 879 1173 1466 1759 2345 2931 3518 4690 5863 7035 8208 
62 125 187 312 624 936 1247 1559 1871 2495 3118 3742 4989 6237 7484 8732 
66 132 199 331 662 993 1324 1654 1985 2647 3309 3971 5294 6618 7941 9265 
70 140 210 350 700 1051 1401 1751 2101 2802 3502 4203 5604 7005 8405 9806 
74 148 222 370 740 1110 1480 1849 2219 2959 3699 4439 5918 7398 8877 10357 
( c) Unlike most other gonad dose surveys which have used direct measurements of 
entrance surface doses, this survey relies on published standard X-ray tube 
output tables . for a fixed filtration and waveform to estimate entrance skin 
exposure for average technique factors. Table 8.2 illustrates that the standard 
deviations for the tube voltage (kV) and focus-film-distance (FFD) are 
estimated as 25% of the mean values, while that for the workload (mAs) could 
be as high as 100% of the mean value (see Chapter 10). Another factor that 
adds to the unce1tainty of the FFD is the average patient thickness (Table 8.4) 
that is required in order to dete1mine the focus-skin-distance. It was assumed 
that all units were three phase and the total filtration to be 2.5 mm Al (ICRP, 
1982), although it is known that it is more than 3 mm Al in many instances. 
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8.5 Gonad doses 
After the skin entrance doses were calculated, it was possible to calculate the gonad 
doses. A computer program was obtained for this purpose from the FDA, US 
Department of Health and Human Services, in the USA (Peterson and Rosenstein, 
1989). It was originally developed for radiographic projections. Many common 
radiographic projections can be specified in the program by projection codes. The 
following information is required to calculate the gonad doses for radiography and 
fluoroscopy of adult patients, namely 
(a) The examination and view (AP, PA and LAT only) 
(b) Entrance exposure (free in air) at skin surface 
(c) Focus-film distance (focus-skin distance for undercouch tubes too) 
(d) High voltage of tube (kV) and half value layer (HVL) 
(e) Workload (mAs) 
(f) Film size (X-ray field size at image receptor) 
(g) Screening time 
(h) Thickness of patient (AP and LAT) 
(i) X-ray field location relative to anatomical landmarks. 
The computer program makes an estimation of the absorbed doses to several tissues 
of a reference patient for a specified X-ray projection using tissue-air ratios. These 
ratios were previously generated by a Monte Carlo technique. The free-in-air 
exposure at the tissue plane is computed from the free-in-air exposure at the skin 
entrance, using the inverse square law. The absorbed dose to the tissue is the 
product of the exposure at the tissue plane and the tissue-air ratio. Tissue doses for 
a female are obtained by minor adjustments to the tissue doses computed for the 
male reference patient. Conversion factors are applied to certain tissue doses 
(active bone marrow, lungs, and total trunk) to account for the effect of shielding or 
scattering due to female breasts (Peterson and Rosenstein, 1989). 
The same input data are required for fluoroscopic projections. The source-to-image 
receptor distance and the source-to-skin entrance distance are both required, since 
the patient, X-ray source and image receptor geometry may not be the same as that 
selected for radiographic projections. The dynamic components of a fluoroscopic 
examination is simulated with stationary X-ray fields. 
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Tables from the "Handbook of Selected Organ Doses for Projections Common in 
Pediatric Radiology" were used for children up to five years (Rosenstein, Beck and 
Warner, 1979). The available literature did not make provision for children over 5 
years regarding the gonad dose conversion coefficients and were therefore assumed 
to be the same as for adults. The computer program was thus also applied for 
children over 5 years. 
The NRPB-R249 Report was used to make an estimation of the gonad doses during 
CT examinations (Shrimpton et al., 1991). Estimates of patient doses were based 
on the use of Monte Carlo computer techniques and a mathematical phantom to 
simulate the rotational beam characteristics of 27 types of CT scanners generally 
used. The calculations provide organ doses normalised to the dose on the axis of 
rotation of each scanner in the absence of the phantom. Values of such free-in-air 
axial doses for a range of scanner models have been determined by dose profile 
measurements using thermoluminescent dosemeters. Estimates of typical patient 
doses for 18 general types of examinations at a sample of National Health Service 
scanners have been obtained. It had been deduced from data provided by 
questionnaires and from Monte Carlo techniques and axial doses regarding the 
model of each scanner (Shrimpton et al., 1991). There is no data available 
regarding children and the available data has thus to be applied. The number of 
children involved were very small, however (see Table 8.8). 
Gonad doses were calculated for each of the views in the four age groups 
(Table 8.6) by means of the average technique factors in Table 8.2. The method to 
calculate the average gonad dose for a specific age-gender group is discussed on 
page 118, paragraphs 1 and 2. This means that the number of exposures are indeed 
implicitly included in the average technique factors. For the CT-examinations, an 
average gonad dose for each age group was obtained by means of the NRPB-R249 
Report (Shrimpton et al., 1991). Data from five scanners that are in use in South 
Africa, were used. Since the average gonad doses were calculated (NRPB-R249 
Report) for specific examinations with the corresponding mean mAs values as well 
as the number of slices, an estimation of gonad doses was made for South Africa 
using the average mAs values and number of slices per examination that was 
obtained in the survey (Table 8.2). The average gonad dose for an age group was 
thus obtained for each scanner and then afterwards the average for the five scanners 
was calculated. 
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Table 8.6 Skin entrance and gonad doses for diagnostic X-ray examinations. (FAE at IR -
Free Air Exposure at Image Receptor; FAE at SE.- Free Air Exposure at Skin Entrance; GD 
-Gonad Dose; 0/AP - Overview/ AP; AX -Axial; 0/LAT- Overview/ Lateral) 
CERVICAL SPINE 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av. GD 
IR SE male female IR SE male female male female 




AP 78.80 119.70 0.05 0.05 
>0.5-5 PA 0.08 0.10 
LAT S0.40 82.70 O.OS O.OS 
AP 64.10 114.00 O.OS O.OS 
> 5-15 PA 0.10 0.10 
LAT 46.10 83.40 0.0S O.OS 
AP 189.10 334.30 O.OS O.OS 
> 15 PA 256.SO 486.10 O.OS O.OS 0.19 0.18 
LAT 167.90 307.30 O.OS O.OS 
THORACIC SPINE 
I RADIOGRAPHY II FLUOROSCOPY I 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 







AP 8.8 11.9 O.OS O.OS 
>5-15 PA 0.0 0.15 
LAT 
AP S37.4 1004.4 0.0S 0.4 
>15 PA 0.12 0.70 
LAT 1388.0 2941.2 0.05 0.2 
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Table 8.6 (cont.) 
LUMBAR SPINE 
I RADIOGRAPHY II FLUOROSCOPY I 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 





>0.5-5 PA 7.8 10.4 0.2 2.8 0.0 2.8 
LAT 
AP 780.0 1299.4 1.7 188.0 
>5-15 PA 477.9 849.6 0.3 29.0 3.6 660.0 
LAT 1023.4 1850.9 0.5 41.0 
AP 1014.3 1965.1 3.2 316.0 
>15 PA 962.4 1811.1 5.2 324.0 9.9 792.0 
LAT 1937.7 4579.4 1.5 116.0 2805.0 5434.0 3.8 459.0 
SCOLIOSIS X-RAYS (FULL SPINE) 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 
(years) (mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 13.0 18.5 2.0 7.0 





AP 405.9 601.6 410.0 132.0 
>5-15 PA 697.3 132.0 
LAT 306.3 441.1 21.0 28.0 
AP 324.0 499.5 .7.4 106.0 
>15 PA 12.4 225.3 
LAT 870.4 480.3 2.5 53.0 
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Table 8.6 (cont.) 
LUNGS 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av. GD 
IR SE male female IR SE male female male female 
(years) {mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 14.3 19.8 0.3 1.0 
0-0.5 PA 10.9 13.7 0.2 0.8 0.35 1.36 
LAT 23.6 31.8 0.2 1.9 
AP 29.2 20.2 0.05 0.05 
>0.5-5 PA 21.7 28.9 0.05 0.60 0.13 0.31 
LAT 28.7 42.3 0.3 0.8 
AP 31.5 47.0 0.05 0.05 
>5-15 PA 31.7 44.1 0.05 0.05 0.07 0.09 
LAT 82.8 124.0 0.05 0.1 
AP 45.3 71.3 0.05 0.1 
>15 PA 75.3 110.3 0.05 0.3 2257.0 3305.0 0.05 2.4 0.08 0.45 
LAT 147.9 240.4 0.05 0.3 
RIBS 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 








>5-15 PA 32.0 47.5 0.05 0.05 0.1 0.0 
LAT 
AP 220.3 363.4 0.05 0.2 
>15 PA 324.3 508.5 0.05 0.3 0.1 0.50 
LAT 110.6 186.9 0.05 0.1 
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Table 8.6 (cont.) 
ABDOMEN SURVEY 
I RADIOGRAPHY II FLUOROSCOPY I 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 
(years) (mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 124.6 174.8 159.0 68.0 
0-0.5 PA 202.0 68.0 
LAT 18.5 26.1 13.0 11.0 
AP 94.2 146.5 157.0 40.0 
>0.5-5 PA 131.5 50.0 
LAT 16.0 21.6 4.0 4.0 
AP 106.7 177.8 2.0 33.0 
>5-15 PA 2.0 38.6 
LAT 162.6 331.8 0.8 14.0 
AP 505.4 938.2 17.0 215.0 3725.0 6915.0 26.0 1296.0 
>15 PA 326.5 570.8 9.2 146.0 16812 29392.0 65.0 3916.0 26.8 407.5 
LAT 390.4 847.8 2.7 52.0 
PELVIS 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av. GD 
IR SE male female IR SE male female male female 




AP 135.1 209.0 224.0 56.0 
>0.5-5 PA 224.0 84.0 
LAT 
AP 335.3 592.1 196.0 108.0 
>5-15 PA 235.2 135.0 
LAT 
AP 568.4 1127.6 461.0 220.0 
>15 PA 2097.6 4161.1 41.0 617.0 9697.0 19236.0 188.0 2720.0 663.8 350.6 
LAT 2890.2 6760.5 83.0 431.0 
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Table 8.6 (cont.) 
SACRUM 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 







AP 916.8 1598.7 110.0 273.0 
>5-15 PA 215.3 420.0 
LAT 1878.9 3711.1 24.0 147.0 
AP 1319.0 2517.7 73.0 486.0 
>15 PA 82.4 918.0 
LAT 1319.4 3118.2 9.4 162.0 
HIP JOINT 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 
(years) (rnR) (rnR) (mrad) (mrad) (rnR) (rnR) (mrad) (mrad) (mrad) (mrad) 
AP 9.2 13.1 14.0 3.0 
0-0.5 PA 14.0 
LAT 
AP 111.8 164.4 176.0 35.0 
>0.5-5 PA 292.5 52.5 
LAT 154.7 259.1 233.0 62.0 
AP 390.7 685.6 115.0 46.0 
>5-15 PA 115.0 115.0 
LAT 
AP 699.2 , 1334.6 1000.0 149.0 
>15 PA 777.7 1749.8 85.0 106.0 9003.0 20257.0 947.0 1121.0 1478.0 314.5 
.. LAT 1188.5 2699.3 86.0 119.0 
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Table 8.6 (cont.) 
FEMUR NECK 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av. GD 
IR SE male female IR SE male female male female 







AP 30.0 53.4 40.0 6.0 
>5-15 PA 120.8 
LAT 34.7 70.8 1.5 2.0 
AP 70.6 140.J 40.0 12.0 
>15 PA 68.2 135.3 5.7 6.9 33.9 19.8 
LAT 201.1 491.0 11.0 16.0 
FEMUR 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 
(years) (mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 17.0 24.2 26.0 5.0 
0-0.5 PA 26.0 
LAT 
AP 43.5 68.0 73.0 14.0 
>0.5-5 PA 143.0 30.5 
LAT 43.5 77.3 70.0 19.0 
AP 128.2 227.9 92.0 0.7 
>5-15 PA 105.2 0.85 
LAT 109.7 213.4 1.7 0.2 
AP 244.5 453.9 209.0 1.2 
>15 PA 51.2 101.6 3.5 0.05 310.5 1.85 
LAT 162.2 375.6 4.6 0.3 
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Table 8.6 (cont.) 
MYELOGRAM (LUMBAR) 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 










AP 289.8 527.7 0.6 57.0 4152.0 7560.0 5.6 707.0 
>15 PA 1755.1 0.9 56.0 37252.0 17.0 1125.0 18.6 1231.2 
LAT 1281.5 3508.1 0.6 43.0 
BARIUM SW ALLOW 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 





>0.5-5 PA 54942.4 3.0 1099.0 26888.0 0.05 5.1 6200.6 
LAT 54942.4 385.0 1044.0 
AP 
>5-15 PA 68358.4 0.05 9.8 0.55 
LAT 68358.4 0.05 5.5 
AP 2636.6 5108. J 0.05 0.6 
>15 PA 32741.8 0.05 6.2 46067.0 0.05 9.7 0.44 42.3 
LAT 53110.0 0.05 4.9 
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Table 8.6 (cont.) 
HEART CA THETERISATION 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 











>15 PA 1511.7 3256.6, 0.05 0.2 28594.0 61599.0 0.05 7.3 178.2 491.9 
LAT 1666.0 4560.7 0.05 0.3 14813.0 40551.0 0.05 7.6 
AORTOGRAM (ABDOMEN) 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av. GD 
IR SE male female IR SE male female male female 










AP 268.8 533.2 2.9 98.0 
>15 PA 344.6 766.6 0.9 72.0 5903.0 13132.0 16.0 1203.0 42.8 3699.0 
LAT 
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Table 8.6 (cont.) 
RETROGRADEPYELOGRAM 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 




AP 160.0 239.0 5.0 65.0 





AP 300.8 554.7 11.0 131.0 
>15 PA 68358.4 180.0 7780.0 61368.0 150.0 8433.0 42.2 4092.5 
LAT 
INTRAVENOUSPYELOGRAM 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 
(years) (mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 89.1 126.9 14.0 49.0 
0-0.5 PA 98.0 
LAT 
AP 130.0 203.1 4.0 55.0 
>0.5-5 PA 40.0 
LAT 
AP 393.3 658.7 3.3 109.0 
>5-15 PA 28.05 436.0 
LAT 
AP 602.3 1141.4 8.8 211.0 
>15 PA 568.7 973.7 11.0 173.0 58.3 1225.8 
LAT 1545.7 3301.8 12.0 299.0 
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Table 8.6 (cont.) 
BARIUM MEAL 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 







AP 4267.8 0.2 10.0 
>5-15 PA 4876.3 0.6 20.0 37619.0 5.1 170.0 204.0 
LAT 13735.6 0.3 21.0 
AP 772.2 1519.5 0.2 10 
>15 PA 5403.5 0.3 13.0 61283.0 8.3 279.0 8.8 344.0 
LAT 18562.2 0.4 21.0 
KIDNEY TOMOGRAPHY 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 







AP 296.0 495.7 1.4 71.0 
>5-15 PA 355.0 
LAT 
AP 689.2 1306.1 6.4 231.0 
>15 PA 17.0 765.9 
LAT 
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Table 8.6 (cont.) 
CYSTOGRAM 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 
(years) {mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 447.8 407.0 175.0 5474.0 247.0 535.0 
0-0.5 PA 3096.0 
LAT 
AP 535.8 573.0 145.0 13351.0 612.0 1328.0 





AP 2477.9 842.0 454.0 11360.0 2692.0 1988.0 
>15 PA 6611.7 351.0 752.0 47944.0 2272.0 7161.0 5505.3 9653.4 
LAT 22140.0 302.0 864.0 
URETHROGRAM 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 










AP 445.0 800.4 226.0 135.0 
>15 PA 55440.0 655.0 9156.0 1661.0 135.0 
LAT 975.0 2066.1 17.0 147.0 
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Table 8.6 (cont.) 
SALPINGOGRAM . 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 








>5-15 PA . 
LAT 
AP 262.8 481.6 16.0 93.0 




Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av. GD 
IR SE male female IR SE male female male female 







AP 247.5 1.3 43.0 
>5-15 PA 2796.7 9.1 379.0 48846.0 88.0 5792.0 9048.0 
LAT 1137.9 0.8 49.0 
AP 2191.5 28.0 604.0 
>15 PA 10864.0 36.0 1672.0 85640.0 188.0 11026.0 485.4 16111.2 
LAT 24899.8 31.0 1426.0 
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Table 8.6 (cont.) 
BIFURCATION ARTERIOGRAMS I ANGIOPLASTY 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 










AP 1425.3 63.0 234.0 
>15 PA 894.4 4.7 89.0 19632.0 96.0 1642.0 96.9 2222.0 
LAT 
PERIPHERAL ARTERIOGRAM AND ANGIOPLASTY (UPPER LEG) 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 








>5-15 PA 566.0 26.0 0.2 1071.0 
LAT 
AP 927.7 28.0 0.3 
>15 PA 670.6 36.0 0.3 1250.2 16.8 
LAT 
Table 8.6 (cont.) 
LUMBAR SPINE 
COMPUTERISED TOMOGRAPHY 
Age View av. GD av. GD 
male female 





>0.5-5 AX 3.0 138.0 
0/LAT 
0/AP 
>5-15 AX 4.0 172.0 
0/LAT 
0/AP 
>15 AX 8.0 400.0 
0/LAT 
ABDOMEN - LIVER, SPLEEN, KIDNEYS, 
VESSELS, LYMPH NODES 
COMPUTERISED TOMOGRAPHY 
Age View av. GD av.GD 
male female 
(years) (mrad) (mrad) 
0/AP 






>5-15 AX 37.0 586.0 
0/LAT 
0/AP 
>15 AX 40.0 630.0 
0/LAT 
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LUNGS / MEDIASTINUM 
COMPUTERISED TOMOGRAPHY 
Age View av.GD av. GD 
male female 








>5-15 AX 0.6 7.0 
0/LAT 
0/AP 




Age View av.GD av. GD 
male female 











>15 AX 127.0 1856.0 
0/LAT 
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Many blanks do appear in the tables and it was assumed that only those views in the 
age groups with data are the examinations involved for the total population. In 
order to calculate the GSD, the average gonad dose for an age-sex group was 
required and not for the views (AP, PA, LAT) separately. It was obtained by 
multiplying the number of exposures in an age-gender-view interval by the 
respective dose. This was done for the total age-gender group, the resultant dose 
was obtained and divided by the number of patients in the specific age-gender 
group. Thus the average gonad doses (Dkl) for both males and females were 
calculated for all age groups. 
It must be stressed that gonad doses were calculated for both male and female 
patients for the various views in Table 8.6 if the average technique factors were 
available for that specific age group in Table 8.2. The average gonad dose with 
reference to the overall age group could only be calculated, however, if there were 
patients in the specific male or female group. It may occur, therefore, that the 
gonad doses for both males and females were calculated, but the average gonad 
dose could only be calculated for either one of the genders (for example Table 8.6, 
Barium swallow). 
It was motivated in Section 8.1 why 30 out of 96 examinations were chosen for the 
calculation of the genetically-significant dose. 
contributors in the dete1mination of the GSD. 
The gonad doses are major 
In order to confirm that the 
remaining examinations could be ignored, an additional 8 examinations were 
chosen and their respective gonad doses calculated or estimated. These 
examinations were chosen in view of the fact that the respective contributions to the 
GSD are potentially larger than any of the remaining examinations, based on the 
distances of the exposures from the gonads as well as the frequency. Gonad doses 
were calculated for six of the examinations (Table 8. 7) and the results of all 8 
examinations are discussed on page 160. 
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Table 8. 7 Skin entrance and gonad doses for a special sub-group of diagnostic X-ray 
examinations. (FAE at IR- Free Air Exposure at Image Receptor; FAE at SE.- Free Air 
Exposure at Skin Entrance; GD - Gonad Dose) 
SKULL 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 
(years) (mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 103.0 147.0 0.0 0.0 
0-0.5 PA 0.0 0.0 
LAT 63.0 88.0 0.0 0.0 
AP 190.0 315.0 0.0 0.0 
>0.5-5 PA 196.0 318.0 0.0 0.0 0.0 0.0 
LAT 174.0 261.0 0.0 0.0 
AP 189.0 334.0 0.05 0.05 
> 5-15 PA 211.0 380.0 0.05 0.05 0.15 0.14 
LAT 165.0 248.0 0.05 0.05 
AP 302.0 533.0 0.05 0.05 
> 15 PA 334.0 594.0 0.05 0.05 0.13 0.12 
LAT 200.0 302.0 0.05 0.05 
S-I JOINTS 
RADIOGRAPHY FLUOR OSCO PY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 




AP 27.0 42.0 45.0 I 1.3 
>0.5-5 PA 45.0 
LAT 
AP 
> 5-15 PA 
LAT 
AP 802.0 1542.0 20.0 185.0 
> 15 PA 60.8 469.5 
LAT 364.0 889.0 3.0 42.0 
120 
Table 8.7 (cont.) 
KNEE 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av. GD av.GD 
IR SE male female IR SE male female male female 




AP 66.2 103.0 0.3 0.05 
>0.5-5 PA 0.35 0.12 
LAT 55.4 98.0 0.05 0.05 
AP 64.8 115.0 0.3 0.05 
> 5-15 PA 33.3 59.0 0.1 0.05 0.35 0.15 
LAT 60.8 124.0 0.05 0.05 
AP 146.2 279.0 0.8 0.05 
> 15 PA 55.3 110.0 0.1 0.05 1.39 0.15 
LAT 161.4 378.0 0.1 0.05 
ANGIOGRAM (HEAD) 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av. GD 
IR SE male female IR SE male female male female 
(years) (mR) (mR) (mrad) (mrad) (mR) (mR) (mrad) (mrad) (mrad) (mrad) 
AP 






> 5-15 PA 
LAT 
AP 
> 15 PA 206.0 413.0 0.05 0.05 8191.0 16439.0 0.05 0.05 0.5 1.73 
LAT 133.0 218.0 0.05 0.05 
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Table 8.7 (cont.) 
SPINE TOMOGRAPHY 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at' GD GD FAE at FAE at GD GD av.GD av.GD 
IR SE male female IR SE male female male female 




AP 21.0 33.0 35.3 8.9 





AP 819.0 1464.0 0.6 69.0 
> 15 PA 3.8 222.0 
LAT 1389.0 2898.0 0.5 36.0 
CHOLANGIOGRAM, CHOLECYSTOGRAM 
RADIOGRAPHY FLUOROSCOPY 
Age View FAE at FAE at GD GD FAE at FAE at GD GD av.GD av. GD 
IR SE male female IR SE male female male female 








> 5-15 PA 
LAT 
AP 1276.0 2369.0 0.3 20.0 
> 15 PA 604.0 1153.0 0.05 1.8 23386.0 0.1 23.0 0.9 86.8 
LAT 838.0 1852.0 0.1 8.7 
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8.6 Age-gender-race groups 
The next stage in the calculation of the GSD was the determination of the number 
of patients, N kb in the various age-gender-race groups (k) that underwent an 
examination of type £. Population data (Figures 8.1 and 8.2) was obtained from the 
Central Statistical Service (Population Census 1991, 1992). The last SA population 
census was in March 1991 which coincided very well with the present survey. The 
complete sample was used to determine these values. In order to determine N kl the 
age, gender and race had to be known. With the exception of three institutions, the 
missing infmmation regarding these aspects was estimated less than 2% of the 
sample. Missing data was imputed according to certain principles as detailed 
below. In 3 institutions, there was a higher incidence of missing information, in 
that there was no indication of race or age of patients for two of the institutions, and 
only a partial response on age for the third. However, all tlrree institutions serve a 
predominantly black population, so that it was assumed that the race of the patients 
undergoing radiological examinations was black. 
8.6.1 Imputation 
(a) Age. The same principle was applicable here as was discussed in paragraph 
8.3(a), i.e. where there was no indication of the age, 30 was imputed. In 
some cases there were indications of patients being children. Further 
investigation into the ages of children for specific types of examinations 
indicated that 6 years could be an acceptable value for imputation. 
(b) Gender. In cases where the gender was omitted, where possible it was 
derived from the patient's name in the registers. Otherwise "male" and 
"female" were imputed alternatively - stmting with a different gender than 
the preceding one that was available. 
(c) Race. As in (b) above it was also possible in some instances to impute the 
race by vi11ue of a person's name. Alternatively, White (W); Coloured (C); 
Asian (A); and Black (B) were imputed sequentially. If, for example, the 
latest entiy on the fmm was a "C", the cycle sta1ted with an "A". 
"' 
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8.6.2 Correction factors 
(a) Three institutions should theoretically have been omitted from the present 
survey since the ages of the patients were not entered on the sources for two 
of the institutions as well as the larger pait of the third one. Since the 
examinations were being pe1f 01med on Black patients only at these 
institutions, the con-ection that had to be can-ied out, applied to the Black 
population only. The following numbers were obtained from the database: 
Total number of examinations in countly (292 institutions; p.66) = 5576235 
Total number of examinations in complete sample, NroT. = 27696 
Number of examinations on Black males in sample, 
NMB(a.u.), with age unknown* = 2677 
Number of examinations on Black females in sample, 
Np8 (a.u.), with age unknown* = 1808 
Total number of examinations on Black males in sample, N MB = 6661 
Total number of examinations on Black females in sample, N FB = 4335 
*N MB ( a. u.) and *N FB ( a. u.) refer to the above-mentioned three institutions 
only. 
The conection, k M• regarding the number of examinations for Black males 










The number of examinations for ~he various Black age-gender groups can 
therefore be calculated according to the formulas: 
Nke(BM) = (kM + l).Nke(Black, three institutions excluded) 
Nke(Bp) = (kp + 1).Nke(Black, three institutions excluded). 
(b) The following con-ection was made in order to extend the sample to represent 
the number of examinations in the countty: 
















Using the above-mentioned correction factors (kM ,kF and k), the examination 
frequencies for the entire South Africa was estimated. These results are given 
in Figures 8.3 to 8.8 and in Table 8.8. 
I D Whites E3 Coloureds ~ Asians 1111111 Blacks 
( -1) (1 • 4) (5- 9) (10.14) (15-19) (20.24) (25-34) (35-44) (45-54) (55-59) (60.64) (6!;+ ) 
Age group 
Figure 8.1 Total population (male and female). 
18.00 














( -1) (1 • 4) (5- 9) (10.14) (15-19) (20-24) (25-34) (35-44) (45-54) (55-59) (60-64) (65+) 
Age group 
Figure 8.2 Percentage of total population (male and female) with respect to race groups. 
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(1 • 4) (5· 9) (10.14) (15-19) (20.24) (25-34) (35-44) (45-54) (55-59) (60.64) (65+ ) 
Age group 
Figure 8.3 Total number of examinations (male and female). 












-1) (1 • 4) (5· 9) (10.14) (15-19) (20.24) (25-34) (35-44) (45-54) (55-59) (60-6•) (65+ ) 
Age group 
Figure 8.4 Ratio of total number of examinations (male and female) to census population (x JOO) 
with respect to race group in the various age intervals. 














-1) (1 • 4) (5- 9) .(10.14) (15-19) (20.24) (25-34) (35-44) (45-54) (55-59) (60.64) 
Age group 
Figure 8.5 Total number of examinations (male). 














-1) (1- 4) (5- 9) (10.14) (15-19) (20.24) (25-34) (35-44) (45-54) (55-59) (60.64) 
Age group 
Figure 8.6 Ratio of total number of examinations (male) to census population (x JOO) with 


















( -1) (1- 4) (5- 9) (10.14) (1S.19) (20.24) (2S.3-4) - (3S.«) (4S.54) (5S.59) (60.64) (65+) 
Age group 
Figure 8. 7 Total number of examinations (female). 












-1) (1- 4) (5- 9) (10.14) (1S.19) (20.24) (2S.3-4) (3S.44) (4S.54) (5S.59) (60.64) (65+ ) 
Age group 
Figure 8.8 Ratio of total number of examinations (female) to census population (x I 00) with 
respect to race group in the various age intervals. 
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Table 8.8 Calculated frequency of radiolgical examinations for entire population 
for a one year period (M=male; F=female; W=White; C=Coloured; 
A =Asian; B=Black). 
Note: If the numbers are added, it may differ by I with the totals. This is due to the correct-
ion factors mentioned in section 8.6.2 and the decimals that are not shown. 
CERVICAL SPINE 
Age groues MW MC MA ?v1B FW FC FA FB Total 
( -1) 0 0 201 673 201 0 0 691 1767 
( 1 - 4) 1007 403 201 2020 805 201 0 1036 5673 
(5 - 9) 403 201 805 673 0 0 0 691 2773 
(10-14) 1007 0 201 1010 604 0 201 345 3369 
(15-19) 4228 805 201 673 3423 0 201 345 9877 
(20-24) 6241 604 604 3703 3020 403 403 2763 17741 
(25-34) 8255 1812 1007 14474 11476 2215 1611 4836 45685 
(35-44) 8255 2013 805 6396 10268 1208 1812 5181 35938 
(45-54) 6443 2416 1409 4713 11476 2416 1409 3109 33391 
(55-59) 3020 805 403 1010 3221 201 805 345 9811 
(60-64) 1611 201 604 2356 2617 403 201 1036 9030 
(65+ ) 3020 403 805 2020 6644 604 0 691 14187 
Total 43489 9664 7248 39721 53757 7651 6644 21069 189243 
THORACIC SPINE 
Age groues MW MC MA MB FW FC · FA FB Total 
( -1) 0 0 0 0 0 0 0 345 345 
( 1 - 4) 201 201 0 0 0 0 0 0 403 
(5 - 9) 604 0 0 0 201 0 0 0 805 
(10-14) 1611 0 0 337 1208 0 0 691 3846 
(15-19) 3221 604 201 337 2617 201 0 0 7182 
(20-24) 1208 403 201 1683 1007 0 201 345 5049 
(25-34) 2013 403 1208 2693 4228 1007 604 2072 14228 
(35-44) 1812 1007 403 2356 3825 805 604 1727 12539 
(45-54) 1812 201 201 2356 1812 1409 201 1036 9030 
(55-59) 805 0 0 337 1812 201 0 0 3155 
(60-64) 201 201 201 1010 3020 201 0 0 4835 
(65+ ) 1812 201 201 337 3825 1007 403 0 7786 
Total 15302 3221 2617 11445 23556 4832 2013 6217 69204 
LUMBAR SPINE 
Age groues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 337 0 0 0 691 1027 
( 1 - 4) 0 201 0 0 201 201 0 0 604 
(5 - 9) 403 0 201 0 604 0 201 345 1755 
(10-14) 2416 0 0 337 2215 201 0 691 5859 
(15-19) 7248 1611 403 0 4027 201 604 691 14784 
(20-24) 5436 1812 805 4039 3221 805 1007 1382 18508 
(25-34) 12684 2617 2617 7406 10268 2215 1409 2763 41980 
(35-44) 12080 3423 1208 5722 14698 1007 1208 5181 44527 
(45-54) 9664 3423 1007 5722 13691 1812 805 6217 42341 
(55-59) 3825 805 201 1346 5235 1409 403 1036 14262 
(60-64) 2617 805 0 2356 5033 1208 403 2418 14841 
(65+ ) 6845 1007 403 2693 12684 1208 1007 345 26192 
Total 63220 15704 6845 29959 71877 10268 7047 21760 226681 
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Table 8.8 (cont.) 
SCOLIOSIS X-RAYS (FULL SPINE) 
Ag_e groues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 337 0 0 0 0 337 
( 1 - 4) 201 0 0 0 0 0 0 1036 1238 
(5 - 9) 201 0 0 0 201 0 0 0 403 
(10-14) 1208 0 0 0 2215 0 0 0 3423 
(15-19) 2013 201 0 0 1409 0 0 0 3624 
(20-24) 201 0 0 337 201 0 0 0 739 
(25-34) 0 0 201 337 201 201 0 0 941 
(35-44) 201 0 0 0 0 0 201 345 748 
(45-54) 0 0 0 0 201 201 0 0 403 
(55-59) 0 0 0 0 201 0 0 0 201 
(60-64) 0 0 0 0 0 0 0 0 0 
(65+ ) 0 0 0 0 0 0 0 0 0 
Total 4027 201 201 . 1010 4631 403 201 1382 12056 
LUNGS 
A~e groues MW MC MA MB FW FC FA FB Total 
( -1) 18120 3825 3020 43423 15100 2617 1812 42483 130402 
( 1 - 4) 21946 11476 . 4631 57561 15704 12080 2215 42138 167751 
(5 - 9) 10067 8859 2617 24573 8255 7852 1409 16924 80557 
(10-14) 6443 3624 1208 12455 4631 3221 1007 11398 43987 
(15-19) 12080 9664 2215 23563 8657 7248 3221 19342 85991 
(20-24) 15906 18523 6845 52175 10872 12282 6040 30049 152693 
(25-34) 31006 37449 13288 109400 31610 34630 8456 80131 345970 
(35-44) 35435 24362 10671 83481 33221 25771 9463 58372 280775 
(45-54) 49328 29597 12886 60927 39059 26979 13087 48010 279872 
(55-59) 28389 11879 7449 27266 18322 14094 7449 17960 132808 
(60-64) 23355 15100 5033 20197 18322 11275 5235 24178 122695 
(65+ ) 79126 24563 9262 42414 96642 31409 9262 29704 322380 
Total 331200 198921 79126 557436 300395 189458 68656 420690 2145881 
RIBS 
Ag_e ~oues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 201 0 0 201 
(5 - 9) 201 0 0 673 0 0 0 0 875 
(10-14) 201 0 0 337 201 0 0 0 739 
(15-19) 0 0 0 337 403 0 0 0 739 
(20-24) 2013 201 0 1683 201 201 0 691 4991 
(25-34) 3020 1611 403 5049 1007 403 201 691 12384 
(35-44) 1812 1409 0 4039 2013 403 0 1036 10713 
(45-54) 1611 403 201 1683 1812 0 0 691 6401 
(55-59) 1007 201 0 337 403 201 0 345 2494 
(60-64) 201 403 0 337 403 201 0 345 1890 
(65+ ) 1007 201 0 673 3825 1007 0 691 7404 
Total 11074 4429 604 15148 10268 2617 201 4490 48832 
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Table 8.8 (cont.) 
ABDOMEN SURVEY 
Age groues MW MC MA :MB FW FC FA FB Total 
( -1) 1007 403 201 5386 1409 0 403 3454 12263 
( 1 - 4) 2215 805 604 4713 2416 604 805 2072 14234 
(5 - 9) 1208 201 604 1683 604 0 0 2072 6373 
(10-14) 1007 201 403 1010 1007 0 0 691 4318 
(15-19) 2819 604 604 1346 2617 0 0 1036 9027 
(20-24) 1611 1611 1812 3030 4429 1812 805 4490 19600 
(25-34) 4228 3825 3825 15148 6241 3423 ,1812 11398 49901 
(35-44) 3825 4027 2617 10772 6845 2617 1007 3799 35510 
(45-54) 4429 2215 1812 3366 5839 2819 2215 3454 26148 
(55-59) 3020 1208 805 2020 4027 1208 805 1727 14820 
(60-64) 4429 1208 1208 2356 1611 604 . 201 691 12309 
(65+ ) 7852 3221 604 3703 12684 2416 604 3799 34884 
Total 37650 19530 15100 54532 49730 15503 8657 38684 239387 
PELVIS 
Age groues MW MC MA :MB FW FC FA FB Total 
( -1) 604 0 0 337 805 0 201 691 2638 
( 1 - 4) 403 403 201 337 604 0 201 345 2494 
(5 - 9) 201 201 201 673 201 0 0 1382 2860 
(10-14) 604 403 201 1010 1007 403 0 691 4318 
(15-19) 3825 805 201 1346 2617 201 201 691 9889 
(20-24) 3624 1007 1007 3703 1208 805 805 2763 14922 
(25-34) 6644 3624 1409 11445 7449 1409 403 4145 36529 
(35-44) 7248 805 805 4039 8859 1208 201 4145 27311 
(45-54) 5436 1409 604 4713 7248 1611 604 4145 25770 
(55-59) 1208 805 201 673 5235 805 403 691 10022 
(60-64) 1812 403 201 673 4631 403 604 1036 9763 
(65+ ) 7449 1409 403 1346 19127 1611 403 691 32439 
Total 39059 11275 5436 30295 58992 8456 4027 21414 178955 
SACRUM 
Age groues MW MC MA :MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 0 0 0 0 0 
(10-14) 201 0 201 337 403 0 0 0 1142 
(15-19) 'O 201 0 0 201 201 0 0 604 
(20-24) 0 0 0 0 0 0 0 0 0 
(25-34) 0 403 0 337 0 201 0 0 941 
(35-44) 0 0 0 0 403 201 0 0 604 
(45-54) 201 0 0 0 604 201 0 0 1007 
(55-59) 0 201 0 0 403 0 0 0 604 
(60-64) 0 0 0 0 201 201 0 0 403 
(65+ ) 201 0 0 0 805 0 0 0 1007 
Total 604 805 201 673 3020 1007 0 0 6311 
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Table 8.8 (cont.) 
HIP JOINT 
Age ~oues MW MC MA :MB FW FC FA FB Total 
( -1) 201 0 0 673 604 0 0 0 1479 
( 1 - 4) 604 403 0 337 805 403 0 345 2897 
(5 - 9) 604 201 0 0 201 0 0 345 1352 
(10-14) 201 403 201 337 805 0 0 0 1947 
(15-19) 201 201 0 337 0 201 0 0 941 
(20-24) 604 201 805 1346 604 403 201 345 4511 
(25-34) 1007 201 604 3366 1007 604 0 1036 7825 
(35-44) 2819 604 201 2693 1007 805 403 2763 11295 
(45-54) 3221 604 403 1683 2416 403 1007 1727 11464 
(55-59) 403 0 201 337 2416 201 201 691 4450 
(60-64) 1007 403 0 1010 2215 403 403 691 6130 
(65+ ) 6241 805 201 0 14496 1007 403 1036 24190 
Total 17114 4027 2617 12118 26577 4429 2617 8980 78480 
FEMUR NECK 
Ag_e groues MW MC MA :MB FW FC FA FB Total 
( -1) 0 0 0 337 0 0 0 0 337 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 201 0 0 0 0 0 201 
(10-14) 0 0 0 337 0 0 0 0 337 
(15-19) 0 0 0 337 0 0 0 345 682 
(20-24) 0 0 201 0 0 0 0 0 201 
(25-34) 0 0 0 337 0 0 0 345 682 
(35-44) 0 0 0 337 0 0 201 0 538 
(45-54) 403 0 0 673 0 0 0 0 1076 
(55-59) 0 201 0 0 0 0 0 0 201 
(60-64) 0 201 0 0 0 201 201 0 604 
(65+ 2 0 0 0 0 604 0 0 0 604 
Total 403 403 403 2356 604 201 403 691 5463 
FEMUR 
Ag_e ~oues MW MC MA :MB FW FC FA FB Total 
( -1) 0 0 0 337 201 0 0 691 1229 
( 1 - 4) 201 0 201 673 201 201 0 691 2169 
(5 - 9) 201 0 201 673 604 0 403 1036 3119 
(10-14) 604 1007 0 673 403 201 0 1382 4270 
(15-19) 604 201 201 3703 0 0 0 345 5055 
(20-24) 805 403 604 3366 201 201 201 1382 7164 
(25-34) 2617 805 604 6059 604 403 0 1727 12819 
(35-44) 604 604 403 5386 0 201 604 1382 9183 
(45-:54) 1409 805 201 4039 201 604 201 2072 9534 
(55-59) 0 604 403 337 201 201 0 0 1746 
(60-64) 201 403 0 673 604 604 403 1382 4270 
(65+ ) 1611 805 201 337 2013 604 0 691 6262 
Total 8859 5637 3020 26256 5235 3221 1812 12780 66820 
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Table 8.8 (cont.) 
MYELOGRAM (LUMBAR) 
Age groues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 0 0 0 0 0 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 0 0 345 345 
(20-24) 201 0 0 0 201 0 0 0 403 
(25-34) 805 403 201 673 1208 0 201 345 3837 
(35-44) 1208 403 0 337 805 201 0 0 2954 
(45-54) 1208 0 0 337 201 201 0 0 1947 
(55-59) 0 201 0 0 201 0 0 0 403 
(60-64) 0 0 0 0 201 0 0 0 201 
(65+ ) 604 201 0 0 805 0 0 0 1611 
Total 4027 1208 201 1346 3624 403 201 691 11701 
BARIUM SW ALLOW 
AB_e B_roues MW MC MA MB FW FC FA FB Total 
( -1) 201 0 0 337 0 0 0 1382 1920 
( 1 - 4) 0 0 0 0 201 0 0 345 547 
(5 - 9) 0 0 0 0 0 0 0 0 0 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 201 0 337 201 0 0 0 739 
(20-24) 0 0 201 673 0 0 0 0 875 
(25-34) 403 201 0 673 1007 0 201 691 3176 
(35-44) 403 0 201 q46 604 403 403 345 3705 
(45-54) 604 604 0 4039 1208 201 403 345 7405 
(55-59) 403 0 0 2020 201 0 0 345 2969 
(60-64) 201 201 0 673 201 0 0 1382 2659 
(65+ ) 2215 0 0 1346 3423 0 0 2072 9056 
Total 4429 1208 403 11445 7047 604 1007 6908 33050 
HEART CATHETERISATION 
AB_e L[OUES MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 337 0 0 0 0 337 
(5 - 9) 0 0 0 0 0 0 0 0 0 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 0 0 0 0 
(20-24) 0 0 0 0 0 201 0 0 201 
(25-34) 1007 0 0 0 0 201 0 0 1208 
(35-44) 1812 403 0 0 604 201 201 345 3567 
(45-54) 5033 604 0 0 805 1208 0 0 7651 
(55-59) 1812 0 0 0 201 201 0 0 2215 
(60-64) 2819 201 0 0 1007 0 0 0 4027 
(65+ ) 4027 403 0 0 1208 201 0 345 6184 
Total 16510 1611 0 337 3825 2215 201 691 25389 
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Table 8.8 (cont.) 
AORTOGRAM (ABDOMEN) 
Age grou:es MW Mc· MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 .o 0 0 0 0 0 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 0 0 0 0 
(20-24) 0 0 0 0 0 201 0 0 201 
(25-34) 0 0 0 0 0 0 0 0 0 
(35-44) 403 0 0 673 201 0 0 0 1277 
(45-54) 0 0 0 0 403 0 0 0 403 
(55-59) 403 201 0 337 201 0 0 0 1142 
(60-64) 0 201 0 0 0 0 0 345 547 
(65+ ) 201 0 0 337 805 0 0 0 1343 
Total 1007 403 0 1346 1611 201 0 345 4913 
RETROGRADEPYELOGRAM 
Age grou:es MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 403 0 0 0 403 
(5 - 9) 0 0 0 0 201 0 0 0 201 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 201 0 0 0 0 0 0 0 201 
(20-24) 0 0 0 0 403 0 201 0 604 
(25-34) 403 0 201 0 1208 201 0 345 2359 
(35-44) 2416 0 0 0 1611 0 0 0 4027 
(45-54) 1611 0 0 0 1007 0 0 0 2617 
(55-59) 1007 0 0 0 0 0 0 0 1007 
(60-64) 604 0 0 0 604 0 0 0 1208 
(65+ ) 2013 0 201 0 403 0 0 0 2617 
Total 8255 0 403 0 5839 201 201 345 15244 
INTRAVENOUSPYELOGRAM 
Age grou:es MW MC MA MB FW FC FA FB Total 
( -1) 0 0 403 0 0 0 0 345 748 
( 1 - 4) 201 0 0 337 403 0 0 0 941 
(5 - 9) 1208 0 0 0 1007 0 0 0 2215 
(10-14) 1208 0 0 0 0 0 201 0 1409 
(15-19) 1007 0 0 0 1208 0 0 0 2215 
(20-24) 604 0 201 673 1208 201 201 345 3435 
(25-34) 3221 805 201 1683 2819 604 201 691 10226 
(35-44) 2819 403 1409 673 3423 1409 805 345 11287 
(45-54) 2819 604 0 1010 2416 604 604 1727 9784 
(55-59) 805 805 201 0 805 0 0 0 2617 
(60-64) 2416 0 604 1346 805 403 0 0 5575 
(65+ ) 2819 805 1007 673 1409 0 403 0 7116 
Total 19127 3423 4027 6396 15503 3221 2416 3454 57567 
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Table 8.8 (cont.) 
BARIUM MEAL 
Ag_e groues MW MC MA MB FW FC FA FB Total 
( -1) 403 0 0 337 805 0 0 345 1890 
( 1 - 4) 805 0 0 0 201 0 0 0 1007 
(5 - 9) 604 0 0 0 403 0 0 345 1352 
(10-14) 201 0 201 337 805 0 0 0 1545 
(15-19) 1007 0 0 0 1409 0 0 1036 3452 
(20-24) 805 0 403 337 604 0 0 345 2494 
(25-34) 1812 604 201 2020 3624 805 201 1382 10649 
(35-44) 2617 805 0 673 3825 604 0 345 8871 
(45-54) 1812 201 0 2020 3825 403 0 0 8261 
(55-59) 1007 0 201 1010 805 1208 0 0 4231 
(60-64) 1409 201 0 337 2013 0 0 0 3961 
(65+ ) 2215 201 0 337 3423 1208 0 345 7729 
Total 14698 2013 1007 7406 21744 4228 201 4145 55442 
KIDNEY TOMOGRAPHY 
Ag_e ~oues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 201 0 0 0 201 
(10-14) 201 0 0 0 0 0 0 0 201 
(15-19) 201 0 0 0 0 0 0 0 201 
(20-24) 0 0 0 0 1007 0 0 0 1007 
(25-34) 805 201 0 337 1409 201 0 345 3299 
(35-44) 1409 201 604 337 1812 1007 201 345 5917 
(45-54) 604 604 0 0 1208 201 201 0 2819 
(55-59) 403 403 0 0 403 0 0 0 1208 
(60-64) 1007 0 0 673 1007 0 0 0 2687 
(65+ ) 1208 403 403 337 604 0 201 0 3155 
Total 5839 1812 1007 1683 7651 1409 604 691 20696 
CYSTOGRAM 
Ag_e g_roues MW MC MA MB FW FC FA FB Total 
( -1) 0 201 201 337 403 0 0 0 1142 
( 1 - 4) 201 0 201 337 604 0 0 0 1343 
(5 - 9) 201 0 0 337 403 201 0 0 1142 
(10-14) 0 0 0 337 0 0 0 0 337 
(15-19) 0 201 0 0 201 0 0 0 403 
(20-24) 201 201 201 0 403 201 201 691 2100 
(25-34) 0 201 201 1010 0 201 0 1036 2650 
(35-44) 201 0 201 337 805 0 201 691 2437 
(45-54) 403 0 0 2356 604 0 0 691 4054 
(55-59) 0 0 0 0 0 0 201 0 201 
(60-64) 0 201 0 337 0 0 0 345 883 
(65+ ) 201 403 0 337 805 0 201 0 1947 
Total 1409 1409 1007 5722 4228 604 805 3454 18639 
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Table 8.8 (cont.) 
URETHROGRAM 
A~e groues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 201 0 0 0 201 
(5 - 9) 0 0 0 0 201 0 0 0 201 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 201 0 0 0 0 0 0 201 
(20-24) 0 0 0 0 0 0 0 0 0 
(25-34) 0 0 0 0 0 0 0 691 691 
(35-44) 201 0 0 0 0 0 0 345 547 
(45-54) 0 0 0 0 0 0 0 0 0 
(55-59) 0 201 0 0 0 0 0 0 201 
(60-64) 0 0 0 0 0 0 0 0 0 
(65+ ) 0 0 0 0 0 0 0 345 345 
Total 201 403 0 0 403 0 0 1382 2388 
SALPINGOGRAM 
A~e groues MW MC MA MB FW FC FA FB .Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 0 0 0 0 0 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 0 0 0 0 
(20-24) 0 0 0 0 403 0 0 1382 1784 
(25-34) 0 0 0 0 1611 1208 201 7944 10964 
(35-44) 0 0 0 0 201 0 0 1036 1238 
(45-54) 0 0 0 0 0 0 0 0 0 
(55-59) 0 0 0 0 201 0 0 0 201 
(60-64) 0 0 0 0 0 0 0 0 0 
(65+ ) 0 0 0 0 0 0 0 0 0 
Total 0 0 0 0 2416 1208 201 10362 14187 
BARIUM ENEMA 
A~e groues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 201 0 0 0 201 0 0 0 403 
(5 - 9) 0 0 201 0 403 0 0 0 604 
(10-14) 201 0 0 0 201 201 0 0 604 
(15-19) 0 0 0 0 403 0 0 0 403 
(20-24) 403 201 0 0 1208 0 0 0 1812 
(25-34) 604 201 0 337 2013 0 0 2072 5228 
(35-44) 805 805 403 337 5436 403 0 345 8534 
(45-54) 2215 201 201 337 4228 201 0 345 7729 
(55-59) 1409 201 0 673 1007 0 0 1727 5018 
(60-64) 1007 201 0 337 2416 0 0 345 4306 
(65+ ) 3020 0 403 673 6845 604 201 691 12438 
Total 9866 1812 1208 2693 24362 1409 201 5526 47077 
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Table 8.8 (cont.) 
BIFURCATION ARTERIOGRAMS I ANGIOPLASTY 
Age ~oues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 0 0 0 0 0 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 0 0 0 0 
(20-24) 0 0 0 0 0 0 0 0 0 
(25-34) 0 0 0 0 0 0 0 345 345 
(35-44) 201 0 0 337 0 0 0 0 538 
(45-54) 201 0 0 0 0 201 0 0 403 
(55-59) 0 0 0 337 0 0 0 0 337 
(60-64) 0 0 0 0 0 0 0 345 345 
(65+ ) 0 0 0 337 0 0 0 0 337 
Total 403 0 0 1010 0 201 0 691 2305 
PERIPHERAL ARTERIOGRAM AND ANGIOPLASTY (UPPER LEG) 
Agegroues MW MC MA MB FW FC · FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 201 0 0 0 0 0 0 201 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 0 0 0 0 
(20-24) 0 0 0 0 0 0 0 0 0 
(25-34) 0 0 0 673 0 0 0 0 673 
(35-44) 201 0 0 0 0 0 0 345 547 
(45-54) 0 0 0 0 0 0 0 0 0 
(55-59) 201 201 0 337 201 0 0 0 941 
(60-64) 0 0 0 0 0 0 0 345 345 
(65+ ) 403 201 0 337 201 0 0 0 1142 
Total 805 604 0 1346 403 0 0 691 3849 
LUMBAR SPINE (CT) 
Age groues MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( 1 - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 0 0 0 345 345 
(10-14) 0 0 0 0 201 0 0 0 201 
(15-19) 0 0 0 0 0 0 0 345 345 
(20-24) 604 0 0 0 604 0 0 0 1208 
(25-34) 1409 0 201 1010 2215 0 201 345 5382 
(35-44) 3423 201 0 337 3020 0 0 345 7326 
(45-54) 3221 0 0 0 1007 0 201 0 4429 
(55-59) 1208 0 0 0 1007 201 0 0 2416 
(60-64) 0 0 0 0 403 0 0 0 403 
(65+ ) 805 0 0 0 403 0 0 0 1208 
Total 10671 201 201 1346 8859 201 403 1382 23264 
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Table 8.8 (cont.) 
LUNGS / MEDIASTINUM (CT) 
Age grouEs MW MC MA MB FW FC FA FB Total 
( -1) 0 0 0 0 0 0 0 0 0 
( I - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 201 0 0 0 0 0 0 0 201 
(10-14) 201 0 0 337 0 0 0 0 538 
(15-19) 0 0 0 337 403 0 0 0 739 
(20-24) 0 0 0 0 0 0 0 0 0 
(25-34) 201 201 0 0 403 604 0 0 1409 
(35-44) 403 201 0 1010 0 403 0 345 2362 
(45-54) 403 201 0 0 201 201 0 0 1007 
(55-59) 403 0 0 337 403 0 0 0 1142 
(60-64) 403 201 0 0 201 0 0 345 1151 
(65+ ) 403 201 0 0 201 201 0 0 1007 
Total 2617 1007 0 2020 1812 1409 0 691 9556 
• ABDOMEN - LIVER, SPLEEN, KIDNEYS, VESSELS, LYMPH NODES (CT) 
Ag_e groues MW MC MA MB FW FC FA FB Total 
( -1) 201 0 0 0 201 0 0 0 403 
( I - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 0 0 0 0 201 0 0 0 201 
(10-14) 0 0 0 0 0 201 0 0 201 
(15-19) 201 0 0 0 0 0 0 0 201 
(20-24) 0 0 0 337 201 201 0 345 1085 
(25-34) 201 403 0 337 201 403 0 345 1890 
(35-44) 805 604 0 337 604 403 0 691 3443 
(45-54) 1409 1409 0 337 1611 403 0 345 5514 
(55-59) 604 403 0 0 604 0 0 345 1956 
(60-64) 1208 403 0 0 604 201 0 0 2416 
{65+ 2 1611 0 0 0 1611 403 0 691 4315 
Total 6241 3221 0 1346 5839 2215 0 2763 21626 
PELVIS (CT) 
Ag_e~OUJ2S MW MC MA MB FW FC FA FB Total 
( -1) 201 0 0 0 0 0 0 0 201 
( I - 4) 0 0 0 0 0 0 0 0 0 
(5 - 9) 403 0 0 0 0 0 0 0 403 
(10-14) 0 0 0 0 0 0 0 0 0 
(15-19) 0 0 0 0 0 201 0 0 201 
(20-24) 201 0 0 0 201 0 0 0 403 
(25-34) 0 201 0 0 403 0 0 0 604 
(35-44) 0 0 0 0 403 0 0 0 403 
(45-54) 201 0 0 0 0 0 0 0 201 
(55-59) 201 0 0 0 0 0 0 0 201 
(60-64) 0 0 0 0 201 0 0 345 547 
(65+ ) 201 0 0 0 403 0 0 691 1295 
Total 1409 201 0 0 1611 201 0 1036 4459 
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8.7 Child expectancy 
The child expectancy for people in the different age groups was not available for 
South Africa. Total fertility numbers are available, however, for the different races. 
It is defined as the average number of children born to a woman during her fertile 
years (15 - 49), assuming that the prevailing fertility rates are unchanged (Chief 
Directorate: Population Development, 1988). Child expectancy (fertility numbers) 
regarding the period 1988 - 1990, were supplied by the Population Development 
Program (Department of Health, 1994) as 
1.7 for Whites 
2.5 for Coloureds 
2.3 for Asians 
4.5 for Blacks 
(Chief Directorate: Planning Support, Division: Contextual Information, 
1994 and Chief Directorate: Population Development, Directorate 
Demographic Monitoring and Evaluation, 1994). 
These fertility numbers were adapted in order to obtain child expectancy values for 
the various age groups that are appropriate to South African conditions by making 
use of the data of Darby et al., (1980), which is shown in Table 8.9. 
Table 8. 9 Child expectancy by age and sex in the UK. 
Age group Male Female 
0 - 1 1.82 1.86 
2-4 1.86 1.89 
5-9 1.86 1.89 
10 - 14 1.87 1.90 
15 - 19 1.84 1.80 
20- 24 1.62 1.39 
25 -29 1.10 0.76 
30 - 39 0.39 0.19 
40-49 0.05 0.01 
50 - 59 0.01 -
60 + - -
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In order to calculate child expectancy in various age groups in South Africa for using in 
the calculation of GSD, the age groups in Table 8.9 was associated with the age groups 
specified in the population census as follows: 
Age group (0-1) in Table 8.9 with age group ( -1) in the census population where the 
group ( -1) denotes that group with age less than one year; age group (2-4) in Table 8.9 
with age group (1-4) in the census population; age groups (5-9), (10-14), (15-19) and 
(20-24) in Table 8.9 correspond exactly with those in the census population; age group 
(25-29) in Table 8.9 with age group (25-34) in the census population; age group (30-39) 
in Table 8.9 with age group (35-44) in the census population; age group (40-49) in Table 
8.9 with age group (45-54) in the census population; and age group (50-59) in Table 8.9 
with age group (55-59) in the census population. 
The child expectancies for the various race-gender-age groups were calculated by means of 
the normalisation of the numbers in all columns in Table 8.9 with respect to the highest 
number in each column respectively, and then multiplied by the relevant fertility number 
(Table 8.10). This implies, for example, in order to obtain the MW-values in Table 8.10, 
that all the "Male" values in Table 8.9 have to be divided by 1.87 and multiplied by 1.7. 
All numbers were rounded to two decimals except for values in two age groups. 
Table 8.10 Child expectancy by age, sex and race in SA (M- male; F-female; 
W - White; C - Coloured; A -Asian; B - Black). 
Age group MW MC MA l\1B FW FC FA FB 
- 1 1.65 2.43 2.24 4.38 1.66 2.45 2.25 4.41 
1-4 1.69 2.49 2.29 4.48 1.69 2.49 2.29 4.48 
5-9 1.69 2.49 2.29 4.48 1.69 2.49 2.29 4.48 
10- 14 1.70 2.50 2.30 4.50 1.70 2.50 2.30 4.50 
15 - 19 1.67 2.46 2.26 4.43 1.61 2.37 2.18 4.26 
20-24 1.47 2.17 1.99 3.90 1.24 1.83 1.68 3.29 
25 -34 1.00 1.47 1.35 2.65 0.68 1.00 0.92 1.80 
35 -44 0.35 0.52 0.48 0.94 0.17 0.25 0.23 0.45 
45 - 54 0.05 0.07 0.06 0.12 0.01 0.01 0.01 0.02 
55 - 59 0.01 0.01 0.01 0.02 0 0 0 0 
60-64 0 0 0 0 0 0 0 0 
65 + 0 0 0 0 0 0 0 0 
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Chapter 9 
THE DETERMINATION OF THE GENE TI CALLY-SIGNIFICANT DOSE 
The final results were obtained with the aid of the formula stated in Chapter 2, paragraph 
2.2 ( equation 2.2). Procedures for the processing of the data in order to obtain a new set of 
data to be used in the formula, were described in Chapter 8. The GSD can be calculated for 
many different groups as well as the contribution of the different types of examinations. 
It can be stressed, however, that this is actually a weighted population dose from a year of 
radiological practice. The accumulated gonad doses were multiplied by a weighting factor, 
namely the child expectancy. 
9.1 General Determination 
The General Determination refers to the population as a whole. All the age-gender-
race groups, N kf> were used in this calculation (Table 8.8). These values were 
multiplied by the respective gonad doses (Table 8.6) and child expectancies (Table 
8.10). The GSD for the overall SA-population was thus calculated, namely 94.6 µGy. 
9.2 Determination within race groups 
The GSD was also calculated for the various races, using the tables mentioned in 9.1. 
The terms in the formula in Chapter 2 were a representation of a specific race only, 
when the GSD was calculated for that race. The results are shown in Table 9.1. 
Table 9.1 GSD within race groups. 
Asian Black Coloured White Overall 
population 
229.0 µGy 66.5 µGy 112.2 µGy 463.4 µGy 94.6 µGy 
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9.3 Determination within race-gender groups 
In a next phase, the GSD was calculated for the various race-gender groups, i.e. the 
terms in the formula in Chapter 2 were a representation of a specific race-gender 
group only, when the GSD was calculated for that group. The results are shown in · 
Table 9.2. 
Table 9.2 GSD within race-gender groups. 
Asian Black Coloured White Overall 
population 
Male 230.4 µGy 37.1 µGy 83.1 µGy 136.3 µGy 49.4 µGy 
Female 227.4 µGy 99.5 µGy 144.4 µGy 850.7 µGy 145.3 µGy 
9.4 Determination within race-gender-examination groups 
The contributions to the GSD from the various examinations were calculated for the 
population groups and the results given in Figure 9.14. Detailed results are 
enumerated in Appendix C. The GSD's due to the race groups were calculated 
according the following formula: 
LL N kt Pke Dkf ( race - examination group) 
GSD(race- examination)= _k_f -------------
LN kpk (race group) 
k 
(cf. equ. 2.2) and the percentage by 
GSD( ) 




The GSD's due to the race-gender groups were calculated according the following 
formula: 
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GSD ( race - gender - examination) 
LL N kt Pk£ Dk£ ( race - gender - examination group) 
- k £ 
L N k Pk ( race - gender group) 
k ' 
(equ. 9.3) 
( cf. equ. 2.2) and the percentage by 
GSD( ) 
GSD(race- gender- examination group) 1000/ percentage = x ,o. 
GSD ( race - gender group) 
(equ. 9.4) 
Factors like the change in child expectancy, change in socio-economic conditions and 
development in technology play a major role regarding the uncertainties of the GSD. 
These aspects are discussed in more detail on pages 179 and 180. It can finally be 
noted that although the population may be homogeneous, there would still be 
variation and variance in the individual determinations. 
(a) The contributions of the various examination types to the GSD of the overall 
population are presented in Figure 9 .1. 
Figure 9.1 Contribution of the various examinations to the GSD of the 
overall population. 
( 1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
Note: lntraven. pyelogr. also known as excretory urogram 
(b) The same presentation is being done for the various race groups (both genders 
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Figure 9.2 Contribution of the various examinations to the GSD of Asians. 
(1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinwn 
( 4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
Note: Intraven. pyelogr. also known as excretory urogram 
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Figure 9.3 Contribution of the various examinations to the GSD of Blacks. 
(1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs/ mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 












Figure 9.4 Contribution of the various examinations to the GSD of Coloureds. 
( 1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs I mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 










Figure 9.5 . Contribution of the various examinations to the GSD of Whites. 
( 1) Bifurcation ruteriograms and angioplasty 
(2) Peripheral ruteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
( 4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
Note: Intraven. pyelogr. also known as excretory urogram 
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( c) The contributions of the various examination types to the GSD of each of the race-
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Figure 9.6 Contribution of the various examinations to the GSD of Asian males. 
(1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen:. liver, spleen, kidneys, vessels, lymph nodes 












• = I ,___ _ __.~j:ii:: 1;Hi!Ei :!!i!Hi 
i[iiilii,..._ ______ _____.1:l[[[i!i 11 !illllf'I---T'""-,,=,.,.-------
rr ~ rn:rn immi, _ ____,.i,.i:;:,:,,!-,!,.1 ... 1,.i,.. 1.,1,11,1 ... 1,,1,,1 ... ,.1-------iH~H: !.,i!,!,i.i,!, •;=:=,= ''*''._ ----11l~l]: 1---------1111111 illilfll ~ rnm: . , .... ,.. lll!lll ••• i;.1·,:,1, •.1,,::.1' ••. i ... 1
ili!!ii i.', •.·1,:,,·,,.::.';,,,'].,.·i,,.;/,,.' ... i !Hi!!!: i,,'i,,;:,.'1,.':1,,·.1,.::·i,·,., 
20 -+--
r=-:, ~ •. ' •• ,'·,.',.'·,'· ••. ',,.'·,. · •.i i,.1,,1,,l,,l,,.1., :.!.i,,i,,i,i,f.i.i,. · · · · l!ill!l; j!;J]!i .l!iiO!M .Hi!iiiil ·- ····-·· i.11.1.1.l.i.!. 0+--+--f=~!--1------1µ=>4.=a+-+~--+__.µ.=+---l--4-_µ,c··~,l~'~1=···~1=+,~!!i!!'4!T---.+i,=4-T----+-,----+-T-T~~~.,,,T~TJ-I------I,, 
UPH 
~ i ~ 
Figure 9.7 Contribution of the various examinations to the GSD of Asian females. 
( 1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs/ mediastinum 
( 4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 














Figure 9.8 Contribution of the various examinations to the GSD of Black males. 
(1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs/ mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
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Figure 9.9 Contribution of the various examinations to the GSD of Black females. 
(1) Bifurcation aiteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
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Figure 9.10 Contribution of the various examinations to the GSD of Coloured males. 
( 1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
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Figure 9 .11 Contribution of the various examinations to the GSD of Coloured females. 
( 1) Bifurcation ruteriograms and angioplasty 
(2) Peripheral arte1iogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
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Figure 9.12 Contribution of the various examinations to the GSD of White males. 
(1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
Note: lntraven. pyelogr. also known as excretory urogram 
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Figure 9.13 Contribution of the various examinations to the GSD of White females. 
(1) Bifurcation arteriograms and angioplasty 
(2) Peripheral arteriogram and angioplasty (upper leg) 
(3) Lungs / mediastinum 
(4) Abdomen - liver, spleen, kidneys, vessels, lymph nodes 
Note: Intraven. pyelogr. also known as excretory urogram 
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( d) A comparison of the contribution to the GSD from the various race-gender groups for 
each radiological examination is presented in Figure 9.14. 
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Figure 9.14 Bar graphs showing GSD contribution by various radiological examinations. 
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Figure 9 .14 (cont.) 
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9.5 Determination of a special sub-group 
It was motivated in Section 8.1 why 30 out of 96 examinations were chosen for the 
calculation of the genetically-significant dose. In order to confirm that the 
remaining examinations could be ignored, an additional 8 examinations were 
chosen and their respective gonad doses calculated or estimated. 
In order to estimate the contribution of six of these examinations to the overall 
GSD, the gonad doses in Table 8. 7 were used, i.e. doses due to examinations of the 
skull, S-1 joints, knee, angiogram (head), spine tomography and cholangiogram/ 
cholecystogram. The GSD was obtained by comparing the respective average 
gonad doses in the various age groups with those of similar examinations regarding 
the contribution to the gonads and the sizes of the files, where the GSD's had 
already been calculated. A value less than 0.3 % of the overall GSD was thus 
obtained. 
The CT examination of the brain was chosen on account of the high frequency with 
which this procedure was requested. The average gonad doses for the various age 
groups were obtained in the same way as was explained in Chapter 8 (section 8.5). 
All values obtained were zero, however, and the contribution of this examination 
could therefore be ignored. 
Mammography was also chosen on account of the relative high frequency of the 
examinations. The low energy X-ray beam (25 - 60 kVp) is greatly attenuated by 
the tissue structures and the image receptor support. If a unit complies with the 
safety requirement that a mammographic image receptor support must limit 
transmission of the primary X-ray beam so that the exposure 5 cm beyond the plate 
of the receptor does not exceed 0.1 mR for each activation of the tube, the gonad 
dose is negligible (NCRP, 1980). 
It can therefore be concluded that the total additional contribution of the chosen 
sub-group is less than 0.3 % of the calculated overall GSD and that the contribution 
from the remainder of the examinations would be less than this. 
9.6 Evaluation of the South African results 
The examinations that make the largest contributions to gonad doses are summarised 
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in Table 9.3. It is illustrated clearly in this table that women are much more exposed 
to high risk examinations than men - not only regarding the high gonad doses 
involved, but examinations also occur more frequently. In these examinations, 
therefore, the ovaries often receive higher doses than the testes from abdominal X-
ray examinations which, moreover, are more frequently conducted on women than 
on men. The following examinations deserve serious attention: lumbar spine; 
intravenous pyelogram; salpingogram; and the barium enema. It is further indicated 
that by far the largest number of intravenous pyelograms and barium enemas, and 
salpingograms to a lesser degree, were performed on White women. The seriousness 
of these results are reflected in the final results. The real problem might be, 
however, the gross underprovision of radiology services to some of the other races. 
The individual contributions of the various examinations to the GSD of the race-
gender groups are presented in Appendix C. 
Table 9.3 Examinations with large gonad doses.* 
GONAD D OS ES (cGy) 
Male Female 
Examination > 0.7 > 3.0 No. Exam. > 0.7 > 3.0 
LUMBAR SPINE 0.792 
SACRUM 0.918 
HIP JOINT 1.478 31711 
MYELOGR.(LUMB.) 1.231 





3.096(0-0.Sa) 739 9.653 
CYSTOGRAM 2.925(>0.5-5a) 739 
5.505 7194 





PA&A 1.071(>5-15a) 201 
1.250 2554 
PELVIS 1.856 
* Age interval> 15 years, except where otherwise indicated in brackets. 























Bifurcation arteriogram and angioplasty 
Peripheral ruteriogram and angioplasty 
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In Appendix D, the frequency of examinations per thousand population as well as the 
genetically-significant dose from diagnostic radiology are compared regarding the 
various countries and it will be discussed in more detail under the graphical 
presentations in Figures 9.18 and 9.19. Figures 9.15 and 9.16 are graphical 
representations of the different race-gender groups regarding the examinations per 
1000 population and the GSD respectively . 
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Figure 9.15 Number of examinations per thousand population for the race-
gender groups in South Africa. 
The South African population is composed of four races and the distribution has 
already been discussed above under the heading "Geographical distribution of 
sample". The small number of examinations per thousand population as well as the 
small GSD of the Black population can be attributed to socio-economic grounds. In 
this regru·d the income per capita must be considered. The income per family 
member is dependent on the income earned and/or received and on the dependency 
ratio, i.e. amongst how many persons must this income be divided. In South Africa 
the per capita monthly income per population group varies substantially. At the time 
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of this survey, the highest income (Whites) being approximately three times larger 
than for Asian, five times more than Coloured and eight times greater than that for 
Blacks (Chief Directorate: Planning Support, 1992). The usual medical care is not 
readily available for the low income groups, especially for people in mral areas. 
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Figure 9.16 'qSD within race-gender groups. 
White Total 
It is observed that the examination frequency (Figure 9.15) is higher for the male 
groups than for the female groups. The opposite is tme, however, when the 
genetically-significant dose is considered (Figure 9.16). The only exception exists 
for the Asians where the GSD is slightly higher for the males. The higher GSD's can 
be attributed to the higher gonad doses to women in the majority of the examinations 
(Table 8.6). The GSD's for the various race-gender groups are given in Table 9.2 
where all calculations were perf01med with respect to a specific race-gender group. 
The female to male ratio is 0.99 for Asians, 2.68 for Blacks, 1. 74 for Coloureds, 6.24 
for Whites and 2.94 for the overall population. 
In order to compare the results of the South African survey with those of countries 
like Great Britain, the United States and France, the contribution to the GSD of each 
gender in a specific race group was calculated and is presented in Figure 9 .17. The 
female to male ratio of the GSD thus calculated is 0.87 for Asians, 2.39 for Blacks, 
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1.58 for Coloureds, 5.27 for Whites, 2.62 for the overall SA population, 1.04 in 1957 
and 0.89 in 1977 for Great Britain (Darby et al., 1980), 2.13 for the United States in 
1980 (NCRP Report No. 100, 1989) and 2.31 for France in 1982 (Maccia et al., 
1988). 
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Figure 9.17 Contribution by gender to the GSD. 
Except for the Asians (the same phenomenon was observed in the 1977 survey in 
Great Britain), the contribution of females to the GSD is always larger than that of 
males. This can be attributed to the fact that the largest proportions of examinations 
involve examinations of the abdomen, pelvis and lumbar spine. In these areas the 
doses to female gonads are much larger than those to the male gonads. 
A tendency is observed that the contribution of females to the GSD is much larger 
than that of males. The only exceptions are the 1977 survey in Great Britain and for 
the Asian population group with a remarkable correspondence of the female to male 
ratio's, namely 0.89 for Great Britain and 0.87 for Asians. It is further observed that 
the contributions of the males and females to the GSD for Coloureds are in good 




Contributions of White and Asian males resemble those of the United States and 
France, while the value of Asian females is between those of Great Britain on the 
one side and the United States and France on the other. The small GSD 
contributions of the Black population can be attributed to socio-economic conditions 
and the large GSD due to White females was caused by the exceptionally large 
contribution of the barium enema examinations. 
Figure 9 .18 is a graphical display of the frequency of the examinations and Figure 
9.19 represents the genetically-significant dose of various countries. The values 
were obtained from Appendix D. It is observed that Iraq has a rather low 
examination frequency but the GSD is the highest of all countries. The child 
expectancy could be a cause for this feature, but high gonad doses administered 
during X-ray examinations could be a more probable cause. Sweden has a relatively 
low examination frequency but a high GSD too. The same is true for the White 
South African population. It has already been indicated that barium enema 
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Figure 9.19 The genetically-significant dose for various countries. 
The genetically-significant dose is a useful index for comparing the radiation safety 
of practices in the various countries as well as in cases of follow-up studies. South 
Africa compares favourably with other countries, except in the case of White 
females. Certain factors must be kept in mind, however, when the results of the 
various countries are compared. Comparison of organ dose data with results from 
similar surveys indeed indicates great discrepancies for certain organs and 
examinations (Wall et al., 1980 and ICRP, 1982). This must be due at least in part to 




The need for particular biomedical studies may arise in many ways. These studies may be 
triggered, for example, by observation of interesting cases or may be instigated by a 
government agency in response to a question perceived to be of national importance. In 
view of the information being unavailable, the South African Forum for Radiation Protection 
recommended that a research project to dete1mine the genetically-significant dose from 
diagnostic radiology for the South African population should be pe1f ormed. 
The need to evaluate the data statistically forces an investigator to sharpen the focus of the 
study. Intuitive ideas need to be translated into an analytical model capable of generating 
data that may be evaluated statistically. Many different studies may have to be considered in 
order to answer a given scientific question. As regards the present study, it was necessary to 
devise a suitable sampling method of institutions involved in radiological practice in South 
Africa. After due consideration, a novel and unique approach to sampling for the purpose of 
GSD dete1mination was employed, namely the Dollar Unit Sampling method, developed for 
the auditing profession. 
An acceptable sample and sampling procedure should comply with the following properties: 
(a) The size of the sample must be sufficiently large in order to represent the sample 
variation. 
(b) The sample should be representative of the temporal position ( conditions at that 
specific period as services may deteriorate or improve or types of examinations may 
change). 
( c) The sample must not be taken during sh011 tem1 changes of the prevailing conditions 
(for example, political upheaval or work stay-aways). 
( d) The sample should be representative of the geographical position. 
( e) The sample should be representative of the development regarding applied technology 
(for example the improvement of X-ray units and the implementation of MRI and CT 
scanning). 
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The survey presented in this thesis as well as other survey methods mentioned in Chapter 5 
can be evaluated by consideration of these properties, and each one is considered separately. 
(a) Sample size 
For the South African survey, a sample of 27 institutions out of a possible 292, 
namely 9%, was drawn. The sample was drawn by consideration of the number of 
examinations performed in one year (1988). The sample of 27 institutions 
represented a total of 27696 examinations performed over a period of one week at 
each institution. This week was chosen during the second half of 1990 or during the 
first half of 1991. The total number of examinations performed during 1988, namely 
5576235, was divided by 52 in order to obtain 107235 examinations per week and it 
was assumed that this rate of examination was the same for the period when the 
survey was done. Therefore, 27696 examinations out of a possible 107235 
examinations represents 25. 8% of all the examinations per week in a recent and 
typical year and although the sample drawn represented only 9% of the number of 
institutions, it represented a much larger 25.8% of all the examinations performed 
during a specific week. This must be expressed as the percentage per week since the 
survey was done over periods of one week and effectively randomly throughout the 
year. The resulting sample was thus well representative of the prevailing conditions 
over a complete calendar year. 
It can be concluded that the South African survey was quite comprehensive in 
comparison with surveys that were done in the following countries: 
In France, 386 out of a possible 4958 institutions (8%) were drawn but technical data 
from 13000 X-ray examinations per week was collected only. This number 
represented only 1.49% of the total number of an estimated 873077 examinations per 
week (Maccia et al., 1988). A similar result was obtained in Great Britain where 112 
out of a possible 1431 hospitals were drawn (8%) while 81 ( 5. 7%) consented to take 
part in the survey, but only information supplied by 77 (5.4%) could be used (Kendall 
et al., 1980). Technical data from 15% of the total number of an estimated 457692 
examinations per week was obtained (Wall et al., 1984). Gonadal dose 
measurements were made on a total of 4565 patients (examinations) covering the 13 
selected types of diagnostic X-ray examinations (Wall et al., 1980), i.e. 0.019% of the 
annual number of examinations or 1 % of the number of examinations per week. 
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In Czechoslovakia (Bohemia, 1965 - 1966), a breakdown of the examinations by age 
was obtained for 253853 examinations over one year, i.e., only 6.4% of the annual 
number of examinations (UNSCEAR, 1972). For Finland 143000 examinations out 
of the annual 2. 7 million examinations were recorded over a period of 4 weeks, i.e. 
5.1 % of the annual number of examinations and 69% of the number examinations 
during the month of the sampling. No sampling process was implemented, however, 
since all medical institutions were requested to supply details of radiological 
examinations (UNSCEAR, 1972). 
In New Zealand (1969) a survey, in which details of 40000 radiological examinations 
were collected and analysed, represented 3.5% of the annual number of examinations 
(UNSCEAR, 1972). The total number of patients radiographed in all centres in 
Thailand was requested for Janua1y 1970 and the 56% return represented some 45% 
of the estimated number of examinations carried out monthly. Although this value 
seems high, a very low frequency of 30 examinations per year per thousand persons 
was reported. Since there was such a relatively small number of X-ray examinations 
conducted in Thailand, it could be expected that the percentage of examinations per 
month in the sample would be large (UNSCEAR, 1972). For Yugoslavia the total 
number of radiographic and fluoroscopic examinations was determined during 1960 
for all the institutions in Slovenia. The annual information on a 25% sample of these 
examinations was obtained in te1ms of age, sex and type of examination (UNSCEAR, 
1972). 
In comparison with studies in other countries and regions it may be concluded that the 
South African sw·vey was of sufficient size. 
(b) Temporal position 
It is essential to keep in mind that results refer to the time at which the survey was 
done. Services may deteriorate or improve or the types of examinations may change 
with time. It was found that during the 1977 survey in the UK (Kendall et al., 1980) 
that the frequency of bronchography, chest tomography and mass miniature chest 
radiography has fallen dramatically compared with the 1957 results (Kendall et al., 
1980). A sharp fall was also found in the frequency of chest fluoroscopy (Kendall et 
al., 1980). The same results were obtained from Sweden (UNSCEAR, 1977). It may 
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be assumed that these changes were mainly associated with the declining prevalence 
of pulmonary tuberculosis and bronchiectasis. 
In the UK the advent of computerised tomography has been found to be associated 
with a significant drop in the number of cerebral angiographic examinations (Kendall 
et al., 1980). The increased number of films per barium examinations (barium 
enemas in particular) compared to that of 1957, was presumably associated with the 
incr~ased diagnostic information afforded by the double contrast techniques 
developed since that time (Kendall et al., 1980). 
Details regarding radiological examinations were collected over periods that range 
from one week to one year for the 16 countries or regions described in Chapter 5. It 
would be the ideal condition if results could be obtained for a full year since the 
genetically-significant dose refers to one year. This is impossible, however, when 
detailed information is required as for the local survey. The additional workload 
would be too much of a burden to radiological practices if such a survey had to be 
carried on for a longer period than one week, and was clearly demonstrated on many 
occasions in the present study. 
( c) Short term changes 
Short term changes, like political upheaval and work stay-aways, may occur in any 
radiological practice and results thus obtained, would not be totally reliable. In Great 
Britain and in France, data was collected over a specific one-week period. In order 
that short term changes were minimised, the survey in South Africa was done over 
one week, effectively randomly chosen, during the second semester of 1990 or the 
first semester of 1991 for all X-ray units at a particular institution. By so doing the 
effects of sh01t te1m changes were minimised. 
( d) Geographical distribution of sample 
The Dollar Unit Sampling is a special case of probability proportional to size-
sampling (PPS-sampling). In the present study all the large institutions (>200000 
examinations per year) were included in the sample and the other institutions were 
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drawn proportionally. The large hospitals are situated in the more densely populated 
areas and this sampling method would ensure that the probability to be drawn, would 
be the largest for the large institutions. It was expected that the more dense 
distribution of examinations being drawn for the sample would appear in the more 
densely populated areas. The results obtained in this way were exactly in agreement 
with the expected values. This is illustrated in Figure 7 .1. 
The vast majority of the 986620 Asians (Population Census 1991, 1992) are Indians 
and more than 11000 are Chinese. More than 80 per cent of Indians live in Natal 
with the majority in a radius of 150 km from Durban of which 90 per cent of the total 
are urbanised (South African Profile, 1991). The Coloured community of 3285719 
(Population Census 1991, 1992) is mainly settled in the Cape Province. About 85 per 
cent of the total Coloured population live in the Cape Province, mostly in the Cape 
Peninsula and vicinity and 78 per cent of the total have been urbanised (South African 
Profile, 1991). Considering the density of the sample distribution in Figure 7.1, it is 
evident that these two large groups were well represented in the sample since the 
respective areas constitute the second and third largest sample density areas. The 
other races are dish·ibuted over the country as a whole while the sample and 
population densities are in good coITespondence. The effectiveness of the Dollar Unit 
Sampling method is herewith clearly illustrated. 
The various previous surveys made use of the number of examinations available 
(Maccia et al., '1988; UNSCEAR, 1972 and Vafi6 et al., 1989). In the Netherlands 
insurance companies were approached to derive the annual total number of 
examinations. Although it was stated that the samples were geographically scattered 
(UNSCEAR, 1972), certain factors like the density of the population distribution 
must be taken into account when a random sample is being drawn and it is therefore 
difficult to understand how it is possible to obtain a sample in this way that is a good 
representation of the population. 
In Chapter 5 (Section 5.5) the national surveys that were done in the United States 
during 1964 and 1970 were discussed. The sampling procedure was thus population-
based, rather than institution-based as was the case in Germany, Yugoslavia, Finland, 
Great Britain, United States of America, Russian Republic, Czechoslovakia, Japan, 
New Zealand, Thailand, France, Spain and the cmTent survey. However, it is 
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arguable whether a population-based sampling procedure would yield a more 
representative sample than an institution-based sampling procedure. 
In 1957 in Great Britain, the Adrian Survey used information from a random sample 
of about 25% of the hospitals in the country to estimate the total number of 
examinations that took place (Wall et al., 1984). In the 1977 survey the workload at 
radiology depru1ments was described in terms of radiography units where each unit 
represents approximately one minute of a radiographer's time. 
The returns regarding the radiography units of the English hospitals were stratified 
according to workload ranges as detailed in Table 5.1. By using a standard 
stratification sampling technique (Kendal et al., 1980), the sample consists of 78 
institutions. However, a single hospital that had a workload of more than 2 million 
units per year, although not being prut of the sample, was nevertheless included in the 
survey. Considerations of prop01tional sampling would suggest that it is better to 
include this one exceptionally large hospital rather than to reject it. The Dollar Unit 
Sampling method automatically included the large institutions which performed large 
numbers of diagnostic examinations. 
In Wales, as discussed in Chapter 5, no sampling technique was used, and the 5 
pruticipant hospitals were selected informally. The same sampling procedure as that 
~sed for English hospitals was used for Scottish hospitals. 
Although a sufficient geographical representation should be obtained by means of 
simple random sampling or the stratified sampling method, Dollar Unit Sampling is a 
simple method that may yield a more representative sample. 
In France, the survey was conducted in two phases. Firstly, about 500 institutions 
were selected based on a rough evaluation of their annual film utilisation. As a 
second phase, in order to estimate the total number of X-ray examinations done 
annually as well as certain technique factors, a questionnaire was sent to a sub-sample 
selected among the X-ray units that equipped the radiological departments mentioned 
above (Maccia et al., 1988). The survey was done in June 1982 over a period of one 
week. No special provision was made for good geographical representation. 
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For Spain, data was available from all the Autonomous Communities through the 
Directorate General of the National Institute of Health (Vafi6 et al., 1989). Although 
the communities Andalucia and Catalufia were excluded the available examinations 
constituted 67% of the population in Spain which should be a good representation of 
the total population (Vafi6 et al., 1989). It appears that a good geographical 
representation was obtained since data was available from all the Autonomous 
Communities through the Directorate General of the National Institute of Health. 
Diagnostic radiology performed in any of the 36 centres of the Department of 
Defence or in local administration centres were not included, however, but one of the 
participating hospitals in the project was the Gomez Ulla Central Military Hospital 
(Vafi6 et al., 1989). It would therefore in futme be possible to obtain some 
parameters in relation to diagnostic radiology at this type of centre. It was also most 
difficult to obtain data from the private sector. 
(e) Development in applied technology 
This aspect is reflected in Table 8.1 smce it is an indication of the types of 
examinations that are applied as well as the technology involved in South Africa. It is 
the responsibility of the Directorate: Electromedical Devices and Radiological Health 
of the Department of Health to license all new X-ray units in South Africa. From.this 
information it can be dete1mined that the latest and most advanced technology is sold 
in South Africa. For examinations like heart catheterisation and computerised 
topography, the most recent techniques are applied involving new and advanced 
equipment. This was the state of affairs at the time of the survey dming 1990 / 1991. 
Due to budgetary constraints, there has been a tendency since 1993 to import second 
hand equipment that are three to five years old. This could cause a negative effect on 
futme services, i.e., higher doses may be the result of second-hand units that are not 
of the same standard as new ones. 
Intensive study regarding the sizes of files (Table 8.1), the gonad doses associated with the 
various examinations (Table 8.6) as well as the estimated contribution to the GSD from 8 
additional examinations (Section 9.5), led to the conclusion that the examinations other than 
the chosen ones could be ignored. This was confirmed by the NRPB-Report of July 1980 in 
which it was stated that 13 examination types had been selected which probably contributed 
to at least 95% of the GSD (Wall et al., 1980). The NRPB collection, which forms a part of 
the 30 examinations chosen for the cmTent project, was composed of the following 
examinations: 
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• Foetal maturity 
• Pelvis 
• Lumbar spine and Lumbo-sacral joint 
• Pelvis, Lumbar spine and Lumbo-sacral joint combined 
• Intravenous pyelography (excret01y urography) 
• Upper femur, hip 
• Pelvimetry 
• Abdomen 
• Barium meal 
• Chest, heart and lungs 
• Barium enema 
• Cystography 
• Lumbar myelography 
A few examination types and institutions were ignored in the present South African survey 
since their contribution to the GSD was believed to be negligible. General Practitioners 
perform in the majority of the cases examinations of lungs and extremities only. All users of 
X-ray equipment must obtain a user's licence from the Department of Health and certain 
types of X-ray units supplied to general practitioners are often restricted to be used for lungs 
and extremities only. The contribution to the gonad dose from examinations of lungs and 
extremities is very small and can therefore be ignored. It can fm1her be stressed that the 
need to take their own X-ray films exists mainly for general practitioners in rural areas and 
that the workload is usually ve1y low. 
About sixty to seventy percent of the licence holders for the use of medical X-ray equipment 
in South Africa are dentists. Since the X-ray beam is ve1y well collimated and the X-ray 
output is relatively low, the gonad doses are ve1y low and no significant contribution to the 
GSD could be expected. Indeed, the contTibution to the GSD was determined in Great 
Britain in 1977 as 0.3 µGy (Darby et al., 1980). 
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Examinations perf 01m by chiropractors usually involve high gonad doses, but it was ignored 
because of the expected low frequency. Although the frequency of mass miniature chest 
examination~ is high, the contribution to the gonad doses are low for chest examinations, 
talcing into account the fact that shielding is always used during examinations. Examinations 
perform by specialists like physicians, 01thopaedic surgeons, urologists, surgeons, and 
gynaecologists will result in some instances in high gonad doses but low frequencies. These 
specialists often perform certain examinations in a theatre at a private hospital. The 
workload regarding the use of X-ray units in such hospitals is low. 
Table 8.2 illustrates that the wide variability in patient exposure is caused by the differences 
in technique factors. The standard deviations for the tube voltage (kV), focus-film distance 
(FFD) and the film sizes are estimated as 25% of the mean values, while that for the 
workload (mAs) and screening time (min.), more than 100% of the mean values. This 
phenomenon of excessively large standard deviations originates from the fact that some of 
the observed investigations contributed a small number of high values, for example 
workload (mAs) and screening time (min.). These mean exposures are transferred to the 
entrance and gonad doses. The choice of such parameters is partly dictated by the needs of 
the particular patient, partly by the limitations of the available equipment, and partly by the 
preferences and experience of the radiologists and radiographers conducting the 
examinations. 
It was not possible and meaningful to apply the uncertainties of the technique factors to 
certain procedures in order to obtain, for example, the uncertainty in GSD, due to the 
following reasons: 
(i) It would have been a ve1y complicated task since the uncertainties in the skin-entrance 
doses had to be calculated due to the uncertainties in the technique factors. These 
uncertainties calculated for skin-entrance doses as well as uncertainties of the technique 
factors have next to be applied in order to calculate the uncertainties for the gonad doses. 
These results could then be used in order to calculate the uncertainties for the GSD. 
(ii) The uncertainties in the calculation of the skin-entrance as well as the gonad doses 
depend on numerous factors and the relevant unce1tainties are unknown. 
(iii) The uncertainties of the population census as well as the child expectancy values are 
unknown. 
According to Wall et al. (1980), there is ample evidence from other surveys of diagnostic X-
ray techniques that if patient differences are eliminated by substituting a standard phantom, 
there still remains considerable variation in doses delivered by different practitioners. 
Operators of diagnostic X-ray equipment were asked to select their usual techniques for 
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conducting a particular examination on a well defined standard sized adult patient and 
exposure measurements were made and organ doses calculated for this standard 
patient. The more recent UK survey ce1iainly found that 2 orders of magnitude for a 
"standard" patient examination were not uncommon. Patient heterogeneity would 
consequently not appear to be the major cause for gonadal dose variability (Wall et al., 
1980). 
A parallel that could be drawn between the UK and SA is the assumption that diagnostic 
radiology contributes about 90% to the overall GSD of the population from all man-made 
sources of radiation exposure. It was dete1mined heuristically that a reduction as small as 
10% in diagnostic medical exposures could therefore have the same effect as the elimination 
of all the other sources (Wall et al., 1980). A relatively modest expenditure would 
consequently be required to obtain a significant reduction in medical exposure. On the other 
hand, to achieve this in the non-medical sector would ce1tainly be much more costly. Thus, 
by simply improving techniques in order to reduce unnecessruy exposures, a substantial 
reduction in the gonad dose to the population could be obtained without reducing the 
benefits of diagnostic radiology. The cost should be insignificant, however, compared to the 
investment to be made in radiological protection in other fields. 
It must be noted that the GSD for the SA population is 94.6 µGy; 463.3 µGy for Whites is 
the largest GSD when the races are considered separately; when even smaller sub-groups are 
considered making provision for the males and females, an extremely high 850.7 µGy for the 
White females is calculated (the second largest value is that for the Asian males, namely 
230.4 µGy). The barium enema contributes an alanning 432.4 µGy to the GSD of White 
females. 
Although the number of examinations per 1000 population in White and Asian males is 
' 
similar, the number in White females is 23% greater than that in Asian females (Figure 9.15) 
but the GSD in White females is some four times that in Asian females (Figure 9.17). When 
Figure 9.7 (Contribution of the various exruninations to the GSD of Asian females) is 
compared with Figure 9.13 (Contribution of the various examinations to the GSD of White 
females), it becomes obvious that the barium enema is by far the largest contributing factor 
to the large GSD of the White female group. 
It can be seen from Table 8.8 that the number of barium enema examinations performed on 
White females differs distinctly from those perf01med on any other race group. For the 
Asian females, however, the number of those females in their reproductive age is zero. This 
is contrruy in what is to be expected since Asians and Whites have more or less the same 
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standard of health care. There is no obvious explanation but it could possibly be attributed 
to the geographical distribution of the population. In this chapter, under the heading 
"Geographical distribution of sample" it is indicated that more than 80 per cent of Indians 
live in Natal with the majority in a radius of 150 km. All groups and examinations should be 
well represented in the two large institutions that were drawn in this area. Regarding the 
barium enema's it appears, however, that Indian females prefer to consult Indian radiologists. 
Two large Indian practices exist in this area, but none of them was drawn for the sample. 
The demographic distribution in the Durban area has thus to be taken into account in a 
future survey. Such a value can possibly be estimated by increasing the frequency of barium 
enema examinations of Asian females proportionally with reference to the total Asian female 
and White female population. 
According to the ICRP Report 34 (1982), a typical skin dose (median value) in the primary 
beam is 1.5 cGy for radiography and the exposure due to fluoroscopy is 20 R (17.46 cGy in 
air) for a barium enema (ICRP, 1982). The NRPB (Wall et al., 1980) determined in their 
latest survey that the average screening time is 3.06 minutes with a lowest value of 1.35 
minutes and a highest value of 4.96 minutes. The mean ovru.y dose was determined as 1.66 
cGy to the ovaries for females older than 45 years of age (Wall et al., 1980). The value 
determined for South Africa is 16.1 cGy. High average tube voltages and mAs values (Table 
8.2) were obtained during the survey. The average fluoroscopy times (6. 74 and 6.13 
minutes) also seem exceptionally long, i.e., more than twice those quoted in the UK survey 
results published in 1980 (and also in 1986). 
Long screening times of barium enema's by radiologists at the beginning of their training 
period could actually provide only a small contribution to the average of the gonad doses 
and thus to the GSD of White females since they comprise only a small group relatively to 
the total group of practising radiologists. Personal communication with a previous head of 
the Department Gastrointestinal Radiology of one of the training hospitals in South Africa 
led to the conclusion that the contribution to the GSD is exceptionally high for Whites 
merely on account of better Health Care to them. The person was not aware of any statistics 
to confirm the existence of specific diseases to cause the higher frequency of barium enema 
examinations. It was remarkable to him that only a few examinations were requested for 
Black women over many years. An inherent aversion to such an examination and/or cultural 
values could make a contribution too. These arguments could also be valid with regard to 
the Coloureds and Asians. 
Two factors play a major role regarding the contribution, from various examinations, to the 
GSD of a population, namely the frequency and gonad doses. The number of barium enema 
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examinations per thousand population for all White females in South Africa is 9.6. The 
corresponding value obtained in the 1977 survey in Great Britain was 5.7 examinations per 
thousand (Kendall et al., 1980). The frequency of these examinations for the total 
population (males and females) in Great Britain was estimated as 4.8 examinations per 
thousand (Kendall et al., 1980). The values estimated for the total populations of France 
and the United States are 15.4 (Maccia et al., 1988) and 21.4 (NCRP, 1989) examinations 
per thousand population respectively. 
Although the frequency is less for Great Britain than for the White females in South Africa, 
its GSD is also less (Figures 9.17 and 9.19). For France and the United States the frequency 
is much higher, however, while the contribution to the GSD is not as large as that of the 
White females in South Africa. It can therefore be concluded that the frequency of the 
barium enema examinati~ns is not the cause of the exceptionally high GSD of white 
females. The large doses involved in barium enema's are likely to be responsible for the 
large contribution of this type of examination to the GSD of White females. 
The reason for the higher gonad doses with regard to values obtained in the literature, for 
example 16.1 cGy for South Africa compared with 1.66 cGy for the UK, is not obvious. An 
attempt should be made, however, to use technique factors that would result in lower 
entrance and gonad doses. This aspect is discussed on page 181. 
It is meaningless, however, to treat a dose as an index of risk in isolation from the benefits 
resulting from an examination. Therefore, if a high dose examination is associated with high 
quality information the benefits may outweigh the risks. Alternatively, a low dose 
examination may produce minimal infonnation with little or no benefit to the patient. 
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Conclusions 
The following aspects may be referred to regarding the way it may affect future results with 
regards to the GSD. 
(a) Demographic changes like child expectancies, will have certain definite results on the 
composite SA population. One of the main policies of the new South African 
government is the upliftment of the living standards of the entire population to 
acceptable levels. It is a well known fact that an improvement in living standard causes 
a decrease in the child expectancy. Inspection of equation 2.2 in Chapter 2 shows that 
a decrease of the child expectancy would affect the genetically-significant dose. 
(b) Other factors may also play a major role to obtain different results than that is to be 
expected. The Department of Health has five requirements for an applicable health 
service - all services should be accessible, efficient, acceptable, affordable and 
equitable (DNHPD, 1992). Previously, large amounts of money was made available 
for advanced and expensive medical equipment and other specialised projects. At the 
present the Department strives for a health service, however, that is acceptable to the 
community and which addresses their real needs. Special attention is paid to the poor, 
the elderly and the children. Plimary health care (PHC) is therefore focused on the 
elimination and control of preventable diseases and deaths. Primary health care, which 
is directed particularly at prevention, must bring basic health services as close as 
possible to users. 
In a special document the Health Priorities contained in the Reconstruction and 
Development Programme (RD.) are categorised, however. In this document 
specialised equipment, pruticularly expensive technology, enjoys a low priority. This 
policy, together with the economic climate, apparently precludes the possibility of an 
increase in the use of X-ray units and thus an increase in the GSD for at least during 
the next decade. 
Another outcome of the Reconstruction and Development Programme is free medical 
care to pregnant women and children up to six years of age as well as the intention to 
make mobile X-ray units available for the diagnosis of tuberculosis. The latter aspect 
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is still in the planning phase, however. Free medical care could be a cause for more 
exposure to X-rays, especially in urban areas, and could thus result in an increase in 
the GSD. It is not expected that the tuberculosis examinations would cause a 
significant increase in the GSD due to the low doses to the gonads during chest X-ray 
examinations. 
(c) The development in technology must always be taken into account. Newer techniques 
and technology may be the cause for higher patient doses, for example in the 
application in double contrast techniques (with the resulting increase in frequency) and 
digital subtraction angiography (DSA) as used in cardiac catheterisation. The 
development in technology would more often be the cause of lower patient doses by 
introducing, for example, more sensitive image intensifiers and rare earth film/screen 
combinations. The new generation high frequency X-ray generators can deliver an 
excellent X-ray output in order to obtain radiographs of a very good quality. The 
resulting decrease in the requirement to repeat some of the exposures would therefore 
be the cause of a lower patient dose. 
( d) The types as well as the frequency of examinations are also determined to a certain 
degree by the expectations and perceptions of individuals. Medical practitioners have 
in many instances to be guided by patients regarding the symptoms if an illness and 
thus the requests for X-ray examinations. It can therefore be concluded that the GSD 
is also determined by the expectations and perceptions of individuals. 
( e) The ideal is that conditions should be the same for all race groups, that is, the RDP 
should result amongst others in the same GSD to the four race groups. That could be 
theoretically obtained only over a very long period (e.g. over a few decades). No 
accurate forecast could thus be obtained, however, since it would be determined by 
various factors like the development in the technology, new radiographic techniques 
and the willingness of the government to invest in equipment in view of the available 
resources. There exists also no fwther scientific grounds to motivate why anyone of 
the other racial groups could serve as a model for the Black population in view of the 
changes in availability of health care. Both the Asians and Coloureds are 
predominantly concentrated in a single province and between 70% and 80% of these 
people are urbanised. The Black population, on the contrary, is distributed in dense 
populated urban areas, as well as in remote rnral areas over the country as a whole. 
This aspect as well as the low income per capita and limited amount of money 
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available from the government prevents the comprehensive upgrading of high 
technology equipment. None of the existing groups could therefore provide at the 
present time a model that will hold for the Black population under the envisaged 
improved health care conditions. 
Certain minor changes to the GSD may be obtained, however, by a future investigation 
of barium enema examination procedures. If the co-operation of radiologists could be 
obtained, the technique factors could be reduced with the resulting lower gonad doses. 
For technique factors like 85 kV and 58.3 mAs for the AP view; 90 kV and 80 mAs for 
PA; 95 kV and 100 mAs for the lateral view as well as a shorter screening time, say 
2.5 minutes, the skin entrance exposure could be reduced from 85.64 R to 26.29 R for 
screening (this value is in good agreement with the value that appears in the ICRP 
Report 34 (1982)). The gonad doses for males and females could thus be reduced to 
154.6 mrad and 5394.5 mrad respectively. For this calculation, the other quantities 
(technique factors) used, were exactly the same as appears in Table 8.2 for the barium 
enema, age group > 15 years (for the fluoroscopy calculations, the tube current was 
assumed to be 3 mA and the field size at the image intensifier as 25 cm x 30 cm). The 
average gonad dose of females in the >5-15 years age group was reduced in the same 
proportion as that of the >15 years age group, i.e., 3029.5 mrad. 
From Table 8.8 it is observed that the number of barium enema examinations 
performed on Asian females in their reproductive age is zero. This is contrary to what 
is to be expected since Whites and Asians have more or less the same standard of 
health care. If the frequency of barium enema examinations for Asians females is 
taken the same as for White females and the newly estimated gonad doses are used in 
all calculations, a future estimation of the GSD could be done. The new results 
obtained were Asians - 282.7 µGy, Black - 60.0 µGy, Coloured - 103.6 µGy and White 
- 330.4 µGy. The total GSD was calculated as 81.9 µGy. These estimated results are 
represented in Figure 10.1. 
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Figµre 10.1 Contribution by gender to the GSD (estimated values for South Africa). 
(f) The ideal is that the GSD should decrease or at least stay constant in subsequent 
studies. To state that ideally the GSD should decrease or at least remain constant, 
however, assumes that any increase in genetic detriment from an increase in provision 
of radiology services would not be outweighed by the concomitant improved health 
benefits to the population. The assumption is not self-evident, particularly for those 
sections of the South African population which currently experience poor living 
standards. By means of follow-up studies it could be determined whether or not 
techniques and circumstances have improved and examinations where special health 
risks are involved, can be identified. This ideal could be pursued within the scope of a 
study like this and a future similar study is therefore recommended. 
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Appendix A 
Al Survey form (short form) 
A2 Instmctions (sh01t fo1m) 
A3 Survey form (detail fonn) 
A4 Instructions (detail fo1m) 
A5 Diagnostic X-ray examinations 
A1 Survey form (short form) 190 
DEPARTMENT OF NATIONAL HEALTH AND POPULATION DEVELOPMENT 
Institution: Room: 
Unit(Make & Model): _______________ _ Date:~~~~-~------~-----~ 
File number: CDU(yes or no): --------------
Patient Examination Age Weight *CODE or jGonad Screening #Radiograph(R) No. of exp. Retake views 
number CODE (years) (esti- Sex Race lshield time or (Radiograph / (e.g. AP; 
( 1 ; 2; (If not mate) (M ~~;~~ ~~~;~;~~e~r Cut film ( C) Cut film/Cine) LAT; etc.) etc.) listed, or ( in min.) or or CT cuts 
name exami- (kg) F) Coloured ( C) ~~~~ N) Cine film per (if any) 









*Anyone of the two columns may be used if a code is used for sex and race. 
# If the cassette(s) is(are) divided, e.g. when strips or spot films are taken, the size(s) of cassette(s) and 






A2 Instructions (short form) 191 
I N S T R U C T I O N S 
1. Complete the form in pencil (in order to make changes easily if necessary). 
2. The column headed "No. of exposures" must include all retake views as- well as all sub-division exposures. 
For Computerised Tomography the length of the patient scanned ·for the overview film must be put in brackets 
after the number of CT cuts. 
3. An example of a partially completed form can be seen below. 
DEPARTMENT OF NATIONAL HEALTH AND POPULATION DEVELOPMENT 
Institution: Room: -------------------Unit(Make & Model): ---------------- Date: -------------------File number: CD U (yes or no): --------------
Patient Examination Age Weight *CODE or }Gonad Screening Radiograph(R) No. of exp. Retake views 
number CODE (years) (esti- Sex Race •shield time or (Radiograph / ( e. g·. AP; 
( 1 · 2 · (If not mate) (M Asian (A)lhised Cut film (C) Cut film/Cine) LAT; etc.) , , 
etc.) listed, or Black (B)l(Y or ( in min.) or or CT cuts 
name exami- (kg) F) Coloured(C)I N) Cine film per (if any) 







.. :: .. :::: 
~~ 
~ 
See overleaf for CODES 
··-- ·- r-
A3 Survey form (detail form) 192 
DEPARTMENT OF NATIONAL HEALTH AND POPULATION DEVELOPMENT 
Institution: Room: ______________ _ 
Unit(Make & Model): ________________ _ 
File number: 
Date: ----~----------CD U (yes or no): ________ ~ 
Pat. Exami- Age Weight * CODE or fa}Gonad Screen- #size of No. of Retakeff: T E C H N I Q u E 
no. nation (esti- Sex Race lshield ing cassette exposures views ~\l and/ and/ and/ Au-
( 1 , 2; CODE mate) (M Asian(A)lused time (cmxcm) (X-photo/ (e.g. f or or or to 
etc.) (If no or Black(B)l(Y or (in or Cut Cut film/ AP; @~iew kV Time mA mAs FFD (Y 
code, (kg) F) Colour- ti N) min. ) film (C) Cine) or LAT; ~\\e.g. per ( cm) or 
name ed( C >Ml or Cine CT cuts etc. ) :(:~P; exp. N) 
exam.) White(W)l!!fl (35/70) per exam. ~~;etc. ( s) 
ii 











*Anyone of the two columns may be used if a code is used for sex and race. 
# If divided, note fraction in brackets after the film size, e.g. 24 x 30 (1/4). 
A4 Instructions (detail form) 
I N S T R U C T I O N S 
1. Complete the form in pencil (in order to make changes easily if necessary). 
2. The section under the heading "TECHNIQUE" may be ignored should it be difficult to provide the required 
information (e.g. in the case of radiographs taken during screening procedures of Ba enemas). 
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3. The column headed "No. of exposures" must include all retake views as well as all sub-division exposures 
for specific technique factors. For Computerised Tomography the length of the patient scanned for the 
overview film must be put in brackets after the number of CT cuts. 
4. An example of a partially completed form can be seen below. 
DEPARTMENT OF NATIONAL HEALTH AND POPULATION DEVELOPMENT 
Institution: Room: ______________ _ 
Unit(Make & Model): Date: ------------------File number: ------,-----------· CDU(yes or no): ________ ~ 
* CODE or :@:Gonad Screen- ff Size of ii No. of ii Retake=~=~ T E 
Sex Race f]shield ing casse .. _ .. · 
(M Asian(AH@used time (cmxc ·· 
Pat. Exami- Age Weight 
no. nation (esti-
( 1 , 2; CODE mate) 
.J.1 
~ reen-!! rr  fll .  
_ .. tte exposures 
m) 11 (X-photo/ 
C H N I 0 u E 
and/ and/ and/ Au-
or or or to 
or Black(B)l(Y or (in or Cu 
F) Colour- I N) min.) film .. 
ed(C)I or Cine· 
White(w)I (3511u1i. 
I lri! illi I 
II I I I I I 1l:::::: ~~~1 I I I I I I II 
: I I : 
etc.) (If no 
code, I I (kg) name 
exam.) 
t II Cut film/ 
( C) 11 Cine) or 
, __ , II CT cuts 
... per exam. 
Time mA mAs FFD (Y 
per (cm) or 
exp. N) 
(s) 
See overleaf for CODES 
AS DIAGNOSTIC X-RAY EXAMINATIONS 
A. GENERAL EXAMINATIONS B. SPECIAL EXAMINATIONS 
HEAD 
Al SKULL 
A2 SELLA TURCICA 
A3 ORBITS 
A4 SINUSES 
AS FACIAL BONES 
A6 MASTOIDS 






Al2 CERVICAL SPINE 
Al3 TIIORACIC SPINE 
Al4 LUMBAR SPINE 







B2 AIR ENCEPHALOGRAM 
B3 MASTOID TOMOS 
SPINE 
B4 MYELOGRAM (CERVICAL) 
BS MYELOGRAM (TIIORACIC) 
B6 MYELOGRAM (LUMBAR) 
B7 DISCOGRAPHY 
BS SPINE TOMOGRAPHY 
CHEST 
B9 AORTOGRAM 
BIO BARIUM SWALLOW 
Bl 1 BRONCHOGRAM 
B12 MAMMOGRAM 
Bl3 TOMOGRAPHY (LUNGS) 
B14 HEARTCATHETERISATION 
BIS SCREENING OF DIAPHRAGM 
ABDOMEN 
AIS STERNUM B16 AORTOGRAM 
A19 STERNOCLAVICULARJOINTS B17 ARTERIOGRAMS: MESENTERIC, 
A20 MASS- MINIATURE RENAL, HEPATIC 
BIS CHOLANGIOGRAM, CHOLECYSTOGRAM 
ABDOMEN B19 RETROGRADEPYELOGRAM 
A21 ABDOMEN SURVEY 





A26 S-I JOINTS 
JOINTS AND EXTREMITIES 






A33 HIP JOINT 






A40 PEL VIMETRY 
B20 INTRA VENOUS PYELOGRAM 
B21 EMBOLISATION, LITHOTRIPSY, 
NEPHROSTOMY 
B22 BARIUM MEAL· 
B23 ECRP 





B2S BARIUM ENEMA 
B29 HIP TOMOGRAPHY 
B30 HIP OPERATIONS 
B31 BIFURCATION ARTERIOGRAMS I 
ANGIOPLASTY 
B32 L YMPHANGIOGRAMS 
JOINTS AND EXTREMITIES 
B33 ARTHROGRAM (SHOULDER) 
B34 ARTHROGRAM (ELBOW) 
B3S ARTHROGRAM (HIP) 
B36 ARTHROGRAM (KNEE) 
B37 PERIPHERAL ARTERIOGRAM AND 
ANGIOPLASTY (UPPER LEG) 
' 
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B3S PERIPHERAL ARTERIOGRAM AND 
ANGIOPLASTY (LOWER LEG) 
B39 L YMPHANGIOGRAPHY: _TOTAL 
LEG 
B40 VENOGRAPHY: LOWER LEG 
B41 ARTEROGRAPHY: UPPER LEG 
B42 SCREENING OF EXTREMITIES 
FOR REDUCTION OF FRACTURES 
DISLOCATIONS 
B43 SCREENING UPPER LEG (FEMUR) 
B44 EXTREMITY TOMOGRAPHY 
C. COMPUTER TOMOGRAPHY 
Cl BRAIN 
C2 ORBITS 
C3 FACIAL BONES I SINUSES 
C4 PETROUSBONE/AUDITORY 
CANAL 
cs CERVICAL SPINE 
C6 TIIORACIC SPINE 
C7 LUMBAR SPINE 
cs LUNGS/ MEDIASTINUM 
C9 ABDOMEN - LIVER, SPLEEN, 
KIDNEYS, VESSELS, LYMPH NODE 
CIO PELVIS 
Cll EXTREMITIES (KNEE, ETC.) 
C12 PITUITARY FOSSA 
SEE OVERLEAF FOR INSTRUCTIONS 
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Appendix B 
B 1 Database fields 
B2 Instructions 
B3 Film sizes for chest X-ray examinations (Al6) 
B4 Long bones 
B5 Pelvimetry 
B6 Field sizes (General) 
B7 Examinations where films are divided 
B8 Film sizes 
B9 Views 
B 10 Gender-race codes 
Bll Age 
































Cassettes - X . 






(Capacitor Discharge Unit: Y or N) 
(Patient number) 
(Examination code) 




[Asian (A); Black (B); Coloured (C); White (W)] 
(Describing patient's sex and race - see later) 
(Gonad shield: Y or N) 
(Screening time: in min.) 
(Size of cassette: X-axis) 
(Size of cassette: Y-axis) 
(Number of divisions of film) 
(Total number of exposures per examination) 
(Number of exposures per view) 
Field S: NoRetakePerView (Number of retakes per view) 
Field T: View (e.g. AP; LAT; etc.) 
Field U: kV 
Field V: Time 
Field W: mA 
Field X: mAs 
Field Y: FFD 
Field Z: Auto 
Field AA: SSD 
(Focus-Film Distance) 
(Automatic: Y or N) 
(Source-Skin Distance) 
B2 Instructions 
1. Number all the patients for a specific institution. 
2. Replace "No" with "0" and 
"Yes" with "l" at CDU; GShield; Auto. 
3. Replace in ExamCode: A with 1 
B with 2 
C with 3 
4. Replace the view: AP with 1 
PA with 2 
LAT (lateral) with 3 
OBL (oblique) with 4 
Overview (AP) scan (CT scanner) with 5 
Axial scan (CT scanner) with 6 
Overview (LAT) scan (CT scanner) with 7 
Cranio Caudal (CC) with 8 
Axilla with 9 
AP - Oblique with 10 
PA - Oblique with 11 
5. Press F2 to repeat a record (for Works spreadsheet only). 
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6. If "Cut film (C)" or "Cine film (35/70)", fill in only in the CassetteS-X-field the 
symbol "C" or "35" or "70". 
Short form: Fill in "R" in the CassetteS-X-field. 
For Axial scan (CT): Insert number of cuts in "NoExpPerView" 
Time in "Time"-column of database 
For Overview scan (CT): Fill in only in the CassettS-X-field (in cm) 
7. The sum of the number of "Retakes" must be subtracted from the total number of 
exposures and entered under "TotNoExp". 
When an exposure is repeated (entered under "Retake views"), press F2 (Works 
only). Enter the view and total number of exposures there. Each retake must 
have its own record. 
8. Ifit is not clear how the data must be entered, the form must be kept aside and 
the patient number and specific data marked. All data must be transferred as far 
as possible. 
9. Use a point instead of a comma in decimal fractions, for e.g. 0.006 instead of 
0,006. 
10. If something omitted, leave an open space ( do not insert a "O", etc.) 
11. Short form 
*Tot NoExp => total number of exposures minus retakes (nothing in NoExp 
column). 
*When more than one examinations are entered in a line, as well as retakes => 
ignore retakes and divide examinations according to TotNoExp. (If the number 
of retakes can be determined, however, it must be entered in the retake-column 
and the distribution of exposures being done according to TotNoExp with no 
retakes included in it.) 
B3 Film sizes for chest X-ray examinations (A16) 
Male: 
Fixed units: PA (35 x 43); LAT (35 x 43) 
Mobile units: AP (35 x43) 
Female: 
Fixed units: PA (35 x 35); LAT (30 x 40) 
Mobile units: AP (35 x 35) 
Children under JO years 
Film sizes are the same as for female. 
Always AP and LAT 
B4 Long bones 
Adults: A28 =:> (30 X 40) 1/i 
A30 =:> (24 X 30) 1/i 
A35 =:> (35 X 43) 
A37 =:> (35 X 43) 
Babies: A35 =:> (24 X 30) 
A28 =:> (24 X 30) 1/i 
or one big film: (35 X 43) 
B5 Pelvimetry 








( entrance field: 4 X 12 cm) 
LAT 1 X (35 X 43) 102 kV 
PA 1 X (35 X 35) 85 kV 
or 
Five views: AP 2 slit records 85 kV 
(entrance field: 4xl2cm) 
LAT lx(35x43) 102 kV 
PA lx(35x35) 85 kV 









B6 Field sizes (General) 




18 x 24 cm 
10 x30 cm 









B8 Film sizes 
2 full films + 2 films divided in 2 
1 full film + 1 film divided in 2 
1 film divided in 2 
1 film divided in 3 or 4 
1 film divided in 3 
1 film divided in 2 
1 full film + 1 film divided in 2 
1 full film + 1 film divided in 2 
inch x inch 
* 5 X 7 
*6 X 15 
8 X 10 
10 X 12 
12 X 15 
14 X 14 
14 X 17 
7 X 17 
* Do not exist in the metric system. 
( 6 exposures) 
(3 exposures) 
(2 exposures) 





cm x cm 
13 X 18 
15 X 38 
18 X 24 
24 X 30 
30 X 40 
35 X 35 
35 X 43 




Al2 and occasionally Al3: Flying => LAT 
Mammography: cc => AP? 
Macro => AP 
Dental P (Panorex) => p 
Al OM => PA 
OF => PA 
FO => AP 
Townes => AP 
SMV/Basal => AP 
Al2; A14; A33; B4; BS; B6; B7 Shoot through => LAT 
A12; A14 Flexion & Ex-
tension(stress) => LAT 
A14 Angle => LAT 
##### Stenvers => AP or PA 
##### Shillers(SHL) => LAT 
All oblique is AP-OBL except A3 and A8 Oblique => AP-OBL 
##### Open mouth => AP 
Lying on side; X-ray horizontal Decubitus => AP or PA 
Lying on back Supine => AP(orPA) 
Lying on stomach Prone => PA(or AP) 
CT scanner (surview; topogram; planar; pilot => overview scan) 
(a) spine & head Overview => LAT 
(b) abdomen & chest Overview => AP 
CT scanner (Pituitary fossa: pituitary gland in brain) Coronal => Angle 













































































CONTRIBUTIONS TO THE GSD FROM VARIOUS RADIOLOGICAL 
EXAMINATIONS USING TABLES 8.6, 8.8 AND 8.10 (SECTION 9.1). 
(M - male; F - female; A - Asian; B - Black; C - Coloured; W - White) 
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Note: Numbers at the top of each section of the table, refer to the contribution to GSD for the 
. overall population. · 
(I) CERVICAL SPINE (1) THORACIC SPINE 
0004 G µ1 ,y; 0 004 'Y< 0 0002 G µ1 ,y ; 0 002 o/c 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 0.01 0.006 MA 0.005 0.002 
FA 0.01 0.005 0.009 0.004 FA 0.008 0.003 0.01 0.005 
MB 0.004 0.01 MB 0.001 0.002 
FB 0.003 0.004 0.002 0.002 FB 0.001 0.002 0.001 0.001 
MC 0.005 0.007 MC 0.002 0.002 
FC 0.004 0.004 0.003 0.002 FC 0.003 0.003 0.005 0.003 
MW 0.03 0.02 MW 0.005 0.004 
FW 0.02 0.005 0.02 0.002 FW 0.02 0.004 0.04 0.004 
(3) LUMBAR SPINE (4) SCOLIOSIS X-RAYS (FULL SPINE) 
5 75 G µ iY; 6 08 °/c 0 040 G µ iy ; 0 42 °/c 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 0.96 0.42 MA 0.05 0.02 
FA 30.11 13.15 63.05 27.72 FA 0.10 0.05 0.17 0.07 
MB 0.12 0.33 MB 0.01 0.02 
FB 2.41 3.62 4.96 4.99 FB O.GI 0.02 0.01 0.01 
MC 0.50 0.60 MC 0.02 0.03 
FC 7.64 6.81 15.51 10.74 FC 0.10 0.09 0.19 0.13 
MW 1.74 1.28 MW 7.70 5.65 
FW 47.32 10.21 101.27 11.90 FW 6.95 1.50 6.06 0.71 
(5) LUNGS (6) RIBS 
0 G .11 µ iy ; 0 12 o/t 0 0 001 G µ iV ; 0 001 o/, 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (~1Gy) % I GSD (µGy) % GSD (µGy) % 
MA 0.11 0.05 MA 0.001 0.000 
FA 0.21 0.09 0.32 0.14 FA 0.001 0.000 0.001 0.001 
MB 0.05 0.13 MB 0.001 0.002 
FB 0.10 0.15 0.16 0.16 FB 0.001 0.001 0.001 0.001 
MC 0.07 0.09 MC 0.001 0.002 
FC 0.15 0.13 0.23 0.16 FC 0.002 0.001 0.002 0.001 
MW 0.11 0.08 MW 0.003 0.002 
FW 0.23 0.05 0.37 0.04 FW 0.004 0.001 0.005 0.001 
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(7) ABDOMEN SURVEY (8) PELVIS 
5 68 G ii ,y ; 6 00 o/c 0 IO 73 G µ ,y; 11 34 o/i 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (11Gy) % GSD (µGy) % 
MA 8.30 3.60 MA 49.51 21.48 
FA 15.67 6.84 24.01 10.56 FA 32.39 14.14 13.05 5.74 
MB 2.79 7.52 MB 11.50 30.97 
FB 4.45 6.69 6.31 6.34 FB 7.47 11.23 2.97 2.98 
MC 2.95 3.56 MC 26.43 31.81 
FC 7.51 6.69 12.53 . 8.68 FC 16.59 14.78 5.75 3.98 
MW 5.30 3.89 MW 65.13 47.79 
FW 19.10 4.12 35.45 4.17 FW 46.72 10.08 24.93 2.93 
(9) SACRUM (10) HIP JOINT 
0 7 G .2 µ1 iy ; 0 28 o/c 0 5 80 G µ ;y ; 6.13 o/c 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 1.41 0.61 MA 53.92 23.40 
FA 0.75 0.33 FA 29.66 12.95 2.23 0.98 
MB 0.12 0.32 MB 8.28 22.30 
FB 0.06 0.09 FB 4.63 6.95 0.54 0.54 
MC 0.33 0.40 MC 10.26 12.35 
FC 1.46 1.30 2.70 1.87 FC 6.70 5.97 2.78 1.92 
MW 0.33 0.25 MW 24.39 17.90 
FW 1.77 0.38 3.47 0.41 FW 15.12 3.26 4.14 0.49 
(11) FEMUR NECK (12) FEMUR 
005 G µ ,y ; 0 06 o/c 0 2 83 G µ y ; 2 99 'X 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 0.98 0.425 MA 13.41 5.82 
FA 0.53 0.23 0.01 0.006 FA 7.13 3.11 0.03 0.01 
MB 0.08 0.222 MB 5.05 13.59 
FB 0.05 0.08 0.01 0.014 FB 2.69 4.04 0.04 0.04 
MC 0.000 0.000 MC 4.29 5.17 
FC 0.000 0.000 FC 2.28 2.03 0.07 0.05 
MW 0.003 0.002 MW 7.95 5.83 
FW 0.001 0.000 FW 4.34 0.94 0.07 0.01 
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(13) MYELOGRAM (LUMBAR) (14) BARIUM SWALLOW 
0 G .60 J.li rv ; 0 63 o/i 0 159 G µ iY ; 1 68 o/i 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 0.07 0.03 MA 0.003 0.001 
FA 1.75 0.76 3.65 1.60 FA 0.09 0.04 0.19 0.08 
MB 0.01 0.03 MB 0.001 0.003 
FB 0.41 0.62 0.86 0.86 FB 1.52 2.28 3.21 3.23 
MC 0.05 0.07 MC 0.001 0.002 
FC 0.15 0.14 0.26 0.18 FC 0.009 0.008 0.02 0.01 
MW 0.13 0.10 MW 0.001 0.001 
FW 3.69 0.80 7.91 0.93 FW 5.25 1.13 11.46 1.35 
(15) HEART CATHETERISATION (16) AORTOGRAM (ABDOMEN) 
011 G µ1 rv ; 0 12 o/i 0 0 21 G ll' rV; 0 22 o/i 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA MA 
FA 0.17 0.07 0.36 0.16 FA 
MB MB 0.008 0.02 
FB 0.01 0.02 0.03 0.03 FB 0.004 0.006 
MC 0.16 0.20 MC 0.000 0.000 
FC 0.68 0.61 1.26 0.87 FC 2.61 2.33 5.49 3.80 
MW 1.51 1.11 MW 0.03 · 0.02 
FW 0.95 0.20 0.29 0.03 FW 0.36 0.08 0.74 0.09 
(17) RETROGRADE PYELOGRAM (18) INTRA VENOUS PYELOGRAM 
155 G ll' ry; 1 64 o/i 0 206 G ll' ry; 2 17 o/i 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 0.16 0.07 MA 1.12 0.48 
FA 10.48 4.58 22.14 9.74 FA 8.70 3.80 17.27 7.59 
MB MB 0.15 0.41 
FB 0.40 0.60 0.85 0.85 FB 0.60 0.90 1.10 1.11 
MC MC 0.31 0.37 
FC 1.58 1.41 3.32 2.30 FC 3.29 2.93 6.58 4.56 
MW 0.32 0.23 MW 2.38 1.75 
FW 16.46 3.55 35.57 4.18 FW 20.88 4.51 42.77 5.03 
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(19) BARIUM MEAL (20) KIDNEY TOMOGRAPHY 
0 83 G µ ,v ; 0 88 o/i 0 0 42 G µ y ; 0 44 o/i 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 0.13 0.06 MA 0.07 0.03 
FA 0.55 0.24 1.02 0.45 FA 0.32 0.14 0.60 0.26 
MB 0.02 0.05 MB 0.006 0.02 
FB 0.50 0.76 1.04 1.05 FB 0.10 0.15 0.20 0.20 
MC 0.04 0.05 MC 0.03 0.03 
FC 0.66 0.58 1.33 0.92 FC 0.68 0.61 1.41 0.97 
MW 0.22 0.16 MW 0.13 0.09 
FW 6.30 1.36 13.49 1.59 FW 5.07 1.09 10.92 1.28 
(21) CYSTOGRAM (22) URETHROGRAM 
14 39 G ll' ,y ; 1521 o/i 0 0 15 G µ ,v ; 0 16 o/. 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA 98.77 42.86 MA 
FA 80.28 35.06 59.38 26.11 FA 
MB 8.02 21.61 MB 
FB 11.01 16.54 14.35 14.42 FB 0.03 0.04 0.06 0.06 
MC 30.26 36.42 MC 3.02 3.64 
FC 26.40 23.52 22.15 15.34 FC 1.58 1.41 
MW 13.97 10.25 MW 0.53 0.39 
FW 30.25 6.53 49.53 5.82 FW 0.28 0.06 
(23) SALPINGOGRAM (24) BARIUM ENEMA 
18 98 G Jl ,v ; 20 07 o/. 0 20 49 G µ ,y ; 21 67 o/. 0 
RACE RACE-GENDER RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % GSD (µGy) % GSD (µGy) % 
MA MA 1.41 0.61 
FA 8.79 3.84 18.73 8.23 FA 0.75 0.33 
MB MB 0.18 0.49 
FB 19.16 28.80 40.63 40.83 FB 9.95 14.95 20.89 20.99 
MC MC 2.07 2.49 
FC 14.63 13.03 30.74 21.30 FC 13.00 11.58 25.04 17.34 
MW MW 3.46 2.54 
FW 25.04 5.40 54.68 6.43 FW 199.86 43.13 432.37 50.83 
(25) BIFURCATION ARTERIOGRAMS / 
ANGIOPLASTY 
O 19 G O 20 o/c U V; 0 
RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % 
MA 
FA 
MB 0.01 0.03 
FB 0.22 0.33 0.46 0.46 
MC 
FC 0.01 0.01 0.02 0.02 
MW 0.03 0.03 
FW 0.02 0.00 
(27) LUMBAR SPINE (CT) 
033 G µ iy ; 0 35 o/c 0 
RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) 
MA 0.03 
FA 0.58 .0.25 1.20 
MB 0.007 
FB 0.19 0.28 0.39 
MC 0.003 
FC 0.002 0.001 
MW 0.13 
FW 2.92 0.63 6.21 
(29) ABDOMEN - LIVER, SPLEEN, KIDNEYS, 
VESSELS, LYMPH NODES (CT) 










GSD (µGy) % GSD (µGy) % 
MA 
FA 
MB 0.03 0.08 
FB 0.22 0.33 0.44 0.44 
MC 0.15 0.18 
FC 1.70 1.52 3.41 2.36 
MW 0.18 0.13 
FW 1.50 0.32 3.07 0.36 
(26) PERIPHERAL ARTERIOGRAM 
AND ANGIOPLASTY (UPPER LEG) 
039 G 041 o/c µ, ,y ; 0 
206 
RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % 
MA 
FA 
MB 0.67 1.79 
FB 0.35 0.53 0.001 0.001 
MC 1.97 2.38 
FC 1.04 0.92 
MW 0.41 0.30 
FW 0.22 0.05 
(28) LUNGS / MEDIASTINUM (CT) 
000 G 1 U' iy ; 0 0 o/c .0 1 0 
RACE RACE-GENDER 
GSD (µGy) % GSD (µGy) % 
MA 
FA 
MB 0.000 0.001 
FB 0.000 0.001 0.000 0.000 
MC 0.000 0.001 
FC 0.006 0.005 0.01 0.008 
MW 0.002 0.002 
FW 0.01 0.002 0.02 0.002 
(30) PEL VIS (CT) 
0 28 G µ1 iy ; 0 29 o/c 0 
RACE RACE-GENDER 





MC 0.14 0.17 
FC 1.77 1.58 3.57 2.47 
MW 0.17 0.13. 
FW 2.77 0.60 5.84 0.69 
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Estimated annual frequency of examinations per thousand population and the GSD 
from diagnostic radiology (excluding mass miniature and dental examinations). 
Country Year Population Number of GSD Reference 
X 106 examinations (µGy) 
per 1000 
population 
Canada 1980 300 NCRP, 1989 
France 1982 55.4 820 295 Maccia et al., 1988 
Great Britain 1977 55 415 120 Darby et al., 1980 
India 1967 - 72 550 35 11 Darby et al., 1980 
Iraq 1972 10 158 520 Darby et al., 1980 
Italy 1974 55 363 300 Darbyetal., 1980 
Japan 1974 108 810 170 Darby et al., 1980 
Netherlands 1972 12.6 890 280 Darby et al., 1980 
Puerto Rico 1968 3 542 430 Darby et al., 1980 
Romania 1970 20.5 560 290 Darby et al., 1980 
Spain 1986 490 Van6 et al., 1989 
Sweden 1974 - 76 8.1 540 460 Darby et al., 1980 
Switzerland 1971 6.3 1350 430 Darby et al., 1980 
USA 1964 170 US Dept. Health, 1976 
USA 1970 195 200 US Dept. Health, 1976 
Darby et al., 1980 
USA 1970 669 US Dept. Health, 1976 
Wall et al., 1984 
USA 1980 307 NCRP, 1989 
USSR 1980-81 200 NCRP, 1989 
West Germany 1974 1.8 1530 410 Darby et al., 1980 
SA (Total)* 1990 - 91 31* 180 95 Present survey 
SA (Asian) 1990 - 91 1 379 229 Present survey 
SA (Black)* 1990 - 91 21.6* 102 67 Present survey 
SA (Coloured) 1990 - 91 3.3 246 112 Present survey 
SA (White) 1990 - 91 5.1 423 463 Present survey 
* The previous TBVC States (Transkei, Bophuthatswana, Venda and Ciskei) were not included 
(±6.6 million people): 
